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ABSTRACT OF DISSERTATION 
 
 
BIOSENSING SYSTEMS FOR THE DETECTION OF BACTERIAL QUORUM SENSING 
MOLECULES: A TOOL FOR INVESTIGATING BACTERIA-RELATED DISORDERS AND FOOD 
SPOILAGE PREVENTION 
 
Quorum sensing enables bacteria to communicate with bacteria of the same or 
different species, and to modulate their behavior in a cell-density dependent manner. 
Communication occurs by means of small quorum sensing signaling molecules (QSMs) 
whose concentration is proportional to the population size.  When a QSM threshold 
concentration is reached, certain genes are expressed, thus allowing control of several 
processes, such as, virulence factor production, antibiotic production, and biofilm 
formation. Not only many pathogenic bacteria are known to produce QSMs, but also 
QSMs have been identified in some bacteria-related disorders. Therefore, quantitative 
detection of QSMs present in clinical samples may be a useful tool in the investigation 
and monitoring of bacteria-related diseases, thus prompting the use of QSMs as 
biomarkers of disease. Herein, we have developed and utilized whole-cell biosensing 
systems and protein based biosensing systems to detect QSMs in clinical samples, such 
as, saliva, stool, and bowel secretions. Additionally, since bacteria are responsible for 
food spoilage, we employed the developed biosensing systems to detect QSMs in food 
samples and demonstrated their applicability for early identification of food 
contamination. Furthermore, we have utilized these biosensing systems to screen 
antibacterial compounds employed for food preservation, namely, generally regarded as 
safe (GRAS) compounds, for their effect on quorum sensing.  
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CHAPTER ONE 
INTRODUCTION 
 
 
Cutting edge scientific and technological research has given rise to a gamut of 
new analytical tools that were previously unimaginable. With advancements in genetic 
research, an understanding of the workings of DNAs, RNAs, and proteins of prokaryotes 
as well as eukaryotes developed. Techniques of molecular biology have been used to 
manipulate and investigate these biological elements. A few of these techniques are 
Polymerase Chain Reaction (PCR) to amplify and mutate DNA, gel electrophoresis to 
purify DNAs and proteins, protein expression and purification techniques to produce 
and isolate proteins, southern and northern blotting to quantitatively detect target 
genes, and enzyme linked immunosorbent assay (ELISA) for analyte detection. 
Subsequently, nucleic acids and proteins as well as entire bacterial cells have been 
modified to be used in the design and development of biosensors1-5.  
A biosensor is defined as a biological element coupled with a transducer so that 
an analyte biospecific recognition event is translated into a measurable output. To date, 
a number of biosensors based on proteins and cells as the recognition elements have 
emerged, and a few of them have been applied as point of care devices6 and for 
environmental monitoring7. Although such biosensing systems offer huge promise in the 
management of a variety of disorders, including bacteria related conditions, such as 
infections, inflammatory bowel disease (IBD), and cystic fibrosis (CF), their use is still 
limited. Furthermore, complexities in the treatment of bacteria related conditions have 
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been on the rise due to the emergence of several antibiotic resistant bacteria and 
demand urgent attention for alternative treatment approaches.  
Bacterial quorum sensing (QS) — a system of communication among bacteria 
that is based on small signaling molecules termed quorum sensing molecules (QSMs) — 
may offer an avenue of alternative therapy. In that regard, bacteria are known to 
employ QS to control processes, such as virulence factor production and biofilm 
formation, in a population size dependent manner; hence, disruption of the bacterial 
chatter necessary for pathogenicity may lead to a new way to treat bacterial infections. 
Additionally, investigations into bacteria related disorders have led to discoveries 
pointing to a role for QS in disease. For instance, QSMs have been identified in clinical 
samples of CF patients8,9. Bacterial communities thrive in the human body; it has been 
suggested that the number of bacteria in the human body is at least one order of 
magnitude higher than the number of human cells. For example, bacteria colonize the 
gastrointestinal (GI) tract from mouth to anus and contribute to about 60 percent dry 
mass of feces. Usually, a symbiotic relationship exists between the host and the 
bacterial flora. However, evidence suggests that there may be changes in the microflora 
and host-microbial interactions during the course of disease. A change in the microflora 
would also result in alteration of the relative balance of QSMs. Therefore, detection of 
QSMs in physiological samples may be a valuable means to evaluate variations in 
bacterial composition and serve as a tool for monitoring the disease status and for 
investigating the disease mechanisms.  
3 
 
 The present thesis work is focused on the development and application of 
biosensing systems that can be employed to detect QSMs in clinical samples. Different 
categories of QSMs exist as described in detail later. Specifically, we developed and 
utilized whole cell based biosensing systems to detect the following QSMs: long and 
short chain N-acyl homoserine lactones (AHLs) and Autoinducer-2 (AI-2). For that, 
several clinical matrices were investigated, including stool, saliva, bowel secretion, 
blood serum, and blood plasma. Each type of biological matrix is unique in its 
composition and, therefore, needs to be assessed for potential effects that it may exert 
on the analytical performance of each whole cell biosensing system.  
 With progress in the field of biotechnology, which led to important 
advancements, such as the large-scale production of recombinant protein drugs and 
vaccines, it has also been easier than ever to create biological threats that can be used 
in a bioterrorism attack and spread by means of daily utilized food products, such as 
milk and beef, thus affecting a larger percentage of the population. Additionally, 
bacteria are well known to be responsible for food spoilage. Forty eight million 
foodborne illnesses per year are reported in the United States, which leads to elevated 
health care costs, with more than a quarter million hospitalizations and more than 3000 
deaths per year10. Therefore, there is a need for rapid, easy-to-use, cost-effective 
analytical tools for early detection of food decay and prevention of biological food 
contamination threats.  
To that end, we evaluated the analytical performance of the developed whole 
cell biosensing systems in food matrices and employed them for the detection of QSMs 
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in food samples as a method for early detection of bacterial contamination in food. In 
addition, we explored a number of Generally Recognized As Safe (GRAS) compounds for 
their effect on bacterial QS. The selected compounds are known to inhibit bacterial 
growth and, due to their safety, have potential to be employed for food preservation; 
however, their mechanisms of action are not fully elucidated. Understanding the 
mechanism of action of these compounds would enable targeted preventive measures 
in combating bacterial contaminations as well as biological threats.  
Lastly, a protein based sensor for the detection of AI-2 was designed and 
developed. This sensor relies on the direct interaction of a binding/recognition protein 
with a target analyte. Therefore, in addition to being useful for AI-2 detection in 
physiological and food samples, it is suitable for binding studies aimed at investigating 
and characterizing a variety of compounds able to interfere with QS, including the GRAS 
compounds mentioned above and molecules to be explored as new treatments for 
bacterial infections. We envision that the availability of a panel of biosensing systems 
for detection of QSMs will help augmenting our understanding of bacterial communities 
and, thus, facilitate the design of alternative strategies to combat bacteria related 
disorders. 
 
Quorum sensing signaling molecules 
Bacteria, although single-cell organisms, have complex behavior. One such 
behavior relates to the ability of bacterial cells to communicate with their neighboring 
cells. This phenomenon was first reported in 1965 by Tomasz11 who described 
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“hormone like activators” that were crucial in the propagation of the Gram-positive 
bacterium Streptococcus pneumoniae, which is one of the organisms responsible for 
pneumonia pathogenicity in their hosts. Later, in 1970, Hastings et al. observed that the 
Gram-negative marine bacterium Photobacterium fischeri produces bioluminescence 
only when bacteria reach a certain cellular density in terms of number of cells present, 
and speculated that light emission was under a bacterial “control mechanism”. It is now 
well understood that bacteria of the same species or of different species communicate 
with each other by producing and sensing small chemical molecules in a process termed 
as quorum sensing. This phenomenon has been observed in a number of bacteria12, and 
it is now understood that by means of QS, bacteria are able to control several processes, 
for example bioluminescence, virulence factor production, biofilm formation, antibiotic 
production, competence, nodulation, sporulation, clumping, and motility. The small 
chemical molecules that bacteria utilize for QS are known as QSMs. By detecting the 
QSMs, bacteria can modulate the above mentioned processes in a cell density-
dependent manner. For example, in a bacterial infection, bacteria do not produce 
virulence factors until they reach a critical population density and, by doing so, they 
ensure that they can overwhelm the host’s immune response13. 
Several groups of QSMs have been identified, which include AHLs in Gram-
negative bacteria and a class of autoinducing peptides (AIPs) in Gram-positive bacteria. 
Whereas AHLs and AIPs are species-specific and, therefore, used for intra-species 
communication, a third category of molecules, AI-2, has been found in both Gram-
positive and Gram-negative bacteria, suggesting a potential role in inter-species 
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communication within bacteria14. Table 1 lists some of these signaling molecules and 
the bacteria that use them in cell-to-cell communication. Briefly, AIPs are peptides 
ranging from 5 to 17 amino acids in length, which are post-translationally modified to 
yield a variety of linear and cyclic structures in Gram-positive bacteria. QSMs of Gram 
negative bacteria, AHLs, are composed of fatty acyl chain of 4 to 18 carbons in length 
attached to a homoserine lactone ring through an amide bond; AHLs present in nature 
have acyl chains of even numbers of carbons. Furthermore, the third carbon in the acyl 
chain can be fully reduced or may contain a hydroxyl or a carbonyl group. This 
substitution at the third carbon varies based on the fatty acid from which it is derived. 
Among the three types of QSMs mentioned above, AI-2 has been discovered more 
recently and shown to be comprised of a group of structurally related compounds; at 
least two of these compounds have been demonstrated to be employed as QSMs by 
bacteria, namely, a furanosyl borate diester form of AI-2 used by the marine bacterium 
Vibrio harveyi and a hydrated form, not containing boron, used by the intestinal 
pathogen Salmonella typhimurium15. Furthermore, some bacteria have multiple QS 
circuits based on more than one kind of QSM; for example, V. harveyi utilizes N-(3-
hydroxybutanoyl)-L-homoserine lactone and the furanosyl borate diester form of AI-2 to 
control bioluminescence16. Recently, Sperandio et al. have discovered an additional 
QSM, autoinducer-3, AI-3 (unknown structure), which binds to the membrane protein 
QseC and activates virulence in enterohemorrhagic Escherichia coli (EHEC)17,18. Further, 
it has been shown that the mammalian hormones, epinephrine and norepinephrine, are 
recognized by the same protein QseC and activate virulence in EHEC7, suggesting 
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involvement of the AI-3 QS system in interkingdom bacterial–mammalian cells 
communication. 
 
Quorum sensing regulatory systems 
The QS pathways of the three major types of bacterial QSMs listed above are 
outlined in Figures 1, 2, and 3. Most Gram-negative bacteria utilize AHLs as QSMs; their 
QS systems are similar to that of Vibrio fischeri, which was one of the first QS regulatory 
systems to be thoroughly investigated. This bacterium uses QS to regulate expression of 
the genes responsible for bioluminescence. It utilizes N-3-oxo-hexanoyl homoserine 
lactone (3-oxo-C6-HSL) as the cognate QSM, which is synthesized in the cytoplasm by 
the AHL synthase protein LuxI. Once formed, 3-oxo-C6-HSL diffuses out of the cell and 
freely enters into the neighboring bacteria, where it binds to the transcriptional 
regulatory protein LuxR upon reaching a threshold concentration. As the population 
density increases, the concentration of 3-oxo-C6-HSL also increases proportionally. By 
being able to synthesize and detect 3-oxo-C6-HSL, V. fischeri can thus estimate its 
population size. The LuxR protein, upon binding 3-oxo-C6-HSL, forms the LuxR–3-oxo-
C6-HSL complex, which binds to the operator/promoter region of the luxICDABE operon 
to express the enzymes involved in bioluminescence. Specifically, the genes luxA and 
luxB encode bacterial luciferase, and the luxC, luxD, and luxE genes code for the 
enzymes required for the synthesis and recycling of the long chain aldehyde substrate 
for luciferase. The light output obtained is proportional to the amount of 3-oxo-C6-HSL 
present in the environment, which is relevant for the development of whole-cell sensing 
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systems based on QS regulatory systems, as highlighted in following sections of this 
work. While AHL based QS controls bioluminescence in V. fischeri, it regulates diverse 
functions in other bacteria by means of a variety of LuxI and LuxR homologue proteins.  
Notable examples are the AHL-dependent LasI/LasR and RhlI/RhlR QS systems of 
Pseudomonas aeruginosa, which control production of virulence factors and biofilm 
formation in this microorganism. Figure 1 shows a general schematic of AHL dependent 
QS system.  
AIPs are utilized by Gram-positive bacteria for QS. Various peptide lengths and 
post-translational modifications have led to diverse structures of AIPs, thus conferring 
selectivity and specificity. Several Gram-positive bacteria have been studied in detail 
and shown to follow a general theme, as outlined in Figure 2. Briefly, AIP originates from 
a precursor peptide through post-translational processing and modifications, and is then 
secreted out of the cell by an ATP-binding cassette transporter. The AIP signaling 
pathways are comprised of two component signaling systems. These two components 
include a sensing receptor protein, which binds the AIP, and a response regulatory 
protein, which translates the binding event into expression of target genes, including 
the QS regulated genes and those responsible for synthesis of the AIP precursor and 
release of AIP. Specifically, AIP binding to the receptor protein, which is a histidine 
sensor kinase, triggers autophosphorylation at a conserved histidine residue, followed 
by a cascade of phosphorylation events, which ultimately transfer the phosphate group 
to a conserved aspartate residue of the response regulatory protein. The 
phosphorylated response regulatory protein then binds to specific DNA regions and 
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activates transcription of the regulated genes. Some examples of two component 
systems include the ComD/ComE competence system in S. pneumoniae, ComP/ComA 
competence and sporulation system in Bacillus subtilis, and AgrC/AgrA virulence system 
in Staphylococcus aureus.   
In contrast to QS systems utilizing AHLs and AIPs, which are usually specific to 
Gram-negative and Gram-positive bacteria respectively, those that utilize AI-2 have 
been found in both types of bacteria. Bassler et al. have reported that AI-2 is not only 
produced, but also sensed by a large number of bacterial species19. Generally, AI-2 
refers to a group of isomers derived from the hydrated form of the precursor 2,3-
dihydroxy-4,5-pentanedione (DPD) (Figure 3A). Although only the borate isomer 
derivative of DPD, S-THMF-borate, was previously thought to be the active form 
recognized by the protein LuxP and its homologues, more recently, a different isomer, 
R-THMF has been found to be the cognate molecule of the sensor protein LsrB in S. 
typhimurium. The mechanism of QS in AI-2 based systems is represented in Figure 3B. 
Briefly, AI-2 is synthesized in the cell by Pfs and LuxS enzymes. Pfs converts S-
adenosylhomocysteine (SAH) to S-ribosylhomocysteine, which is converted to DPD by 
action of LuxS. Once formed, DPD undergoes instantaneous cyclization to form an 
isomeric mixture (Figure 3B). In the presence of borate, which is abundant in the 
oceanic environment, S-THMF-borate is formed. AI-2 diffuses out of the cell and can 
enter bacteria of the same or other species. The receptor of AI-2 in V. harveyi is the 
protein LuxP, which belongs to the class of periplasmic binding proteins. Upon AI-2 
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binding to LuxP, the LuxP-AI-2 complex regulates the expression of controlled genes 
through a cascade of phosphorylation/dephosphorylation steps.  
 
Quorum sensing molecules in disease 
 Numerous in vitro and in vivo studies have demonstrated that expression of 
bacterial virulence factors responsible for infections in mammalian hosts is regulated by 
QS. Several such studies concerning GI tract infections have been discussed in a recent 
review by Kaper and Sperandio20. For example, in the case of EHEC, which causes bloody 
diarrhea and hemolytic-uremic syndrome, involvement of AI-3 in regulating the 
expression of virulence factors was demonstrated in a HeLa cell infection model using 
wild-type EHEC and a LuxS mutant-LuxS has been shown to be involved in the 
production of AI-321. In an animal study22, burn wounds of mice models were infected 
with wild-type P. aeruginosa and variants of the same bacterium carrying mutations in 
the genes encoding for AHL synthase. The objective of the study was to determine the 
efficiency of infection by assessing the ability of the bacteria to spread the infection and 
the time required for the onset of infection. It was observed that in mice infected with 
P. aeruginosa mutants unable to synthesize AHLs, the extent of infection was lower than 
in those infected with wild type bacterium. The evidence gathered is indicative of the 
relevance of bacterial communication in diseases of bacterial origin and, thus, the 
importance of detecting QS signaling molecules in physiological samples. 
 Identification of QS regulatory pathways in a number of bacteria12 has enabled 
whole-cell-based biosensing systems to be engineered to detect QSMs by coupling the 
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genes coding for different QSM recognition and/or regulatory proteins to those of a 
variety of reporter genes20. As an example, Winson et al. designed reporter plasmids by 
placing the reporter gene cassette luxCDABE under the control of the PlasI and PRhlI 
promoters from the P. aeruginosa QS regulatory systems LasI/LasR and RhlI/RhlR, 
respectively. The plasmids also contained the sequences of the LasR and RhlR proteins, 
which, upon binding AHLs, bind to the respective promoters, thus activating expression 
of the reporter protein23. In another example16, Bassler et al. engineered a strain of V. 
harveyi in such a way that the bacterium’s bioluminescence, which depends on 
expression of the luxCDABE gene cassette, was only triggered by AI-2, thus enabling 
detection of this QSM (as reported above, in wild-type V. harveyi expression of the 
bioluminescence genes is triggered by both AI-2 and an AHL, N-(3-hydroxybutanoyl)-L-
homoserine lactone).  
 Most of the above cell-based systems have been used as bioassays to evaluate 
the ability of cultured bacteria to produce QSMs. However, only a few have been 
applied to the detection of QSMs in physiological and clinical samples in order to 
correlate the presence of pathogenic bacteria with the onset or status of disease. Two 
independent studies demonstrated the presence of AHLs in sputum samples from 
patients with cystic fibrosis8,9 by using whole-cell sensing systems. It is known that P. 
aeruginosa and Burkholderia cepacia colonize the airway passage and lungs in CF 
patients, leading to chronic lung infection and finally to destructive lung disease24. These 
two species of bacteria use AHL-dependent QS regulation. In the study conducted by 
Middleton8 et al., sputum samples from CF patients colonized by either P. aeruginosa or 
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B. cepacia, were extracted and then analyzed using an E. coli whole-cell-based 
biosensing system containing plasmids pSB401 and pSB1075 to detect short and long-
chain AHLs, respectively. Among P. aeruginosa-colonized sputum samples, 71% showed 
the presence of short-chain AHLs and 61% showed presence of long-chain AHLs. 
Similarly, among B. cepacia-colonized sputum samples, 81% contained short chain AHLs 
and 50% contained long-chain AHLs. This AHL production profile was different from that 
of laboratory cultures of the same microorganisms isolated from sputum samples, in 
which long-chain AHLs were predominant. The difference in AHL profile was thought to 
be explained by dissimilar growth conditions, in vitro and in the lung. In that regard, this 
varied behavior of P. aeruginosa from lung infection had previously been observed by 
Singh25 et al., who hypothesized that P. aeruginosa exists predominantly as a biofilm in 
CF sputum. Further, LC–MS analysis of the same samples revealed the presence of 
short-chain AHLs, but not that of long-chain AHLs, indicating that the whole-cell-based 
biosensing system was more sensitive for detection of AHLs in sputum samples. Another 
study published the same year by Erickson et al. further corroborated the presence of 
AHLs in sputum samples from CF patients9. P. aeruginosa-based whole-cell biosensing 
systems containing plasmids pKDT17 (to detect long-chain AHLs) and pECP61.5 (to 
detect short chain AHLs), both utilizing lacZ as a reporter, were used. 
Although the levels of AHLs detected were low, over 75% of the samples had 
long-chain AHLs whereas only 26% of the samples had short-chain AHLs. This finding is 
in contrast with the results of the study by Middleton8 et al. However, differences in the 
groups of patients, along with different sample extraction and/or processing methods 
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and the use of sensing systems based on different microorganisms might explain 
different results. Along the same lines, Chambers et al. detected a broad range of AHLs 
in mucopurulent respiratory secretion samples obtained from CF patients26. They used 
Agrobacterium tumefaciens-based whole-cell biosensing system A136, containing 
plasmids pCF218 and pMV26 with luxCDABE as a reporter, allowing it to respond to both 
long and short-chain AHLs (4–12 carbon atoms). AHLs were extracted from the 
mucopurulent respiratory secretion samples, separated by reversed-phase fast pressure 
liquid chromatography (FPLC), and each fraction was then assayed with the A. 
tumefaciens A136 sensing system in 96-well microtiter plate format. Further, identities 
of the AHLs present in positive fractions were confirmed by comparing their retention 
times with those of standard AHLs. Using the whole-cell sensing system combined with 
FPLC, the authors were able to detect low concentrations of AHLs in small volumes of 
samples from nine (out of thirteen) CF patients and to identify seven different AHLs.  
Our research group used whole-cell biosensing systems to evaluate QSMs in 
physiological samples from individuals affected by bacterial GI disorders, including IBD. 
Two of the major conditions of IBD, ulcerative colitis (UC) and Crohn’s disease (CD), 
involve chronic and relapsing acute inflammation in the large and small intestine, 
respectively, with CD being able to affect any portion of the GI tract. Current methods of 
diagnosis and monitoring rely on endoscopic techniques and analysis of mucosal tissue 
biopsies taken from the inflamed regions. Alternative tools that can serve as non-
invasive biomarkers for such diseases can prove very beneficial. To that end, we have 
developed and optimized E. coli based bioluminescent whole-cell sensing systems 
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containing plasmids pSB406 and pSB1075, which bear luxCDABE as a reporter, for 
detection of short and long-chain AHLs, respectively23,27. These biosensing systems have 
then been used to evaluate AHLs in human samples, for example saliva and stool 
samples, which bear the advantage of being collected non-invasively. The effect of 
components of the sample matrix was evaluated by generating dose–response curves in 
spiked pooled samples after minimal processing (no sample extraction or extensive 
preparation). Importantly, nanomolar limits of detection were obtained in biological 
matrices, which is relevant in that nanomolar concentrations of QSMs are necessary to 
initiate cell-to-cell communication 27. Saliva samples from IBD and healthy individuals, 
and stool samples from newborns admitted to a neonatal intensive care unit (NICU) 
were then assayed27. AHLs were detected at different levels in the specimens tested, 
showing for the first time the presence of these QSMs in such physiological samples. 
More recently, we also detected QSMs in blood samples of IBD patients (manuscript in 
preparation). If a correlation is established between the QSM levels in samples and the 
health status of a patient, it may be possible to use QSMs as biomarkers of bacteria-
related disorders, which should aid in the management of the disease. Studies are 
currently in progress in our group in which physiological samples from selected sets of 
GI patients and matched controls are analyzed for their QSM content to evaluate 
relationships between QSM levels and disease status. One such clinical study involved 
stool samples that were obtained from infants admitted to the NICU for a variety of 
illnesses, including bowel inflammation and bacterial sepsis28 (submitted manuscript). 
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Interference with quorum sensing 
QS has evolved to assist bacteria to effectively communicate among each other 
and regulate expression of phenotypes that are involved in pathogenicity, such as, 
virulence determinant production and biofilm formation. In the past few decades, 
several examples of interference with bacterial communication as a means to interrupt 
the bacterial chatter and, thus, block pathogenicity, have been reported. Since bacterial 
QS depends on the presence of QSMs and their interaction with cognate receptors, any 
molecule or enzyme that either blocks the synthesis or accumulation of QSMs, or 
prevents them from binding to the receptor proteins, can interfere with QS.  
QS interfering compounds include those from natural sources29-31 as well as those that 
are synthesized32,33 in the lab. Jakobsen34 et al. have analyzed over 60 extracts of 
vegetables, fruits, and spices, and found that extracts from horseradish, Tasmanian blue 
gum, and ginkgo  showed a clear QS inhibitory activity in the screening assays employed. 
Further investigation using LC-MS and NMR spectroscopy led to the identification of 
iberin, an isothiocyanate (Figure 4A), as the compound responsible for the potent 
inhibitory effect of horseradish on QS in P. aeruginosa. Widmer and co-workers35 
studied several fatty acids from poultry meat and proved that four of them, linoleic acid, 
oleic acid, palmitic acid, and stearic acid, exhibited an inhibitory effect on the AI-2 based 
QS system (Figure 4B). Few other natural compounds that have been reported to 
interfere with QS include cinnamaldehyde from cinnamon36 and ursolic acid from 
apples37. Works by Koh et. al and by Zahin et. al  provide further evidence of the anti-QS 
activities of the traditional Chinese medicinal plants38 and  medicinal plants from India39, 
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respectively. These studies prompted us to investigate GRAS compounds for their effect 
on QS. GRAS compounds are food additives that are considered to be safe and are 
approved by food and drug administration10. A database of GRAS compounds is 
maintained by the FDA40, and currently includes 373 compounds, with more compounds 
added each year. 
 
Inhibition of QSM synthesis 
 Since all types of QSMs are synthesized in the bacterium by their respective 
synthases, it is apparent that if the synthase enzyme is inhibited, QS and the genes 
regulated by QS will also be affected. As a result, several compounds that interfere with 
QS by inhibiting the synthesis of QSMs have been identified. For example, in P. 
aeruginosa the AHL synthase RhlI synthesizes N-butanoyl-L-homoserine lactone (C-4 
HSL) by using crotonyl-acyl carrier proteins and S-adenosylmethionine (SAM). The 
compounds S-adenosylhomocysteine and sinefungin are analogues of SAM (Figure 5A) 
that inhibit the RhlI catalyzed synthesis of C-4 HSL41. Similar studies have been 
conducted to find inhibitors that can block AI-2 synthesis42-44. The precursor S-ribosyl-L-
homocysteine (SRH) is required for AI-2 synthesis; Zhou et. al reported that the SRH 
analogues, S-anhydroribosyl-L-homocysteine and S-homoribosyl-L-cysteine, exhibited 
inhibitory activity against the AI-2 synthase, LuxS43 (Figure 5B). In addition, Shen et.al 
synthesized and analyzed several SRH analogs for their activity as LuxS inhibitors. They 
found that two analogs of SRH, (2S)-2-amino-4-[(2R,3S)-2,3-dihydroxy-3-N-
hydroxycarbamoylpropylmercapto]butyric acid and (2S)-2-amino-4-[(2R,3R)-2,3-
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dihydroxy-3-N-hydroxycarbamoylpropylmercapto]butyric acid, acted as potent 
inhibitors of LuxS42. 
 
Degradation of QSMs 
 A well-studied example of interference with AHL-mediated QS is that of QSM 
degradation by AHL lactonases, which break open the lactone ring of AHLs to produce 
the corresponding acyl homoserines, thus reducing the activities regulated by QS45. In 
addition to lactonases, there are acylases that work by breaking the AHL amide bond to 
produce fatty acids and homoserine lactones45. Genome analysis revealed that acylase 
and lactonase homologues are present in a number of bacterial species. The 
fundamental knowledge of lactonases was put to use by Dong et. al, who introduced the 
aiiA gene encoding for an AHL-lactonase into the genome of tobacco and potato 
plants46. After infecting these plants with pathogenic Erwinia carotovora, the transgenic 
plants showed a substantial reduction in the extent of infection as compared to the 
control plants without aiiA. In addition to these naturally existing interfering enzymes 
that exert their action by degrading the QSMs, an alternative approach was proposed by 
Janda47 et. al who produced an anti-autoinducer monoclonal antibody that could inhibit 
QS by sequestration of the AIP-4 produced by group 4 S. aureus. Further, they utilized 
the anti-autoinducer antibody in a mouse model and found that it did not only suppress, 
but also provided complete protection against the S. aureus infection. 
 
Interference with QSM receptor 
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 Irrespective of the type of bacteria, a QSM either binds to a membrane bound 
receptor or passively transported in the cell where it binds to its cognate receptor48. 
Therefore, molecules that bind to the QSM receptor but do not elicit subsequent 
biological response, can serve as inhibitors of QS and the processes regulated by the 
QSM receptor.  
 A number of molecules have been investigated that inhibit QS by binding to the 
QSM receptor. In the Gram positive bacteria S. aureus, a truncated form of an 
autoinducing peptide specific for a certain group of bacterial strains was able to inhibit 
the agr virulence response in all four groups of S. aureus strains49; it was found that the 
inhibited target was the AIP receptor, histidine sensor kinase AgrC. Further studies 
identified several compounds that were able to show an inhibitory effect due to binding 
to the AIP receptors50,51. QS systems utilizing AHLs as QSMs can also be inhibited by 
compounds that bind to the AHL receptors. Efforts have been mostly focused on finding 
AHL antagonists by modifying AHLs, which are comprised of a lactone ring and an acyl 
side chain. Therefore, inhibitors that block the AHL-receptor interaction usually are AHL 
derivatives with structural modifications in the lactone ring or acyl side chain or both52.   
Gram-negative bacteria have evolved to express different receptors for recognizing 
structurally diverse AHL molecules. While a type of AHL molecule might act as agonist in 
some bacterial species, it might act as antagonist in others. As an example, C-6 HSL is an 
agonist of CviR of Chromobacterium violaceum, but an antagonist of LuxR of V. fischeri53. 
By using a QS inhibitor selector system30, Persson et. al designed and synthesized a 
number of derivatives of AHLs that showed an inhibitory effect in the las system of P. 
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aeruginosa54, with N-(heptylsulfanylacetyl)-L-homoserine lactone demonstrating the 
highest inhibitory activity (Figure 6A). In bacteria employing AI-2 based QS systems, two 
periplasmic binding proteins have been identified as AI-2 receptors thus far, that is, LuxP 
in V. harveyi and LsrB in S. typhimurium and E. coli; the former binds to the borate form 
of AI-2, (2S,4S)-2-methyl-2,3,3,4-tetrahydroxytetrahydrofuran-borate (S-THMF-borate), 
while the latter binds to (2R,4S)-2-methyl-2,3,3,4-tetrahydroxytetrahydrofuran (R-
THMF) in S. typhimurium15. There is a limited amount of research to develop 
agonists/antagonists of the receptors LuxP and LsrB. Although Lowery et. al have 
developed several analogs of DPD55, the precursor of AI-2, none of them were effective 
as agonists or antagonists. On the other hand, Ni et. al screened a number of boronic 
acids and aromatic diols that would form a complex with boric acid and found that para 
substituted boronic acids56 and pyrogallols57 were capable of inhibiting AI-2 based 
quorum sensing (Figure 6B). 
 
Interference by other bacterial species and strains 
 S. aureus uses AIP and AgrCA two-component systems to regulate various 
activities, including production of virulence factors and biofilm formation. Among 
different strains of S. aureus, the AIP and its receptor AgrC show considerable 
intraspecies variations, which account for signal specificity and are used to identify four 
major groups of S. aureus strains. Interestingly, while each group AIP activates 
expression of virulence in bacteria of its own group, it represses the virulence in other 
groups of S. aureus. Mayville et. al studied this phenomenon in a mouse model. Addition 
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of AIP II, the AIP signal produced by group II S. aureus, to a lesion infected with group I S. 
aureus reduced the infection, as apparent from the reduced size of the lesion58. In 
another study, Xavier et. al have shown that, in a mixed species community of bacteria 
that are able to produce and/or detect AI-2, one species of bacteria degrades the AI-2 
produced by another species, thus interfering in the communication system of the 
latter59. 
  
Biosensors 
The need of living organisms to recognize and respond to changes in their 
environment exemplifies biosensing in nature. Biosensing involves selective and 
sensitive molecular recognition between proteins and a target ligand analyte, even 
when present at very low concentrations. Researchers have tried to mimic the exquisite 
properties found in nature by utilizing naturally occurring recognition elements to 
develop biosensing systems for analytical applications. To that end, a biological 
recognition element capable of reversible binding to a target ligand analyte is coupled to 
a transducer element that converts the recognition event into a readable/measurable 
output. Several biological recognition elements, including proteins, nucleic acids, cell 
organelles, and intact cells, have been used as sensing elements in biosensors for 
applications in environmental, biological, pharmaceutical, and clinical analysis60,61. 
Proteins with high specificity for analytes of interest have been extensively used in the 
development of biosensors. These proteins include enzymes, antibodies, and binding 
proteins, among others. For instance, glucose oxidase catalyzes oxidation of β-D-glucose 
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to D-glucono-1,5-lactone, which is further hydrolyzed to gluconic acid26. A range of 
commercially available biosensors for blood glucose monitoring and diabetes 
management use glucose oxidase as the sensing element coupled to appropriate 
mediators and transducers6. Antibodies have exquisite specificity for their cognate 
antigens. In an immunosensor62, antibodies are used as recognition elements coupled 
with a variety of detection methods, including, electrochemical, piezoelectric, 
fluorescence, bioluminescence, absorbance, and surface plasmon resonance; labeled 
secondary antibodies can also be used in a different format for detection of target 
analytes.  
A variety of sensing systems have also been developed by using hinge motion 
binding proteins (HMBPs), for example periplasmic binding proteins and the messenger 
protein calmodulin, with an incorporated signal-generating reporter molecule63. In 
general, these proteins have extraordinary selectivity to their corresponding ligand 
and/or analyte, with affinities, KD, typically in the sub-micromolar range—in some cases 
as low as in the nanomolar range—and undergo conformational changes upon binding 
to their ligands. As representative examples of periplasmic binding proteins64, the KD of 
the sulfate-binding protein is 10 nmol L−1 whereas that of the glucose-binding protein is 
20 nmol L−1. Specifically, upon ligand binding, two protein domains bend around a 
“hinge” region of the protein. Such conformational change can be used to quantify a 
target analyte and/or ligand by measuring the change in signal intensity of the 
transduction molecule, which can either be an environmentally sensitive fluorescent 
probe strategically conjugated to the protein or a reporter protein genetically fused to 
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the HMBP. The advantages of this type of protein-based biosensor are their high 
specificity toward their ligand analyte, thus resulting in high selectivity, low limits of 
detection, rapid response times, and amenability to incorporation into various analytical 
devices. Potential disadvantages of protein-based biosensors can be their storage 
conditions, transport, and shelf life. In most cases, protein biosensors must be stored 
and transported refrigerated, which limits their utility and compromises their shelf life 
when used at room temperature. 
Intact cells, including bacterial, yeast, and mammalian cells, are used as sensing 
elements in biosensing systems. Bacterial cell-based biosensing systems use genetically 
engineered bacteria capable of generating a signal on selective recognition of the 
analyte or class of analytes of interest. The ability to produce dose-dependent 
detectable signals in response to the analyte, as described in the next section, enables 
selective determination of the bioavailable analyte or class of analytes present in a given 
sample. Cell-based sensing systems are relatively easy and inexpensive to prepare and 
store, and are robust: they tend to be stable to environmental changes, for example 
variations in temperature or pH. In addition, these sensing systems can provide 
physiologically relevant data and evaluate the bioavailability of the analyte of interest, 
because the target chemical must enter the cells to trigger a response. Moreover, by 
using different recognition element–reporter protein pairs, multiple analytes can be 
detected simultaneously in a sample. Cell-based biosensing systems have high-
throughput features because they are amenable to miniaturization and incorporation 
into high-density analytical devices, thus enabling assay of large numbers of samples in a 
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single analytical run. This is a distinct advantage over conventional physicochemical 
analytical methods. However, a whole-cell biosensing system is not without limitations. 
In whole-cell biosensing systems, analytes must enter the bacteria by diffusion, which 
may, depending on the rate of diffusion, result in a slow sensor response. Additionally, 
because the cell biochemical machinery must be activated to produce the reporter 
protein, the response of a whole-cell sensing system is slow compared with that of 
protein-based biosensors, which is of the order of seconds or minutes. Additional 
drawbacks include potential interference with the sensor’s response by components of 
the bacterial cell and high background signal when fluorescent proteins are used as 
reporters, because of the presence of fluorescent molecules in the cell. Cell batch-to-
batch variability, which is intrinsic to living organisms, is a further aspect that may have 
to be taken into consideration65. 
  
Bacterial whole-cell-based biosensing systems 
Bacterial biosensing systems can be categorized into two different types, 
depending on the mode of expression of the reporter protein66. Expression of the 
reporter can either be constitutive or inducible. In constitutive expression systems, the 
reporter is expressed at high basal levels. An increase in the amount of compounds that 
are toxic to the cell causes its death, thus reducing the reporter protein expressed and 
its generation of signal. Whole-cell biosensing systems based on constitutive expression 
have been used to measure the general toxicity of a sample or test compound. A well-
known example is Microtox® toxicity testing7, a standardized, commercially available 
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toxicity testing system that uses the spontaneously bioluminescent marine bacteria V. 
fischeri as bacterial sensor for detection of toxic compounds in water samples. When V. 
fischeri in the test kit is exposed to a sample containing toxic compounds, a dose-
dependent reduction in bioluminescence is observed, indicating the toxicity level of the 
sample. The second class of whole-cell bacterial biosensing systems comprises inducible 
expression systems in which the cells are genetically engineered to contain a plasmid in 
which an inducible promoter fused to a reporter gene controls its expression66. In the 
absence of analyte/inducer, the reporter gene is expressed at very low basal levels, 
while in the presence of analyte/inducer it is expressed in a dose-dependent manner. 
Inducible expression systems can be further classified as stress inducible or chemically 
inducible, depending on the mechanism of activation of the response. In stress inducible 
cell-based biosensing systems, the reporter gene is placed under the control of a 
promoter that is activated by stressful conditions, for example heat shock and osmotic 
stress. Several structurally unrelated compounds can activate these response 
mechanisms; therefore, such sensing systems are not specific to target compounds and 
are defined as semi-specific. On the other hand, chemically inducible cell-based systems 
harbor a plasmid that contains a specific promoter and the genes for regulatory and 
reporter proteins. The presence of an analyte or class of analytes activates the 
promoter, triggering the expression of the regulatory and the reporter proteins in a 
specific manner. The mechanism by which this occurs involves binding of the analyte to 
the recognition/regulatory protein, which then undergoes a change in conformation, 
subsequently activating expression of the reporter gene. Reporter gene expression can 
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be negatively or positively regulated. In negative regulation (Figure 7A), the regulatory 
protein is bound to the operator/promoter region of an operon and inhibits expression 
of downstream genes, including the reporter gene. When the analyte is present, it binds 
to the regulatory protein, which is then removed from the operator/promoter region, 
thus enabling expression of the reporter gene. In positive regulation (Figure 7B), the 
analyte first binds to the regulatory protein and the complex then binds to the 
operator/promoter region, triggering expression of the reporter gene. The reporters 
used in whole-cell sensing systems are typically proteins that can be detected by optical, 
i.e., colorimetry, fluorescence, bioluminescence, and chemiluminescence, or 
electrochemical methods. Although the recognition component is important in 
determining the selectivity, the reporter is crucial in determining the sensitivity of the 
bacterial sensor. A wide variety of reporter genes have been used in several 
applications, including gene expression, gene transfer, and cell signaling. The reporter 
proteins encoded by such genes have also been used as signal-transduction elements in  
bacterial sensors. These proteins include β-galactosidase67,68, bacterial luciferase69, 
firefly luciferase70, and the green fluorescent protein and its variants. Table 2 lists 
reporters that are commonly used in whole-cell sensing systems, with their catalyzed 
reactions and methods of detection. 
 
Miniaturization of cell-based biosensing systems 
Cell-based bioluminescent biosensing systems have still to reach their fullest 
potential. Attractive technologies where these systems could find applications include 
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rugged, compact portable sensing platforms and instrumentation for on-site 
measurements of environmentally and clinically relevant analytes. To date, several 
important strides toward miniaturization have been achieved. An example of the 
progress made towards constructing miniaturized systems includes the whole-cell 
bioluminescent-bioreporter integrated circuit device developed by Simpson et al.71 In 
this system, a toluene-selective genetically engineered Pseudomonas putida bioreporter 
strain was incorporated onto a chip provided with an optical application-specific 
integrated circuit (Figure 8). Upon interaction with toluene vapor, a bioluminescence 
signal was generated and measured by the integrated circuit, allowing detection of 
toluene concentrations down to 50-10 ppb, depending on the signal integration time. 
The main advantage of this system lies in the direct coupling of the bioluminescent 
bioreporter cells to an integrated circuit designed for detecting, processing and 
reporting of the light signal. This eliminates the need for large detection 
instrumentation and optical components for light collection and transfer, thus providing 
a self-contained portable device suitable for on-site applications.  
Miniaturized cell-based biosensing systems have also found application in 
genome-wide transcription analysis. In a study performed by Van Dyk72 et al., 
sequenced random segments of E. coli DNA were inserted into plasmids as gene fusions 
with Photorhabdus luminescens luxCDABE gene cassette and transformed into host cells. 
A group of functional gene fusions known as Lux Array 1.0 was selected, which 
contained a total of 689 diverse reporter strains. These strains were printed on a porous 
nylon membrane (8 cm x 10 cm) at 16 spots cm-2 by means of a commercially available 
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automated workstation. During and after this process the membrane was kept in 
contact with LB growth media in a culture dish. These reporter strains were employed 
for simultaneously evaluating gene expression in the presence of nalidixic acid, an 
antibiotic that induces DNA damage stress response by causing a change in gene 
regulation. Specifically, in the described reporter gene assay, upregulation of certain 
genes translated to increased bioluminescence signals. This system showed the 
feasibility of obtaining high-density bioluminescent reporter cell arrays and suggests 
their potential use for analytical purposes. Notably, a further increase in the density of 
the arrays may be limited due to cross-illumination from neighboring spots. 
In another attempt towards miniaturization, fiber optic based systems have been 
designed and developed in which whole-cell biosensing bacteria were immobilized onto 
an exposed core of a fiber-optic73,74. In one case, reporter cells containing a gene fusion 
of the genotoxicant-inducible recA promoter of E. coli to the P. luminescens luxCDABE 
reporter were constructed74. These sensing cells emitted light in a dose-dependent 
manner in the presence of DNA damaging (genotoxic) agents, such as mitomycin C, 
which can react with the DNA structure, destabilize it and potentially cause deadly 
genetic mutations. The optical fiber was treated with acid for proper cleaning. The 
sensing cells were mixed with a polymeric solution, such as sodium alginate, and the 
fiber optic tip was dipped into the mixture containing the cells (Figure 9). Further 
treatment with calcium chloride solution was performed to harden the cell-alginate 
matrix onto the fiber-optic core. When the cell-deposited fiber-optic tip was exposed to 
solutions of mitomycin C at various concentrations, a dose-dependent bioluminescence 
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response was triggered, and then measured by the fiber optic system. Notably, this 
fiber-optic system was able to achieve the same detection limit, in a shorter period of 
time, as its larger scale counterpart. In another work by Gil et al.75, genetically 
engineered constitutively bioluminescent bacteria were deposited on an optical fiber, 
employing a solid matrix of glass beads and agar, to develop a biosensor for the 
detection of toxic gases. Specifically, the presence of toxic chemicals reduced the cells' 
bioluminescence intensity. Addition of glass beads increased both the porosity of the 
cell matrix, which facilitated the diffusion of vapors through the cell matrix layer, and 
the contact surface area of the cells with the gases, thus resulting in improved sensing 
ability of the bacterial sensor. This sensor is not as specific because it measures cell 
death, which can be caused not only by gases but also by other toxic compounds 
present in the sample. Technologies such as biological laser printing (BioLP™) have been 
reported for the rapid deposition of biomolecules and live bacterial sensing cells onto 
various surfaces76. Forward transfer BioLP™ uses laser pulses to transfer material from a 
carrier support onto a receiving substrate (Figure 10). The carrier support is an 
absorption layer (mostly quartz coated with metal oxides) on which properly grown 
bacterial sensing cells are spread prior to printing. In the reported example, the sensing 
strain was E. coli harboring a plasmid-borne fusion of the recA gene promoter to the red 
fluorescent protein gene from Discosoma, capable of responding to genotoxicants like 
nalidixic acid. Then, the sensing cells on the carrier support were printed onto a 
receiving surface composed of a LB agar plate or a sterile glass slide with a thin film of 
LB agar. The laser pulse was focused on a spot in the absorption layer. The laser-
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material interaction produced photo-absorption, propelling a three-dimensional pixel of 
biomaterial towards the receiving substrate through photomechanical and/or 
photothermal effects. This method of printing was reported to be precise, with an 
average spot diameter of 70 ± 6 μm and an approximate volume of 5 pL. An alteration in 
the bioluminescence emission was observed and attributed to the genotoxicity caused 
by nalidixic acid. This BioLP™ technique may be applied to several diverse sensing cells 
to produce miniaturized chip-based sensing systems that can be used in a laboratory 
setting or in the field. 
During the last two decades, there has been considerable interest in and efforts 
made to miniaturize conventional bench-top analytical techniques and incorporate 
them into microfluidic chip-based platforms1 as well as to integrate multiple analytical 
processes into a single chip77. The physical principles that govern mass transfer and fluid 
flow at the microscale level allow for rapid mass transfer and kinetics as well as high 
surface-to-volume ratio, which endow microfluidic systems with unique characteristics 
when compared to conventional volume analytical systems. Microfluidic devices such as 
micro-total analysis systems (µTAS) and lab-on-a-chip platforms have been developed 
for several analytical tasks, including whole-ceIl based biosensing. Generally, computer 
numerical control (CNC) machining and lithography techniques are used to fabricate 
these devices, employing polymeric materials such as poly(methyl methacrylate) 
(PMMA), glass and silicon. Various microfluidic structures can be fabricated that 
incorporate features such as micro reservoirs, microchannels, mixing devices, filtration, 
fractionation and separation devices and microvalves. The choice of structures 
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incorporated into a microfluidic device depends on the specific application desired78. 
Propulsion of fluids on microfluidic platforms is accomplished by employing varied 
instruments such as syringe and peristaltic pumps, or by applying acoustic, magnetic or 
centrifugal forces79. 
Microfluidic platforms employing centrifugal forces can be designed in the form 
and size of a compact disk (CD). This kind of centrifugal microfluidic device has been 
used for cell-based detection systems. Specifically, bacterial biosensing cells containing 
the gene for green fluorescent protein (GFP) under the transcriptional control of the 
promoter and regulatory genes of the ars operon were employed80. The biosensing 
system relies upon the recognition and binding of the target analytes 
arsenite/antimonite by the transcription regulatory protein ArsR, and the resulting 
expression of the reporter protein GFP inside the cytoplasm. The biosensing cells were 
incorporated into a CD microfluidic platform made of PMMA for detection of arsenite 
and antimonite. In this application, miniaturization significantly reduced the assay time 
(30 min versus < 1 min) along with the volumes of reagents used, while retaining similar 
micromolar detection limits and dynamic ranges, when compared to the benchtop 
assay. The decrease in detection time is due to faster diffusion of the analyte into the 
cells, thus increasing the reaction kinetics. The sensing system proved to be highly 
selective for arsenite and antimonite when incorporated into the microfluidic platform. 
Owing to precise manufacturing, all the structures have identical physical 
characteristics, making these platforms a very attractive solution for multiple parallel 
assays with potential for high-throughput screening as well as on-site monitoring. This 
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type of sensing platform is suitable for the development of simple instrumentation 
based on readily-available, cost effective hardware consisting of a drive motor, a power 
supply, a controller, lens optics and compact CCD cameras for the detection and 
quantification of emitted light. These components along with software for system 
control and data acquisition, processing and analysis can be easily integrated into a 
portable system. Figure 11 shows an example of centrifugal CD microfluidic platform. 
Multiple structures consisting of an arrangement of reagent reservoirs, burst valves and 
microchannels leading to detection reservoirs are shown. Fluid release from the reagent 
reservoirs is controlled by burst valves, located a very short distance from the 
reservoirs. Sufficient centrifugal force is needed to overcome the capillary force holding 
the liquids into the reservoirs and allow their flow to the detection chamber. Such force 
is generated by appropriate frequency of rotation (burst frequency) of the disk. 
Whole-cell based biosensing systems employing firefly luciferase as a reporter 
for the detection of genotoxicants have been integrated into a chip-based three-
dimensional microfluidic device, which was obtained by placing a silicon substrate 
between two poly(dimethylsiloxane) (PDMS) layers. Microchannels (volume 3 µL) in the 
two PDMS layers were connected via perforations in the silicon layer that served as 
microwells (volume 0.25 µL) to hold the sensing strains, thus forming a three-
dimensional microfluidic network. The sensor strains were immobilized onto the 
microwell array of the silicon chip by gelation upon injection of a cell/agarose mixture 
through the microchannels of one of the PDMS chips. Luciferase gene expression was 
then induced by passing sample genotoxicant solutions through the microchannels 
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present on the second PDMS chip (Figure 12). Bioluminescence was triggered when a 
solution of luciferin/ATP was passed through the channels and detected by means of a 
CCD camera. The bioluminescence response obtained with this miniaturized microfluidic 
system (1 h) was significantly faster than the assay using test tubes (4 h). Low-cost 
materials were employed to make these platforms and low volumes of reagents were 
consumed, thus rendering the system very cost-effective. In addition, multi-analyte 
detection in multiple samples can be performed simultaneously by immobilizing 
different sensor bacteria on a single chip. 
 
Paper strip based whole cell sensors 
 While a number of biosensing systems are available that can detect a number of 
analytes by employing various detection principles, most of these biosensing systems 
cannot be used outside of the laboratory due to required bulky instrumentation. This is 
particularly limiting for on-site environmental and biomedical applications. In addition 
to the miniaturized devices described in the previous section, another approach towards 
development of biosensors that could be used on site has been demonstrated by 
Stocker et. al who created paper strip based biosensing systems to detect arsenic in 
polluted water81. β-Galactosidase was employed as a reporter and detected by means of 
a chromogenic substrate generating an insoluble colored product that could be 
visualized on the paper strips. Five water samples obtained from Bangladesh indicated 
arsenic contamination to much higher than permissible levels (10 µg/L) (Figure 13A). 
Our group developed paper strip based whole-cell sensors that could be used for on-site 
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monitoring of AHLs present in biological and environmental samples82. E. coli cells 
harboring plasmid pSD908, which is based on the lasR/lasI regulatory system of P. 
aeruginosa with lac-Z encoding β-galactosidase as the reporter gene, were employed. 
These sensing cells were liquid-dried in vacuum on filter paper strips. A dose-dependent 
development of color was seen when the paper strips were incubated with various 
concentrations of N-dodecanoyl-DL-homoserine lactone followed by addition of the 
chromogenic substrate, 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-gal). The 
applicability of the sensor was validated by employing the paper strips to detect AHLs 
present in saliva of healthy and diseased individual (Figure 13B). The sensor can be 
employed not only to detect AHLs in samples, but also to evaluate molecules that 
interfere with AHL based QS. 
 
Binding proteins as recognition elements in biosensors 
 Proteins constitute the working machinery of every living organism. Proteins 
perform a variety of tasks, including recognizing specific molecules, transferring 
messages across the cell, catalyzing biochemical reactions, and participating in immune 
responses. Hinge-motion binding proteins (HMBPs) are a group of proteins with high 
selectivity and high binding affinity towards their respective ligands, with Kd values 
down to the nanomolar level64. HMBPs are generally composed of two domains 
connected by a hinge region, with the ligand binding site present at the interface of 
these domains. Ligand binding results in a change in conformation of the protein, 
consisting in bending of the two domains around the hinge region. The unbound or 
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analyte free conformation is generally referred to as “open” form and the analyte bound 
conformation is referred to as “closed” form. Hinge-motion binding proteins include 
various types of proteins, such as, periplasmic binding proteins, transcriptional 
regulatory proteins, enzymes, and the messenger protein, calmodulin. These proteins 
bind to the respective analytes with high specificity and selectivity. This property makes 
them appealing for use in sensing applications. As an example of HMBP, in E. coli 
glucose is transferred from the periplasmic space to the cytoplasm through binding to 
the periplasmic protein, glucose binding protein (GBP). Binding of the sugar to the 
protein occurs through various interactions, such as van der Waals, ionic, salt-bridges, 
and hydrogen bond formation with amino acids in the binding pocket, which causes the 
protein conformation to change from the open to the close form (Figure 14). The 
change in the conformation of a protein upon binding to a ligand can be harnessed to 
create protein based sensors for target analytes. In order to make a biosensor from a 
hinge-motion binding protein, the change in conformation due to ligand binding needs 
to be translated into a readable output. This can be achieved by several methods, 
including chemical conjugation of an environment sensitive fluorophore near the ligand 
binding site, genetic fusion of a fluorescent or bioluminescent protein to either the C or 
N terminus of the binding protein, and genetic insertion of the binding protein between 
two fragments of a fluorescent or bioluminescent reporter protein to form a molecular 
switch. Irrespective of the approach used to create a protein based biosensor, binding of 
the ligand to the specific protein generates a dose-dependent change in the reporter 
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molecule signal, thus allowing for the biosensor to be utilized for quantitative detection 
of the target ligand/analyte.  
 A commonly used strategy to make protein based biosensors employs strategic 
placement of environment sensitive fluorophores, such as, 5-({2-
[(iodoacetyl)amino]ethyl}amino)naphthalene-1-sulfonic acid (IEDANS), 7-diethylamino-
3-((((2-maleimidyl)ethyl)amino)carbonyl)coumarin (MDCC), acrylodan, and Alexa-fluor 
near the ligand binding site of the protein. Conjugation of the fluorophore at a site 
within the binding pocket would not be a good choice as it could disrupt analyte 
binding.  Sites on the protein that experience a substantial conformational change upon 
ligand binding are determined from X-ray crystal structure, NMR, and modeling studies. 
These sites are ideal for fluorophore conjugation in that the analyte-induced 
conformational change is likely to perturb the microenvironment surrounding the 
fluorophore. Amino acids in the protein that are amenable to direct conjugation of the 
fluorophore include cysteine (through sulfhydryl group), lysine (through amine group), 
and aspartic and glutamic acid (through carboxyl group). When such amino acids are not 
present at the required fluorophore attachment site, genetic mutations can be 
performed to introduce the amino acid of interest. In our lab, a range of such 
fluorophore labeled binding proteins have been constructed as biosensing systems to 
detect environmental pollutants83 and clinically relevant analytes84.  Salins84 et. al 
utilized the glucose/galactose binding protein from E. coli to develop a glucose 
biosensor based on the principle outlined above. Specifically, cysteines were introduced 
into the structure of GBP via mutagenesis at three different positions.  A set of four 
36 
 
fluorophores were conjugated at these cysteines and evaluated, with MDCC providing 
the maximum response and limits of detection in the submicromolar range. More 
recently, Siegrist et. al utilized fluorescently labeled glucose recognition polypeptide 
elements to detect glucose AT physiologically relevant millimolar levels85. Similar 
strategies were used to develop protein biosensors for the detection of environmental 
pollutants, such as inorganic phosphates86, nickel87, and sulfates83.  
 Partial or full protein sequences can be joined together via recombinant DNA 
technology resulting in fusion or hybrid proteins. An important application of fusion 
protein technology is in the field of protein purification. As an example, GE Healthcare 
Life Sciences offers a series of vectors that encode for glutathione-S-transferase (GST). 
The DNA of the protein of interest can be cloned in these vectors, thus allowing 
expression of a fusion of the GST tag and target protein, which can then be purified by 
affinity chromatography88. In fusion protein constructs for sensing, an inherently 
fluorescent or bioluminescent protein is attached to either the N or C terminus of a 
binding protein. When the analyte binds to the binding protein, a change in 
conformation of the binding protein leads to altered light emission from the reporter 
protein. Using this principle, Dikici89 et. al developed a fusion protein using calmodulin 
(CaM) as the recognition element to detect phenothiazine, and enhanced green 
fluorescent protein (eGFP) as the reporter protein. When excited at a wavelength of 488 
nm, eGFP emits at 510 nm. CaM is a calcium binding protein and when it binds to 
calcium, a change in conformation of CaM exposes a hydrophobic pocket that interacts 
with the antidepressant phenothiazine. When CaM binds to antidepressants, a further 
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change in conformation of CaM induces a change in microenviroment of eGFP, thus 
altering the emission intensity in a dose-dependent manner. Dikici et. al demonstrated a 
system that serves as model to develop binding assays that employ binding proteins as 
drug-recognition element. Based on the concept of fusion protein, a few fluorescence 
resonance energy transfer (FRET) based biosensors have been reported90-93, in which 
the binding protein is sandwiched between two fluorescent proteins acting as members 
of a FRET donor-acceptor couple. Analyte binding leads to the fluorescence resonance 
energy transfer between the two proteins.   
Another approach in engineering protein based sensors is the development of 
molecular switches.  A protein molecular switch is comprised of a binding protein with 
two fragments of a reporter protein fused to either end. In the absence of the analyte, 
the two split fragments of the reporter protein stay apart and the switch is in “off” 
mode, while in the presence of the analyte the binding protein undergoes a 
conformation change that brings the two fragments of the reporter protein together, 
thus forming an active protein and turning on the switch readout signal. A novel 
molecular switch for detecting glucose was designed and developed by Teasley 
Hamorsky et. al, employing the photoprotein aequorin as the reporter94. In brief, by 
using genetic engineering tools, aequorin was split in two fragments and each of the 
two fragments was fused to either the N or C terminus of GBP. In the presence of 
glucose, the change in the conformation of the binding protein allowed the two 
fragments of the aequorin to come together and triggered a dose-dependent light 
emission in the presence of coelenterazine and calcium (Figure 15).  
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Miniaturization of protein-based biosensing systems 
 Efforts have been made to further augment the utility of protein based 
biosensing systems by incorporating them in miniaturized devices, thus facilitating on-
site applications.  An approach to incorporate protein-based biosensing systems into 
miniaturized devices was demonstrated by Puckett95 et. al. A fusion protein comprised 
of calmodulin and the enhanced green fluorescent protein was integrated into a 
microfluidic compact disk based µTAS (figure 16). This miniaturized device was 
employed to detect phenothiazine, an antidepressant, which binds to the protein CaM. 
The microfluidic platform contained μL-size reservoirs in which solutions of sensor 
protein and analyte were added. When the disk was spun at a certain velocity, the 
solutions flew through micro channels into a detection reservoir, due to centrifugal 
force. As shown in Figure 16, the phenothiazine solution was contained in reservoir 3, 
while the dried sensing protein was contained in reservoir 2. The flow of solutions was 
controlled by passive valves, which opened only at a specific angular velocity. By 
controlling the angular velocity, water was initially released from reservoir 1 into the 
protein chamber to reconstitute the protein, and later, at a higher angular velocity, the 
phenothiazine solution and reconstituted protein flew to the detection chamber. The 
binding between CaM and phenothiazine resulted in fluorescence emission from the 
reporter protein eGFP, which was measured using a fiber-optic based detection system. 
Such microfluidic platforms are easy and inexpensive to manufacture, and are amenable 
to multiplex and high-throughput analysis in that each disk may contain multiple 
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identical microfluidic structures comprised of the required microchannels and 
reservoirs.  
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Figure 1. General schematic of AHL based quorum sensing system. Upon entering the 
bacteria, AHL binds to LuxR type protein, and the LuxR-AHL complex regulates 
expression of target genes, including AHL synthase. The label LuxR indicates LuxR types 
proteins. 
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Figure 2. General schematic of AIP based quorum sensing system. Initially, a precursor 
peptide is produced, which undergoes modification to form a mature AIP and 
transported out of the bacteria by ABC transporter. AIP is recognized by sensor kinase 
protein, and via a cascade of phosphorylation/dephosphorylation steps, quorum sensing 
regulated genes are expressed. Adapted from Xavier et al.19 
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Figure 3. Autoinducer-2 and quorum sensing circuit in Vibrio spp. (A) Isomers deriving 
from DPD cyclization. Copyright from Tavender et al.96 (B) Schematic of AI-2 based 
quorum sensing system. Copyright from Vendeville et al. 97 
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Figure 4. Natural compounds as quorum sensing inhibitors.  
Iberin inhibits AHL based QS in P. aeruginosa 
 
Fatty acids that inhibit AI-2 based QS in V. harveyi 
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Figure 5: Inhibition of QSM synthesis.  
(A) Compounds that inhibit AHL synthesis.  
 
(B) Compounds that inhibit AI-2 synthesis.  
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Figure 6: Interference with QSM receptors.  
(A) Analogue of AHL demonstrating inhibitory activity 
 
(B) Analogue of AI-2 demonstrating inhibitory activity 
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Figure 7. Chemically inducible whole-cell biosensing systems. 
 (a) Negative regulation of reporter gene expression. (b) Positive regulation of reporter 
gene expression. Adapted from Struss et al.65 
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Figure 8. Bioluminescent-bioreporter integrated circuit featuring (i) enclosure containing 
bacterial biosensing cells and optical application-specific integrated circuit (OASIC); (ii) 
enclosure mounted on the chip; and (iii) the enclosure showing bacterial biosensing cells 
on agar plug. A tight seal between chip and enclosure is maintained by using an O-ring. 
Figure copyright of Simpson et al.71 
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Figure 9. Fiber optic-based miniaturization. An optical fiber is placed in a conical tube 
containing the sample solution. The fiber optic tip is coated with an alginate matrix that 
incorporates the sensing bacterial cells. Bioluminescence is triggered when the analyte 
enters the cells and is recognized by the biosensing element. The bioluminescence 
emitted travels to the detector through the optical fiber. Adapted from Polyak et al.74 
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Figure 10. Schematic showing a BioLP™ device. A laser beam is focused on a spot at the 
interface of the support and absorption layers, causing ejection of the sensing cells 
containing material, which is then deposited on the substrate. Figure adapted from 
Barron et al.76  
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Figure 11. Example of centrifugal CD microfluidic platform. Reagent reservoirs contain 
the necessary reagents, which flow through the mixing channels when the platform is 
spun at high rpm. Finally the two solutions arrive in the detection reservoir where 
measurements are made using a suitable detector. Copyright from Turner et al.98 
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Figure 12. Three dimensional microfluidic network. (i) The solution of sensor cells is 
immobilized in the wells of chip 1. (ii) Analyte solutions are introduced in channels of 
chip 2. (iii) Schematic of the 3 dimensional structure of the platform. Copyright from 
Tani et al.99 
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Figure 13: Immobilization of whole-cell based biosensing system on paper strips. (A) 
Detection of arsenic in water samples from Bangladesh. Total arsenic concentration 
(μg/L) measured by atomic fluorescence spectroscopy is indicated in parentheses. 
Copyright from Stocker et al.81 (B) Detection of AHLs in saliva samples using the filter-
paper-based strip biosensor containing the plasmid pSD908. Samples 1−5 were from five 
healthy volunteers and sample 6 was from one patient with Crohn’s disease. Copyright 
from Struss et al.82 
 
    (A)           (B) 
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Figure 14. Crystal structure of GBP without glucose (A, open form; PDB: 2FWO) and with 
glucose (B, closed form; PDB: 2FVY).  
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Figure 15. Protein biosensor based on molecular switch approach. The reporter protein 
aequorin is split into two fragments; each fragment is fused to the two ends of the 
recognition protein GBP. In the absence of glucose, the two fragments of aequorin are 
separated from each other and no emission of light is observed (off mode). In the 
presence of glucose, the two fragments of aquorin are brought close to each other due 
to conformational changes in GBP, and emission of light is observed (on mode).  
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Figure 16.  Microfluidic architecture utilized in the protein-based assay. Copyright from 
Puckett et al.95  
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Table 1: Quorum sensing molecules utilized by various bacteria.  (a) AHLs employed by 
Gram-negative bacteria.  (b) AI-2: borate diester form employed by V. harveyi and 
hydrated form, not containing boron, employed by S. typhimurium.  (c) Linear and cyclic 
peptides employed by Gram-positive bacteria.  The underlined tryptophan residue (W) 
in the ComX pheromone indicates isoprenylation. 
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Table 2: Reporter proteins commonly used in whole-cell sensing systems. Copyright 
Struss et al.65 
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STATEMENT OF RESEARCH 
Bacteria communicate with members of the same species or other species by 
production, secretion, and detection of small signaling molecules termed quorum 
sensing molecules (QSMs), whose concentration is proportional to the bacterial cell 
density. This system of cell-to-cell communication is named quorum sensing (QS) and 
allows bacteria to modulate their behavior in a population-size dependent manner. 
When a certain QSM threshold concentration is reached, certain specialized genes are 
expressed that are involved in a variety of phenotypes, including, virulence factor 
production, biofilm formation, motility, sporulation, and bioluminescence. In general, 
Gram-negative bacteria utilize N-acyl homoserine lactones (AHLs), while Gram-positive 
bacteria utilize autoinducing peptides (AIPs) as QSMs. Autoinducer-2 (AI-2) is a third 
category of molecules that are employed, both, by Gram-negative and Gram-positive 
bacteria and are believed to be involved in interspecies communication. 
Bacteria have been associated with the pathogenesis of various disorders, such 
as, inflammatory bowel disease (IBD), a chronic inflammatory condition of the intestine 
with recurrent bouts of acute inflammation. Since QS is known to modulate various 
bacterial functions,many of which are critical for bacteria to successfully colonize a host 
and evade the host’s defense system, we aimed at studying the role of QS in relation to 
bacterial conditions, mainly IBD. Specifically, we hypothesized that QSMs may serve as 
biomarkers for the diagnosis and monitoring of bacteria related disorders, as well as for 
the evaluation of treatment efficacy. To that end, we designed and developed 
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biosensing systems, based on engineered cells and proteins, for the detection of QSMs 
in physiological samples from IBD patients and control subjects. Moreover, bacteria are 
known to be involved in the spoilage of food by forming biofilms and producing food 
degrading enzymes, whose expression is often regulated by QS. Hence, we developed 
methods for the detection of QSMs in food samples in order to investigate the 
relationship between food spoilage and QS. Finally, we employed the developed 
biosensing systems to test target compounds for their ability to disrupt QS and evaluate 
their potential use as food preservatives. 
 In chapter two, we developed an analytical method for the detection of QS AI-2 
molecules in saliva, stool, and intestinal samples. For that, we developed a whole-cell 
biosensing system, which is based on the QS regulatory circuit of the marine bacterium 
Vibrio harveyi and uses the LuxP periplasmic binding protein as the sensing/recognition 
element and luxCDABE gene cassette as the reporter element. This method enabled the 
quantitative and sensitive detection of AI-2 in the types of clinical samples mentioned 
above. To the best of our knowledge this is the first reported cell-based sensing system 
for quantitative detection of AI-2 molecules. This analytical approach has significant 
advantages over physical chemical methods in terms of simplicity, rapidity, and cost-
effectiveness. 
 In chapter three, we developed, optimized, and applied whole-cell biosensing 
systems to the detection of QSMs in blood serum. We utilized a panel of three 
biosensing systems able to detect short-chain AHLs, long chain AHLs, and AI-2 
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molecules, respectively. In order to validate our method, we confirmed the presence of 
QSMs in serum by employing a conventional physical chemical technique, LC-MS-MS. 
Furthermore, using a mice animal model of colitis, which represents an experimental 
model of human IBD, we demonstrated altered serum levels of QSMs in colitic mice as 
compared to the controls. This indicates that the QSM levels in serum may reflect the 
known altered composition of the intestinal microflora in IBD (less diversity and 
modified relative abundance of species), thus supporting our hypothesis of employing 
QSMs as biomarkers of disease. To the best of our knowledge this is the first time that 
the presence of QSMs in serum has been demonstrated. This is an important finding due 
to the ready availability and minimally invasive collection of serum, as well as its 
extensive use as the biological fluid of choice for a number of clinical laboratory 
investigations. 
 In chapter four, we developed methods based on whole-cell sensing systems for 
the detection of AHLs and AI-2 molecules in food samples. Ground beef and milk were 
chosen as representative food matrices. After the method optimization, the biosensing 
systems were employed to detect QSMs in simulated spoiled foods, obtained by 
artificially contaminating the food samples. A wide variety of microorganisms are 
responsible for food spoilage, thus rendering contamination difficult to identify; on the 
other hand, QSM production is a feature shared by many bacteria, thus supporting the 
use of QSMs as general quantitative markers of bacterial presence. To that end, the 
analytical methods developed herein should allow for the early detection and 
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prevention of food contamination, thus helping to minimize the related foodborne 
illnesses and reduce the costs associated with the waste of degraded food. 
 In chapter five, we employed the developed whole-cell sensing systems for AHL 
and AI-2 detection to test a number of compounds, originating from Generally 
Recognized As Safe (GRAS) substances, for their ability to interfere with QS. The GRAS 
compounds chosen in this study had previously been demonstrated to possess an 
antibacterial effect, although their mechanisms of action had not been elucidated. To 
that end, these compounds were evaluated for their effects on the QS circuits of the 
sensing bacteria, in terms of ability to induce a sensor’s response and to interfere with 
the sensor’s response to cognate QSMs. In addition, effects on the QSM synthesis by 
QSM-producing bacteria were analyzed. Quorum sensing inhibition has been proposed 
as an alternative approach to combat bacterial infections, especially in light of the 
frequent occurrence of antibiotic resistant microorganisms. Along the same lines, the 
identification of GRAS compounds with QS inhibitory properties may lead to their safe 
and successful employment as food preservatives, in the form of food additives and/or 
components of food packaging materials. 
 In chapter six, we designed and developed a protein based biosensing system for 
the detection of AI-2 molecules. A fusion protein, comprised of the LuxP 
recognition/binding protein and enhanced green fluorescent protein (EGFP), was 
designed using molecular cloning techniques. The sensing system worked on the 
principles of Förster Resonance Energy Transfer (FRET) and utilized the fluorophore 7-
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diethylamino-3-[N-(2-maleimidoethyl)carbamoyl]coumarin (MDCC) as donor and EGFP 
as acceptor in the FRET pair, based on the ability of MDCC to bind to LuxP. This 
biosensing system allowed us to quantitatively detect AI-2 molecules with high 
sensitivity, selectivity, and rapidity (3 min incubation time with the analyte). It was then 
applied to detect AI-2 in saliva and serum samples. A protein based sensing system 
could also be employed as a rapid tool for the investigation and characterization of 
agonists and antagonists, with potential to be utilized as QS disruptors. 
 In chapter seven, we discussed the conclusions and future prospects of the work 
presented in this thesis. 
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CHAPTER TWO 
WHOLE-CELL SENSING SYSTEM FOR DETECTION OF THE QUORUM SENSING UNIVERSAL 
SIGNAL AUTOINDUCER-2 IN PHYSIOLOGICAL SAMPLES 
Introduction 
 Bacteria have long been considered as independently living organisms focused 
on survival and propagation of single cells. However, in the past few decades it was 
discovered that they can communicate with and respond to neighboring bacteria of the 
same species or of other species by means of small signaling molecules12,14. This system 
of communication among bacteria is termed quorum sensing (QS). Quorum sensing 
allows bacteria to regulate behaviors as diverse as bioluminescence, horizontal transfer 
of DNA, sporulation, formation of biofilms, as well as production of pathogenic factors, 
antibiotics, and metabolites12,100. Bacteria synthesize quorum sensing signaling 
molecules and release them in the surrounding media, where they are recognized by 
other bacteria. The signaling molecule concentration increases as a function of cell 
density, thus allowing bacteria to sense their population size. When a threshold 
concentration of signaling molecules is reached, bacteria express certain specialized 
genes and, thus, coordinate their behavior in a cell-density dependent manner. 
Interestingly, bacterial communication is often involved in establishing relationships of 
bacteria with their respective hosts, both in beneficial and detrimental bacteria-host 
interactions. Well-characterized examples of such relationships include the symbiosis 
between the bioluminescent marine bacterium Vibrio fischeri and the Hawaiian bobtail 
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squid Euprymna scolopes, as well as the pathogenesis caused by the human 
opportunistic pathogen Pseudomonas aeruginosa, which colonizes the lungs of 
individuals affected by cystic fibrosis101. Furthermore, recent research has shown that 
bacterial signaling molecules enable interkingdom communication and are involved, for 
instance, in the relationship of the intestinal microbial flora, both commensal and 
pathogenic, with human and other mammalian hosts102,103. Bacteria employ various 
chemical compounds as signaling molecules for quorum sensing communication. Some 
of them are species-specific, while others are used by different species of bacteria. 
Quorum sensing signaling molecules can be categorized based on the types of bacteria 
that produce them. In general, Gram negative bacteria use N-acyl homoserine lactones 
(AHLs) and Gram positive bacteria employ autoinducing peptides (AIPs) as quorum 
sensing molecules. AHLs and AIPs are used for communication between bacteria of the 
same species.  Another group of molecules, collectively called autoinducer-2 (AI-2), are 
found in culture supernatants of both Gram positive and Gram negative bacteria and are 
used for inter-species communication12. 
 The term AI-2 refers to a group of interconverting molecules formed from a 
common precursor, 4,5-dihydroxy-2,3-pentanedione (DPD), whose production in 
bacterial cells is catalyzed by the LuxS enzyme. LuxS has a crucial function as it is 
responsible for metabolism of the toxic intermediate S-adenosyl-L-homocysteine (SAH), 
which is formed from S-adenosyl-L-methionine (SAM) upon the release of methyl groups 
to be employed in the methylation of proteins, nucleic acids and metabolites. A two 
step enzymatic conversion of SAH by Pfs and LuxS enzymes produces DPD as a 
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byproduct. DPD undergoes spontaneous cyclization to generate either the R or S form of 
the thermodynamically favorable compound, 2,4-dihydroxy-2-methyldihydro-3-
furanone (DHMF). In the presence of water and borate, S-DHMF forms S-THMF-borate 
(Figure 1), a furanosyl borate diester, which is the form of AI-2 employed for QS 
regulation of bioluminescence in Vibrio harveyi104. AI-2 diffuses out of the cells and, 
upon entering other cells and binding to the periplasmic binding protein LuxP, triggers a 
cascade of phosphorylation/dephosphorylation events ultimately leading to the 
expression of luciferase and production of light48.  
Bacterial quorum sensing molecules, namely AHLs, have been identified in 
physiological samples, such as sputum samples of patients with cystic fibrosis8,25,26. 
Studies have shown that not only quorum sensing molecules activate bacterial virulence 
systems and bacterial proliferation at a particular defined cell density, but also modulate 
the host immune system to the advantage of bacteria105. Bacteria are known to play an 
important role in many diseases, from infections to chronic inflammation. Therefore, 
quorum sensing is involved in a variety of disorders of bacterial origin or where bacteria 
play a crucial pathogenic role. One such condition is inflammatory bowel disease (IBD), a 
chronic inflammation of the gastrointestinal (GI) tract that includes debilitating diseases 
such as ulcerative colitis (UC) and Crohn’s disease (CD). The inflammation in ulcerative 
colitis is concentrated in the colon as has a continuous distribution, whereas Crohn’s 
disease encompasses inflammation in the ileum and other regions of the alimentary 
tract in patches106. Both diseases are characterized by periods of increased 
inflammatory activity that can occur against a background of chronic ongoing 
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inflammation. The causes of IBD are not fully elucidated. However, studies carried out in 
animals and humans have established that gut bacterial flora play an essential role in 
these inflammatory states of the bowel. Specifically, IBD appears to be caused by an 
overly aggressive immune response to commensal enteric bacteria in genetically 
predisposed individuals107. Hence, monitoring of quorum sensing molecules over the 
course of time can give an idea of the bacterial load, extent of inflammation and 
progress of the disease. Recently, our group has developed whole-cell sensing systems 
for the detection of AHLs and shown that these signaling molecules are present at 
distinct concentrations in saliva and stool samples from CD patients and infants with 
various types of intestinal inflammatory illnesses.  These results suggest that quorum 
sensing molecules may be potential non-invasive biomarkers of gastrointestinal 
inflammatory disease27. 
 A bioassay based on the V. harveyi strain BB170, which is able to emit 
bioluminescence in the presence of AI-2 molecules, was developed by Bassler et al.16. 
This bioassay has mainly been employed to screen cell culture supernatants to identify 
and investigate bacteria able to produce AI-2; as such, it has not been characterized in 
terms of analytical performance and standardized for detection of AI-2 in clinical 
samples. Herein, we present the design, development, optimization, standardization, 
and characterization of a biosensing system based on V. harveyi BB170, as well as its 
application for the quantitative detection of AI-2 in saliva, stool and intestinal samples 
from IBD patients and control subjects.  
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Experimental Section 
Materials: Sodium chloride and anhydrous magnesium sulfate were purchased from 
Sigma (St. Louis, MO). Vitamin free casamino acids were purchased from BD Scientific 
(Franklin Lakes, NJ). Autoinducer-2 was purchased from Omm Scientific (Dallas, TX). 
Reverse osmosis (RO) filtered water (Milli-Q water purification system, Millipore, 
Bedford, MA) was utilized for all experiments. Sterile 14-mL culture tubes were 
purchased from BD Biosciences (San Jose, CA). 1.5-mL microcentrifuge tubes were 
purchased from Eppendorf (Westbury, NY). 96-well polystyrene microtiter plates were 
purchased from Costar (Corning, NY). The orbital shaker incubator was from Fisher 
Scientific (Fair Lawn, NJ). Bioluminescence measurements were performed using the 
FLUOstar Optima microplate reader (BMG Labtech, Durham, NC). 
Bacterial Strain and Culture Conditions: V. harveyi strain BB170 was purchased from 
ATCC (Manassas, VA). The BB170 strain is genetically modified to express luciferase and 
emit light only in response to the autoinducer-216. The autoinducer bioassay (AB) media 
described by Greenberg et al. was used to grow cells108. Cells were grown overnight in 
AB media in the orbital shaker at 30 °C, 250 rpm and glycerol stocks were prepared by 
adding 250 µL glycerol to 750 µL cell culture; the stocks were then stored at -80 °C. 
Fresh cell cultures were grown from the glycerol stocks as needed by incubation in the 
orbital shaker at 30 °C, 250 rpm until an optical density at 600 nm (O.D.600nm) of 0.01-
0.02 was reached. 
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Sample Collection and Preparation. Saliva, stool and intestinal samples were assayed 
for the presence of AI-2 molecules. Saliva and intestinal samples were obtained from 
patients with inflammatory bowel disease in the Gastroenterology Clinic of the 
University of Kentucky Medical Center (Lexington, KY). Intestinal samples were 
comprised of rectal samples, which can be assimilated to stools, and ileal as well as 
duodenal washings collected during endoscopy. Saliva samples were also obtained from 
healthy volunteers. Additionally, stool samples were obtained from infants in the 
Newborn Intensive Care Unit (NICU) of the University of Kentucky Medical Center. Saliva 
samples were collected in the morning immediately after brushing the teeth in order to 
minimize collection of oral bacteria and debris. They were then processed by 
centrifugation in sterile microcentrifuge tubes at 13,000 rpm for 7-8 minutes to facilitate 
settling of any debris and particles to the bottom of the tubes. Supernatants were then 
stored in sterile tubes at -80 °C till needed. For analysis, saliva samples were diluted 1:10 
(v/v) and 1:100 (v/v) using RO filtered water. Stool and intestinal washing samples were 
frozen right after collection and stored at -80 °C until assayed. Stool samples were 
prepared for analysis by weighing certain amounts of specimens and then suspending 
and diluting them in RO filtered water to a final dilution of 1:750 (w/v). Washing 
samples were analyzed directly without any sample preparation. 
Dose-Response Curves. A commercially available 3.9 mM stock solution of AI-2 in water 
was employed. Just before use, the stock solution was serially diluted with RO filtered 
water to prepare AI-2 standard solutions at concentrations ranging from 1 × 10-4 M to 
2.5 × 10-8 M. RO filtered water served as blank. 10 µL of each AI-2 standard solution and 
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blank was added in triplicate to the microtiter plate wells containing 90 µL of cell culture 
grown to an O.D.600nm of 0.010. The plate was incubated in the orbital shaker at 30 °C, 
175 rpm for 2.5 hours. Bioluminescence was recorded in the microplate reader and 
measurements were expressed as relative light units (RLU) and plotted using Microsoft 
Office Excel 2007. 
Dose-Response Curves in Saliva and Stool Matrices. Dose-response curves were 
generated in saliva and stool matrices. A pool of saliva was prepared by mixing equal 
volumes of processed saliva samples obtained from healthy volunteers. Pooled saliva 
was then diluted 1:100 (v/v) with RO filtered water. The 3.9 mM stock solution of AI-2 
was serially diluted with 1:100 (v/v) pooled saliva to prepare AI-2 solutions at 
concentrations ranging from 1 × 10-4 M to 2.5 × 10-8 M. A solution containing 1% RO 
filtered water in 1:100 (v/v) pooled saliva served as blank. 10 µL of each AI-2 solution 
and blank was added in triplicate to the microtiter plate wells containing 90 µL of cell 
culture, and the assay was performed as described above. A dose-response curve 
without matrix was also obtained in the same analytical run, which served as a 
reference. In order to prepare a pool of stool samples, 10 samples from infants admitted 
to the NICU were weighed in equal amounts, mixed together, and then suspended and 
diluted 1:750 (w/v) in RO filtered water. The 3.9 mM stock solution of AI-2 was serially 
diluted with 1:750 (w/v) pooled stool to prepare AI-2 solutions at concentrations 
ranging from 5 × 10-4 M to 5 × 10-8 M. A solution containing 1% RO filtered water in 
1:750 (w/v) pooled stools served as blank. 10 µL of each AI-2 solution and blank was 
added in triplicate to the microtiter plate wells containing 90 µL of cell culture, and the 
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assay was performed as described above. A typical dose-response curve without matrix 
was also obtained in the same analytical run as a reference. 
Analysis of Physiological Samples. Collection and processing of saliva, stool and bowel 
secretion samples is described above. A final volume of 10 µL of each of the processed 
samples was added in triplicate to the microtiter plate wells containing 90 µL of cell 
culture, and the assay was performed as described above. Each analytical run included a 
dose-response curve generated using standard AI-2. 
 
Results and Discussion 
 Several recent reports implicate intestinal microorganisms in the pathogenesis of 
IBD. Studies on animal models have shown that IBD does not occur in germ free 
environments and that enteric bacteria are essential for development of colitis109. A 
number of bacteria have been postulated to play a role in the pathogenesis of Crohn’s 
disease, including Mycobacterium avium subspecies paratuberculosis, Pseudomonas 
species, adherent-invasive Escherichia coli, and Streptococci106; however, no definitive 
evidence exists to support any specific microorganism as the causative agent of IBD. 
Additionally, some Crohn’s patients subjected to prolonged treatment with antibiotics 
have shown improvement110, indicating that bacterial flora must play a crucial role in 
IBD. Importantly, it has been demonstrated that the bacterial composition of IBD 
inflamed intestine differs from that of healthy intestine, with decreased microbial 
diversity and increased relative abundance of certain taxa in IBD111,112. 
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The above mentioned reports, along with other published data point to the presence of 
bacterial quorum sensing molecules in human samples; however, only a few analytical 
studies have been performed to identify and quantify these signaling molecules in 
physiological specimens. Kumari et al. have utilized whole-cell based biosensing systems 
for detecting and quantifying nanomolar levels of AHL molecules in complex clinical 
samples, like saliva and stool27.  Sperandio et al. report that fecal filtrates contain AI-2, 
although quantitative analysis has yet to be performed113. Recently, Campagna et al. 
have utilized liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) 
to quantify AI-2 molecules in saliva of healthy individuals114.  The method required 
analyte derivatization, which is time consuming and may result in inaccurate 
measurements caused by low efficiency of the derivatization reaction due to the 
complex nature of the biological matrix. 
Herein we developed, optimized, and characterized a whole-cell sensing system 
based on V. harveyi BB170 for the quantitative detection of AI-2 in physiological 
samples, i.e., saliva, stool and intestinal fluids, from healthy individuals as well as IBD 
patients. The bioluminescent bacterium V. harveyi, in its natural wildtype form has 
multiple parallel quorum sensing circuits that regulate bioluminescence.  Among those, 
there is a circuit that responds to AHLs and another one to AI-2 (Figure 2). The V. harveyi 
BB170 variant employed in this study was, in contrast, genetically modified to only 
respond to AI-2. When AI-2 enters the cells, it binds to the periplasmic binding protein 
LuxP, which undergoes a change in conformation upon binding to AI-2 and initiates the 
transcription of the luxCDABE cassette, which codes for bacterial luciferase and other 
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enzymes that catalyze the synthesis of the luciferase substrate. Thus, presence of AI-2 
triggers the expression of luciferase, its substrate, and ultimately results in the 
generation of bioluminescence.  In the optimized conditions described in this work, the 
light signal derived from the luciferase-dependent reaction is proportional to the AI-2 
present in the environment of the sensing cells. Therefore, the whole-cell sensing 
system is appropriate for monitoring the levels of AI-2 in saliva, stool, and intestinal 
washing samples. It is well established that the concentration of biomolecules and drugs 
in saliva reflects their systemic concentration because of the ability of many substances 
to reach saliva via intracellular and extracellular routes115. On the other hand, stool and 
rectal samples as well as intestinal washings are considered to be representative of the 
environment present in the bowel116.  
As mentioned above, the V. harveyi strain BB170 has been employed as the 
detection element in a bioassay aimed at investigating the ability of a variety of bacterial 
species and strains to produce AI-2. For that, the bacteria under examination are grown 
for a period of time and the culture supernatants are then exposed to the reporter 
strain for induction of bioluminescence due to the presence of AI-2. The conventional 
experimental protocol employed in these studies is time-consuming (4 hours) and only 
provides qualitative data117,118.  In that regard, the goal of this work was to develop a 
whole-cell sensing system based on V. harveyi BB170 for the quantitative detection of 
AI-2 molecules in physiological samples.  To that end, we first developed a sensing 
system for the detection of AI-2 quorum sensing molecules.  We then optimized and 
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standardized the experimental protocol for effective and efficient use of the biosensing 
system in clinical applications.  
Modifications to the conventional assay protocol allowed for a 40% reduction in 
time to perform the entire assay (2.5 h vs. 4 h). By exposing the sensing cells to standard 
solutions containing various concentrations of AI-2, we were able to establish a dose-
response curve with a detection limit of 2.5 × 10-8 M AI-2 and a dynamic range of 2.5 × 
10-8 M to 1 × 10-5 M. The limit of detection (LOD) was defined as sum of the average of 
the blank signal and three times its standard deviation. The sensing system proved to be 
precise and reproducible, with intra- and inter-assay percent relative standard deviation 
(%RSD) values less than 8%. It is noteworthy to point out that the limit of detection 
obtained with our whole-cell sensor is well below the levels of AI-2 found in human 
saliva (244-965 nM) by Campagna et al. using LC-MS/MS119. This further supports the 
applicability of the cell-based sensing system to the analysis of physiological/clinical 
samples. 
When the whole-cell biosensing system was used for detection of AI-2 in stool, 
significant quenching of the bioluminescence signal was observed.  Dilution studies 
were then performed in order to determine a proper stool dilution that did not show 
any matrix interference (data not shown). A 1:750 (w/v) dilution of stool with RO 
filtered water was found to be required to eliminate matrix effect. A dose-response 
curve was constructed in 1:750 diluted pooled stool samples and compared with a 
standard dose-response curve (Figure 3). As observed in the figure, the two dose-
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response curves virtually overlapped and exhibited similar analytical characteristics 
(Table 1). Thus, a 1:750 (w/v) dilution was chosen to test unknown stool samples. A 
matrix effect was also observed when saliva samples were analyzed directly, without 
dilution. A dose-response curve was obtained by adding AI-2 solutions at known 
concentrations to a pool of saliva samples, which showed signal intensities lower than 
those observed when the dose-response curve was generated with known AI-2 
standards in water.  Optimization studies determined that a 1:100 (v/v) dilution of saliva 
was able to eliminate the matrix effect and allowed for the generation of analytically 
sound dose-response curves (Figure 4). The analytical parameters of dose-response 
curves obtained in different matrices are reported in Table 1.   
After optimizing the assay conditions, we employed the whole-cell sensing 
system to detect AI-2 levels in individual saliva, stool, and intestinal samples collected 
from IBD patients and healthy subjects (Table 2). The obtained data proved that AI-2 
was detectable in all three different types of samples. Although only a few samples were 
analyzed, it is interesting to observe that distinct levels of AI-2 were detected in the 
tested samples. Specifically, AI-2 levels varied considerably in stool samples from IBD 
patients, which may support the hypothesis that variations in the concentrations of 
QSMs in those samples may reflect perturbation of the microflora in the inflamed 
intestine111,112. To the best of our knowledge, this is the first time that the levels of AI-2 
are quantified in human stool and intestinal samples.  The results obtained point out to 
a potential use of our method as a rapid and inexpensive tool for diagnosis and 
monitoring of bacterial-related conditions, including IBD, where bacteria is thought to 
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play an important role.  We postulate that correlation of AI-2 levels in physiological 
samples with the status of the disease may have implications in the potential use of AI-2 
as a biomarker of disease.  Work toward the verification of this hypothesis by 
performing clinical studies is underway in our laboratories. 
Conclusion 
In conclusion, we have designed, developed and optimized a whole-cell based 
biosensing system that allows for quantitative detection of AI-2 quorum sensing 
molecules in human samples. When employed for the detection of AI-2 in physiological 
specimens, the method proved to be rapid, reproducible, and sensitive, with a detection 
limit of 2.5 × 10-8 M. Additional advantages of the method lie in the requirement of 
small unprocessed sample amounts (approximately 1 µL of saliva and less than 1 mg of 
stool) and the potential for high-throughput analysis which are important for clinical 
applications, such as monitoring of IBD patients for their AI-2 levels over a period of 
time. This sensing system should also be applicable to other bacteria-related conditions. 
Furthermore, the analytical features of this method make it amenable to investigation 
of compounds that may act as agonists or antagonists in the AI-2-mediated QS system; 
this may lead to the identification of QS inhibitors that could be employed as drugs in an 
alternative approach for the treatment of bacteria-related disorders. 
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Figure 1.  Synthesis of DPD in bacteria. By the action of methyltransferases, S-
adenosylmethionine (SAM) is converted to S-adenosylhomocysteine (SAH). SAH is 
metabolized to adenine and S-ribosylhomocysteine (SRH) by Pfs enzyme. SRH is the 
substrate for the enzyme LuxS catalyzing the synthesis of 4,5-dihydroxy-2,3-
pentanedione (DPD). (b) DPD undergoes spontaneous cyclization and forms (2R,4S)- and 
(2S,4S)-2,4-dihydroxy-2-methyldihydrofuran-3-one (R- and S-DHMF, respectively). R- 
and S-DHMF undergo hydration to form (2R,4S)- and (2S,4S)-2-methyl-2,3,3,4-
tetrahydroxytetrahydrofuran (R- and S-THMF, respectively). In the presence of borate, 
S-THMF converts to (2S,4S)-2-methyl-2,3,3,4-tetrahydroxytetrahydrofuran-borate (S-
THMF-borate), i.e., the autoinducer-2 form utilized by Vibrio harveyi. R-THMF is the 
autoinducer-2 form utilized by other bacteria, such as, Salmonella typhimurium. Figure 
copyright from Xavier et al.19 
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Figure 2. Quorum sensing regulation of bioluminescence in V. harveyi BB170. System 1, 
which uses an AHL as quorum sensing molecule, has been silenced. Therefore, 
production of bioluminescence only depends on AI-2 (System 2). 
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Figure 3. Standard dose-response curve (black) compared with dose-response curve in 
1:750 (w/v) stool (red). 
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Figure 4. Standard dose-response curve (blue) compared with dose-response curve in 
1:100 saliva (red). 
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Table 1. Analytical parameters of the whole-cell biosensing system in buffer and 
physiological matrices. 
 
Signal Intensity 
with 5 x 10-5 M 
AI-2 
(× 104 RLU) 
Signal Ratio LOD 
(M) 
Dynamic Range 
(M) 
Buffer 7.9 1 
2.5 × 10-
8 
2.5 × 10-8 - 5.0 × 
10-5 
1:750 (w/v) 
Stool 7.1 1.11 
5.0 × 10-
8 
5.0 × 10-8 - 5.0 × 
10-5 
1:100 (v/v) 
Saliva 7.7 1.03 
2.5 × 10-
8 
2.5 × 10-8 - 5.0 × 
10-5 
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Table 2. Detection of AI-2 in clinical samples from IBD patients (white) and healthy 
subjects (gray).  
Samples 
Signal Intensity 
(× 104 RLU) 
%RSD 
Stool 1 1.8 6 
Stool 2 3.8 7 
Ileal washing 2.5 7 
Saliva 1 2.5 6 
Saliva 2 2.4 10 
Saliva 3 1.9 1 
Saliva 4 1.2 6 
Saliva 5 1.3 5 
Saliva 6 2.3 6 
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CHAPTER THREE 
DETECTION OF QUORUM SENSING MOLECULES IN BLOOD SERUM 
 
Introduction 
 Bacteria are known to cause a variety of disorders from acute and chronic 
infection to inflammation, within and on the surface of the human body. Bacterial 
infections can be caused by a variety of microorganisms and result in mild to life-
threatening conditions. Furthermore, certain bacteria are involved in chronic diseases, 
such as, inflammatory bowel disease (IBD)120 and cystic fibrosis26. A notable feature of 
bacteria is their ability to form biofilms. Biofilms were first reported by J. W. Costerton 
in 1978; using light and electron microscopy, he demonstrated the presence of biofilms 
on inanimate surfaces in an aquatic environment121. The presence of biofilms in cystic 
fibrosis lung infections has been shown by Singh et al.25. Bacterial infections are 
generally treated by antibiotic administration. Formation of biofilms contributes to 
pathogenicity and makes the treatment less effective as bacteria are encased in a matrix 
composed of polysaccharides and proteins that reduces the contact between bacteria 
and antibacterial agent122. In addition, due to extensive usage of antibiotics, several 
pathogenic bacteria have gained antibiotic resistance through mutations and lateral 
gene transfer. Indeed, alternative strategies against bacterial infections that involve new 
classes of antibiotics are needed more than ever. In that regard, compounds that are 
inhibitors of quorum sensing, the mechanism by which bacterial cells communicate and 
ultimately leads to biofilm formation, provide with a new approach to combating 
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bacterial infection. Other bacterial behaviors such as virulence factor production, 
swarming, and motility are also modulated through quorum sensing. Bacterial quorum 
sensing circuits operate via synthesis and secretion of small organic molecules, termed 
as quorum sensing molecules (QSMs), which are recognized by bacteria of the same 
species (intra-species communication) or of other species (inter-species 
communication). Once these molecules enter the bacterial cell, they initiate a cascade 
of events leading to the expression of certain target genes. A general schematic of the 
quorum sensing circuits in the pathogenic bacterium Pseudomonas aeruginosa is shown 
in Figure 1. The expression of the aforementioned genes is regulated in a cell-density 
dependent manner. When cell density is low, the amount of QSMs in the environment 
around bacteria is low and the expression of genes is repressed. As the cell density 
gradually increases, the amount of QSMs in the environment also increases 
proportionally and, when a certain QSM threshold concentration is reached, the genes 
are expressed12. Gram-negative bacteria utilize N-acyl homoserine lactones (AHLs) and 
Gram-positive bacteria utilize autoinducing peptides (AIPs) for intra-species 
communication. A third category of molecules, known as autoinducer-2 (AI-2), is used 
for interspecies communication as the genes coding for the proteins that either 
synthesize or bind AI-2 are present in both Gram-negative and Gram-positive bacteria. 
Recently, Sperandio et al. postulated that a new type of QSM, autoinducer-3, is involved 
in interkingdom communication between bacteria and their hosts17. Figure 2 lists few 
examples of QSMs and the bacteria that synthesize them. 
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 Reports relating quorum sensing to bacterial infections have emerged in the last 
decade. Singh et al. reported the presence of biofilms of the pathogenic bacterium P. 
aeruginosa in the lungs of cystic fibrosis patients. It has been demonstrated that the 
presence of biofilms reduce the effectiveness of even aggressive antibiotic treatment25. 
Two AHLs, N-butyryl-L-homoserine lactone (C-4 HSL) and N-(3-oxododecanoyl)-L-
homoserine lactone (3-oxo-C-12 HSL), used by P. aeruginosa to control biofilm 
formation as well as virulence determinant production, were identified in sputum 
samples from these patients. The significance of quorum sensing in burnt wound 
infections in mice was demonstrated by Rumbaugh et al. who found that mice infected 
with mutant strains of P. aeruginosa that were unable to synthesize AHLs had lower 
levels of virulence expression as compared to those infected with wild type P. 
aeruginosa22. Another study also highlighted the importance of quorum sensing using a 
mouse model with ascending urinary tract infections123. These studies demonstrate the 
relevance of detecting and quantifying QSMs. If a relationship between levels of QSMs 
in physiological specimens and status of the disease is established, QSMs could be used 
as biomarkers of bacteria-related disorders. 
The most common techniques to detect QSMs include various physical-chemical 
methods and biosensing systems. Physical-chemical methods, such as, GC-MS124,125, 
HPLC-UV126, and LC-MS-MS127 require extensive sample preparation steps, often 
including derivatization119, expensive instrumentation, and specialized laboratory 
personnel, along with being time consuming and low throughput. While protein-based 
biosensing systems to detect QSMs are rapid, cost-effective, and easy to use, they are 
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limited by the stability of the sensing proteins in biological matrices and relatively high 
limits of detection128. Our group developed and employed two bioluminescent bacterial 
whole-cell biosensing systems based on the recognition and signal generation afforded 
by plasmids pSB406 and pSB1075, respectively, to detect with high sensitivity, 
selectivity, and reproducibility short and long chain AHLs in human saliva and stool 27.  
Bodily fluids such as saliva and blood are known to contain a variety of small molecules 
and proteins, many of which have been investigated for potential utility as biomarkers 
of diseases. We have previously demonstrated that AHLs are present in saliva and stool 
specimens27. However, until now blood has not been studied for the presence of QSMs. 
Blood transports oxygen and nutrients to cells and takes metabolic waste away from 
cells. In addition, it helps maintain body temperature, regulates pH, and allows 
protection against foreign agents by the action of white blood cells. Furthermore, blood 
represents one of the most commonly used fluids where clinically relevant molecules 
and drug metabolites are detected.   
In this study we aimed at investigating blood for the detection of QSMs. To the 
best of our knowledge, this is the first time that the presence of AHLs in blood serum is 
reported. Moreover, we validated our findings, which were achieved in human blood 
serum employing whole-cell sensing systems, by analyzing the serum samples using LC-
MS-MS. Furthermore, we demonstrated that AHLs can also be detected in animal 
serum. Specifically, in order to support the hypothesis of employing QSMs as biomarkers 
of disease, we report the results of a pilot study investigating the effects of 
experimentally induced colitis on the serum and stool levels of QSMs in mice models. 
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Experimental section 
Materials. N-hexanoyl-DL-homoserine lactone (C-6 HSL), N-dodecanoyl-DL-homoserine 
lactone (C-12 HSL), sodium chloride, anhydrous magnesium sulfate, Luria Bertani (LB) 
media, ampicillin, and kanamycin were purchased from Sigma-Aldrich (St. Louis, MO). 
Acetonitrile and methylene chloride used in all experiments were of HPLC grade and 
were purchased from VWR Scientific (Pittsburgh, PA). AI-2 was purchased from Omm 
Scientific (Dallas, TX). The 96-well microtiter plates were purchased from Costar 
(Corning, NY). Vitamin free casamino acids were purchased from BD Biosciences 
(Franklin Lakes, NJ).  
Plasmids, bacterial strains, and culture conditions. The plasmids pSB406 and pSB1075 
were originally provided by Dr. Paul Williams (University of Nottingham, Nottingham, 
UK) and previously transformed in Escherichia coli JM109 cells. The transformed cells 
were then stored at -80 °C as glycerol stocks. Fresh cell cultures were obtained from the 
glycerol stocks and grown in LB media (100 µg/mL aAmpicillin) overnight in an orbital 
shaker at 37 °C, 250 rpm, refreshed in the morning, and allowed to grow until an optical 
density at 600 nm (OD600nm) of 0.45-0.50 was reached. Vibrio harveyi MM32 cells were 
purchased from American Type Culture Collection (ATCC), and glycerol stocks were 
stored at -80 °C. Fresh cell cultures were obtained by growing cells in autoinducer 
bioassay (AB) media with 30 µg/mL of kanamycin overnight in the orbital shaker at 30 
°C, 250 rpm, and then refreshing the cultures in the morning to obtain an OD600nm of 
0.01-0.02. The procedure to prepare AB media has been described elsewhere16,129. 
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Dose-response curves. Commercially available N-acyl-homoserine lactones were 
dissolved in acetonitrile to obtain 1 x 10-2 M stock solutions, which were serially diluted 
with RO filtered water to obtain standard solutions at concentrations ranging from 1 x 
10-4 M to 1 x 10-8 M. A 1% (v/v) solution of acetonitrile in RO filtered water (0.1% (v/v) 
acetonitrile after adding to the sensing cell suspension) was used as blank. This amount 
of acetonitrile was not toxic for the sensing cells. A volume of 10 μL of each of these 
solutions was added in triplicate to a 96-well white polystyrene microtiter plate 
containing 90 µL/well of the corresponding E. coli cell culture grown to an OD600nm of 
0.45-0.50. C-6 HSL solutions were employed for the whole-cell sensor with pSB406, 
while C-12 HSL solutions were employed for the whole-cell sensor with pSB1075. The 
microtiter plate was then incubated in an orbital shaker at 37 °C at 175 rpm for two 
hours. Commercially available aqueous AI-2 solution (3.7 × 10-3 M) was serially diluted 
using RO filtered water to obtain solutions at concentrations ranging from 1 × 10-4 M to 
1 × 10-8 M. RO filtered water was used as blank. A 10 µL volume of each AI-2 solution 
and blank in triplicate was incubated with 90 µL of V. harveyi MM32 cell culture grown 
to an OD600nm of 0.01-0.02, in a microtiter plate. The produced bioluminescence from all 
the sensing systems was then measured using the FLUOstar Optima microplate reader 
(BMG Labtech, Durham, NC). The light intensity was expressed in relative light units 
(RLU). 
Human blood serum samples. Blood serum samples were obtained from IBD patients 
and healthy volunteers (Division of Gastroenterology, Department of Medicine, 
University of Miami Miller School of Medicine). Individual serum samples were stored at 
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-80 °C until analyzed. To prepare a pool of serum for matrix effect studies, equal 
volumes of serum samples from various healthy individuals were mixed together in a 
14-mL tube and vortexed for 5 minutes. Several aliquots of pooled serum were prepared 
and stored at -80 °C until needed.  
Serum dilution study. One aliquot of pooled serum was removed from -80 °C, thawed, 
and equilibrated to room temperature. To test for potential matrix effect, the serum 
was serially diluted with RO filtered water to obtain 1:10, 1:100, and 1:1000 dilutions. 
Each standard QSM (C-4 HSL, C-12 HSL, or AI-2) was added to aliquots of undiluted and 
diluted serum to achieve a final 1 × 10-6 M concentration. A 10 µL volume of each of 
these spiked and non-spiked serum samples at various dilutions was added in triplicate 
to 90 µL of the appropriate sensing cells, and the assay was performed as described 
above. A dose-response curve with the respective QSM was also included in each 
analytical run. 
Dose-response curves in serum matrix. 1 × 10-2 M stock solutions (prepared in 
acetonitrile) of C-6 HSL and C-12 HSL were serially diluted with 1:10 serum/water 
solution to obtain AHL concentrations ranging from 1 × 10-4 to 1 × 10-8 M. Acetonitrile at 
1% in the 1:10 serum/water solution was used as blank. Similarly, the available stock of 
AI-2 (aqueous solution at 3.7 × 10-3 M) was serially diluted with 1:10 serum/water 
solution to obtain AI-2 concentrations ranging from 1 × 10-4 to 1 × 10-8 M. A 10 µL 
volume of each of these solutions was added in triplicate to the wells of a microtiter 
plate, followed by addition of 90 µL of cell culture of the respective biosensing system. 
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The assay was then performed as described above. A reference dose-response curve 
was included in each analytical run.  
Serum storage study. Aliquots of pooled serum were spiked with C-6 HSL to obtain final 
concentrations in serum of 1 × 10-6 M and 1 × 10-7 M. Three sets of spiked serum 
samples were prepared; the first set was assayed immediately, the second set was kept 
at room temperature for six hours and then assayed, and the third set was kept at room 
temperature for two hours, later stored at -80 °C for 48 hours, and then assayed. Final 
concentration of Serum containing RO filtered water, instead of C-6 HSL solution, was 
used as blank for each storage condition. Aqueous solutions of C-6 HSL at 1 × 10-6 M and 
1 × 10-7 M concentrations served as controls. The serum samples were diluted 1:10 using 
RO filtered water, 10 µL of each diluted sample was added in triplicate to a microtiter 
plate containing 90 µL/well of the whole-cell biosensing system bearing pSB406, and the 
assay was carried out as described above.  
Analysis of human serum samples. After optimizing the experimental conditions, 
individual serum samples were diluted 1:10 using RO filtered water. A 10 µL volume of 
each diluted sample was added in triplicate to the wells of a microtiter plate and 
incubated with 90 µL of cell culture of each of the biosensing systems for detection of 
short chain AHLs, long chain AHLs, and AI-2, respectively. The assays were performed as 
described above. 
LC-MS-MS analysis of serum samples.  
Preparation of AHL standard solutions. Commercially available standard N-acyl-
homoserine lactones were dissolved in acetonitrile to obtain 1000 μg/mL solutions. 
90 
 
Twenty microliters of each of these 1000 μg/mL solutions of N-butyryl-DL-homoserine 
lactone (C-4 HSL), N-hexanoyl-DL-homoserine lactone (C-6 HSL), N-(3-oxohexanoyl)-DL-
homoserine lactone (3-oxo-C-6 HSL), N-octanoyl-DL-homoserine lactone (C-8 HSL), N-
decanoyl-DL-homoserine lactone (C-10 HSL), N-dodecanoyl-DL-homoserine lactone (C-
12 HSL), and N-tetradecanoyl-DL-homoserine lactone (C-14 HSL) was added to 860 μL of 
methanol/water (35:65, v/v) with 0.1% formic acid, in order to obtain a stock mixture 
solution containing 20 μg/mL of each of the seven AHLs. From this stock solution, AHL 
standard mixture solutions, which contained 50, 25, 10, 5, 1, and 0.5 ng/mL of each AHL, 
respectively, were prepared for calibration. N-heptanoyl-DL-homoserine lactone (C-7 
HSL) was used as an internal standard (since C-7 HSL is not produced by bacteria) for all 
the standard mixtures. A specific volume of 1 μg/mL solution of C-7 HSL in 
methanol/water (35:65, v/v) with 0.1% formic acid was added to each of the standard 
mixture solutions to achieve a final internal standard concentration of 25 ng/mL. These 
standard mixture solutions with the added internal standard served as laboratory 
control spike (LCS) solutions. Similarly, a specific volume of 1 μg/mL internal standard 
solution was added to water to obtain a final C-7 HSL concentration of 25 ng/mL. The 
resulting solution served as blank.  
Extraction of AHLs from serum samples. An extraction protocol similar to that used by 
Kumari et al. to extract AHLs from saliva samples130 was employed with modifications in 
this study. Briefly, an equivalent volume of acetonitrile was added to a pool of serum to 
precipitate the proteins out. The precipitate formed was centrifuged and the 
supernatant separated. The supernatant was then extracted using methylene chloride, 
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evaporated to dryness, reconstituted using mobile phase to about 100 µL and C-7 HSL 
was added as internal standard. The LC-MS-MS analysis was performed at the 
Environmental Research Training Laboratories (ERTL) of the University of Kentucky as 
previously described130. 
Animal Study. Wild type C57BL/6 mice were purchased from Jackson Laboratories (Bar 
Harbour, Maine). A total of nine mice, between 13 and 17 weeks of age, were used. In 
the course of study, mice were fed manufacturer prescribed diet (LabDiet® 5K52/5K67). 
Over a period of seven days, five mice were given a 3% aqueous solution of dextran 
sulfate sodium (DSS) through drinking water (5 mL per day) to experimentally induce 
colitis. Four mice that received equivalent amount of water, without DSS, served as 
controls. Serum and stool samples were collected from both animal groups on day 0 
(before DSS administration) and on day 7. Serum and stool samples were frozen at -80 
°C immediately upon collection. Serum samples were processed and analyzed as 
described above for human serum. Stool samples were processed by following the 
procedure described by Kumari et al.27. Briefly, a 20 mg/mL suspension of stool was 
prepared using 25:75 acetonitrile/water solution and diluted using RO filtered water to 
obtain a 1:1600 stool suspension. For analysis, a 10 µL volume of this stool suspension in 
triplicate was then incubated with 90 µL of cell culture of each of the whole-cell sensing 
systems. The assays were performed as described above. 
 
Results and Discussion 
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 A biosensing system consists of a biological recognition component coupled to a 
transducer component. A whole-cell biosensing system consists of the intact bacteria as 
the recognition component; the bacteria are genetically engineered to generate a 
readable output upon selective recognition of the analyte. The biosensing system 
produces a dose-dependent readable output in response to the analyte. The whole-cell 
biosensing systems carrying plasmids pSB406 and pSB1075 respond to short and long 
chain AHLs, respectively. Plasmid pSB406 contains the gene rhlR, which codes for the 
recognition/regulatory protein RhlR, and the reporter gene cassette luxCDABE, which is 
under the transcriptional control of promoter PrhlI. Similarly, plasmid pSB1075 bears the 
gene lasR, which codes for the recognition/regulatory protein LasR, and the reporter 
gene cassette luxCDABE, which is under the transcriptional control of promoter PlasI. The 
gene cassette luxCDABE encodes for the bioluminescent enzyme luciferase and enzymes 
that catalyze the synthesis of the luciferase substrate. In the presence of AHLs, the 
reporter is expressed in a dose-dependent manner and the produced bioluminescent 
signal is proportional to the AHL concentration present inside the cell.  In a similar 
manner, the whole-cell biosensing system based on V. harveyi MM32 responds to AI-2 
by producing bioluminescence in a dose-dependent fashion. V. harveyi is a 
spontaneously bioluminescent marine microorganism that controls light emission 
through various quorum sensing systems, which employ various QSMs. Specifically, the 
bacterium uses QS circuits that utilize N-3-hydroxybutanoyl homoserine lactone (HAI-1), 
(S)-3-hydroxytridecan-4-one (CAI-1), AI-2, and recently discovered nitric oxide (NO). V. 
harveyi strain MM32 is genetically modified in such a way that it only emits 
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bioluminescence in response to AI-2. Additionally, it lacks the gene luxS encoding for 
LuxS protein, which synthesizes AI-215; in this way the cells do not produce their own AI-
2 and they can only produce bioluminescence in response to exogenous AI-2. Therefore, 
this strain can be employed as a sensor that responds with emission of light to AI-2 
present in the environment of the cells. In this work we optimized, characterized, and 
utilized E. coli pSB406 and pSB1075 based whole-cell biosensing systems, and V. harveyi 
MM32 based whole-cell biosensing systems, to detect AHLs and AI-2, respectively, in 
blood serum samples. 
 In our studies, we collected individual blood serum samples from healthy 
volunteers and mixed them together to obtain a pool of serum in order to take in 
account possible variations between samples.  Serum electrolytes, antibodies, 
hormones, and exogenous substances can affect the performance of biosensing 
systems, and therefore, serum needs to be evaluated in terms of its potential matrix 
effect on the determination of the AHLs in this sample.  For that, dilution studies were 
undertaken by preparing serial dilutions of serum with water followed by spiking studies 
in which a known concentration of analyte was added to serum. Serum 1:10, 1:100, and 
1:1000 dilutions were prepared using RO filtered water and incubated with the whole-
cell biosensing systems employed in this study. RO filtered water served as control. 
When undiluted pooled serum was incubated with the whole-cell biosensing systems, 
reduced bioluminescence was observed as compared to that of the control; the control 
bioluminescence was due to the background signal of the sensing cells. However, signals 
equivalent to that from the control were obtained from all the serum dilutions tested, 
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which showed that the quenching/inhibiting matrix effect was eliminated at even a very 
low dilution of the serum, i.e., 1:10 dilution of serum in water. These data were 
confirmed by spiking the undiluted serum and above serial serum dilutions with a 
known concentration of QSM and employing the corresponding whole-cell biosensing 
system to detect the AHLs as described in the Methods Section. As an example, Figure 3 
shows the results of the matrix effect studies performed using the whole-cell biosensing 
system containing pSB406. Dose-response curves using 1:10 dilution of the serum were 
then obtained. Standard solutions of QSMs were prepared by serial dilution in either 
1:10 serum or water and incubated with the sensing cells. As shown in Figure 4 for 
detection of short chain AHLs with the pSB406-based sensing system and AI-2 with the 
V. harveyi MM32-based sensing system, the two dose-response curves of each sensing 
system overlap, thus confirming that a 1:10 dilution of serum eliminates the matrix 
effect. Similar results were obtained with the sensing systems for detection of long 
chain AHLs. Limits of detection of 1 × 10-9 M for short and long chain AHLs, and of 5.0 × 
10-8 M for AI-2 were obtained in 1:10 diluted serum.  
Following optimization and characterization of the sensing systems for use in 
serum by evaluating and eliminating matrix effect through serum dilution, and defining 
the analytical parameters of the sensing systems in serum, we analyzed the blood serum 
samples obtained from IBD patients and control individuals. Inflammatory bowel 
disease is a chronic inflammatory condition of the intestine, which is characterized by 
recurrent acute inflammation episodes (flare-ups) over chronic persistent inflammation. 
The most common forms of IBD are Crohn’s disease (CD), which mainly affects the small 
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intestine as well as other parts of the gastrointestinal tract, and ulcerative colitis (UC), 
which affects the colon. The causes of IBD are not well understood; it is believed that 
several factors, including bacteria, play a role in the etiology of the disease. Specifically, 
there is evidence that an overly aggressive immune response towards the intestinal 
microflora occurs in genetically predisposed individuals131. Additionally, altered gut 
bacterial composition, with less diversity and changed relative abundance of species, 
has been demonstrated in IBD patients as compared to healthy subjects132. For this 
study, we obtained 6 samples from control individuals, 10 samples from UC patients, 
and 8 samples from CD patients. The serum samples were analyzed after a 1:10 dilution 
with RO filtered water. When the whole-cell biosensing system containing plasmid 
pSB406 was employed, short chain AHLs were detected in a number of samples. 
Specifically, all control samples, except one, exhibited undetectable levels of AHLs; on 
the other hand, AHLs were detected in the majority of IBD samples, with UC patient 
samples showing a trend of higher bioluminescence signal intensities as compared to CD 
patient samples (Figure 5). Each sample was tested at least twice to confirm the above 
observation; consistent results were achieved, with good reproducibility as expressed by 
percent relative standard deviation (%RSD) values ranging from less than 1% to 10%. 
Although a limited number of samples were analyzed as proof of principle, the obtained 
data suggest that the differences in intestinal bacterial composition between IBD and 
healthy subjects, as reported in the literature, may be revealed by differences in QSM 
levels in physiological samples. This would support the use of QSMs as biomarkers of 
bacteria-related diseases. However, more samples derived from larger numbers of IBD 
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patients and controls need to be analyzed in order to confirm the observed trend. When 
the whole-cell biosensing system containing plasmid pSB1075 was employed, long chain 
AHLs were not detected in any of the tested samples. Additionally, when samples were 
analyzed using the MM32-based sensing system, none of them showed AI-2 levels in our 
detection range. One could speculate that this may be due to limited stability of certain 
QSMs, e.g., AI-2 in serum. On the other hand, stability of long chain AHLs in human 
serum should not be an issue, as shown by the LC-MS-MS study discussed below. 
Further investigations are required to clarify the obtained data.  
Since no studies have previously reported the presence of QSMs in serum, we 
deemed it necessary to confirm our findings using a conventional physical-chemical 
technique, such as LC-MS-MS. Recently, our group developed an LC-MS-MS method to 
detect AHLs in saliva130. In this work, using HPLC coupled to tandem mass spectrometry 
and the above protocol with slight modifications, we were able to separate and 
quantitate AHLs present in standard mixture solutions, with nanomolar limits of 
detection. We subsequently analyzed pooled serum samples. Unlike saliva, serum forms 
an emulsion if methylene chloride is used for AHL extraction. Therefore, we first 
precipitated the proteins from serum by adding acetonitrile. This step ensured that AHLs 
were solubilized in acetonitrile. After separating supernatant from precipitate, 
methylene chloride extraction was performed; the extract was then evaporated, dried, 
and reconstituted with mobile phase to run the sample on LC-MS-MS. As shown in 
Figure 6, C-8 HSL, C-10 HSL, C-12 HSL, and C-14 HSL were detected in extracted serum 
samples. The daughter ion analysis (Table 1) further confirmed the identity of AHLs that 
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were present in serum. These results are significant because they support that AHLs are 
actually present in serum and validate the use of whole-cell sensing systems for 
detection of AHLs in this type of physiological sample.  
Sample storage conditions are crucial when collecting and analyzing clinical 
samples. To that end, we carried out a study where we spiked pooled serum samples 
with C-6 HSL to obtain two final concentrations of, 1 × 10-6 M and  1 × 10-7 M, and then 
stored these spiked samples in various conditions before assaying them with the whole-
cell biosensing system containing pSB406. The storage conditions tested were meant to 
represent those actually employed when collecting patient serum samples in hospital 
settings. After spiking, sets of serum samples were either assayed immediately, or after 
being kept at room temperature for 6 hours, or after being kept at room temperature 
for 2 hours followed by storage at -80 °C for 48 hours. We found that (Figure 7), among 
these spiked serum samples, only those that were assayed immediately showed a 
bioluminescence signal intensity similar to that of the control (same AHL concentrations 
in water. This indicates that AHLs rapidly degrade in serum at room temperature; hence, 
serum samples should not be left at room temperature and should rather be frozen as 
soon as possible after collection. 
 While no reports are available with regard to stability of AI-2 in blood, few 
studies have indicated that blood of mammals carries enzymes, known as paraoxonases 
(PONs), which are capable of degrading AHLs133-136. In humans, three kinds of 
paraoxonases have been identified – PON1, PON2, and PON3. PON1 and PON3 are 
synthesized in the liver and secreted into the blood. PON2, which has the highest 
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activity for AHLs hydrolysis, is expressed in many tissues, including brain, kidney, liver, 
and testis, but not in blood. While PON1 and PON3 are mostly involved in hydrolysis of 
organophosphates, both of them are active lactonases, although with activity much less 
than that of PON2134,136. The presence of PON1 and PON3 in blood may affect the 
stability of lactones, including AHLs, and thus affect the amount of AHLs detected. 
Interestingly, one report has indicated reduced levels of PON1 enzymes in the serum of 
CD and UC patients as compared to controls137. This reduced lactonase activity may 
explain, at least in part, the higher levels of short chain AHLs that we observed in IBD 
patients with respect to controls. In healthy individuals, higher levels of PON enzymes 
may degrade AHLs more effectively, while in IBD patients lower levels of PON enzymes 
are unable to degrade AHLs effectively, leading to accumulation in serum.   
In order to further test the hypothesis that intestinal inflammation may be 
associated with changes in the gut microflora, which can be detected by changes in 
QSM production, we employed a well-established animal model of colitis and monitored 
the QSM levels. Specifically, we used mice that were orally administered dextran sulfate 
sodium (DSS) for 7 days to induce colitis40,138. DSS-induced murine colitis represents an 
experimental model for human IBD. A group of five mice were treated with DSS, while a 
group of 4 mice served as control. Serum and stool samples from all mice were collected 
at day 0 and day 7. Serum samples were analyzed by using the protocol developed in 
this work. Stool samples were analyzed by using a protocol that was previously 
developed in our lab27. Figure 8 shows the comparison of long chain AHL levels between 
day 0 samples and day 7 samples in control and DSS treated mice. At day 0, before the 
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beginning of DSS treatment, the bioluminescence signals were nearly the same for most 
samples, without distinctions between the two groups of animals, as expected. At day 7, 
the control mice samples exhibited bioluminescence signals either at the same level or 
higher than those at day 0. On the other hand, four out of five DSS treated mice showed 
a marked decrease in bioluminescence signals. Further, it is important to note that a 
similar trend was observed in all animals, with the exception of mouse DSS4, when 
comparing the changes in AHL levels in stool and serum samples; for example, if the 
serum AHL levels increased between day 0 and day 7 in a certain mouse, the stool AHL 
levels also increased in that same mouse. These results further support the feasibility of 
analyzing serum samples for AHL molecules. Although a very limited number of mice 
were employed in this study, the data clearly suggested that, under the conditions of 
colitis, changes in the levels of AHLs occurred that might be related to changes in 
bacterial flora. 
 
Conclusion 
In conclusion, we successfully utilized whole-cell biosensing systems to detect 
AHL molecules in serum samples of IBD patients and animal models. The method was 
standardized using a pool of serum and 1:10 dilution allowed to overcome the serum 
matrix effect. Nanomolar limits of detection were obtained in water as well as in 1:10 
diluted serum. Similar slopes of the dose-response curves obtained in water and 1:10 
diluted serum, indicating that whole-cell biosensing systems can be utilized to detect 
AHLs in serum samples without loss of analytical performance. While we did not yet 
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analyze a substantial number of samples, doing so may enable us to confirm our 
observation that there is a difference between the levels of AHLs in control and IBD 
samples, and between the levels of AHLs in the two types of IBD conditions, UC and CD. 
As we analyze more serum samples, a relationship between the levels of AHLs in serum 
and the status of the disease may be established, thus pointing out at the potential of 
employing AHLs as biomarkers of IBD. Additionally, the ability to detect AHLs in serum 
may also serve in studies aimed at investigating the role and relationship between the 
levels of AHLs in serum and the concentration and activity of paraoxonase enzymes in 
individuals suffering from IBD, which have been suggested to have quorum-quenching 
activity137. These studies should aid in understanding the role of bacteria and, in general, 
the microbiome in IBD. 
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Figure 1. Schematic of LasI/LasR and RhlI/RhlR quorum sensing circuits in P. aeruginosa. 
LasI catalyzes synthesis of 3-oxo-C-12 HSL (triangle), which accumulates in the 
environment. At a threshold level, 3-oxo-C-12 HSL binds to LasR; 3-oxo-C-12 HSL bound 
LasR activates transcription of several virulence genes along with the rhlR gene, which 
encodes for RhlR, thus initiating the RhlI/RhlR quorum sensing circuit. RhlI catalyzes 
synthesis of C-4 HSL (pentagon), which accumulates in the environment and, at a 
threshold level, binds to RhlR. C-4 HSL bound RhlR activates transcription of target genes 
including a subset of virulence genes. Adapted from Miller et al.12. 
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Figure 2. Quorum sensing molecules. (A) N-acyl-homoserine lactones. (B) Autoinducer-2. 
(C) Quinolone signaling molecule. (D) Autoinducing peptides (AIPs). 
(A)  
 
(B)  
 
(C) 
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Figure 3. Undiluted and diluted serum samples were incubated with whole-cell 
biosensing system containing plasmid pSB406 (yellow). Undiluted and diluted serum 
samples were spiked with 1 × 10-7 M C-6 HSL and incubated with whole-cell biosensing 
system containing plasmid pSB406 (green). Blank 1 contains RO filtered water. Blank 2 
contains RO filtered water spiked with 1 × 10-7 M C-6 HSL.  
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Figure 4. Comparison of dose-response curves in clinical samples with standard dose-
response curve. (A) Using solutions of C-6 HSL, a dose-response curve was obtained in 
pooled serum (red) and compared with that obtained in water (black) in the same 
analytical run. C-6 HSL solutions were incubated with whole-cell biosensing system 
containing plasmid pSB406. (B) Using solutions of AI-2, a dose-response curve was 
obtained in pooled serum (red) and compared with that obtained in water (black) in the 
same analytical run. AI-2 solutions were incubated with V. harveyi MM32-based whole-
cell biosensing system.  
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Figure 5. Analysis of serum samples from IBD patients and controls. Yellow – Serum 
samples obtained from healthy volunteers. Red – Serum samples obtained from UC 
patients. Green – Serum samples obtained from CD patients. Short chain AHLs were 
detected using the whole-cell sensing system containing plasmid pSB406. The reported 
signal values are blank-subtracted. 
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Figure 6. LC-MS-MS analysis of serum. (A) A standard mixture of AHLs (1 ng/mL each). 
(B) Mobile phase alone. (C) Pooled serum was extracted using acetonitrile/methylene 
chloride followed by reconstituting in the mobile phase. 
  
(A) 
(B) 
(C) 
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Figure 7. Stability of C-6 HSL in serum stored under various conditions. Serum was 
spiked with (1) 1 × 10-6 M C-6 HSL (yellow) and (2) 1 × 10-7 M C-6 HSL (blue). Control 1 is 
serum spiked with 1 × 10-6 M C-6 HSL and control 2 is serum spiked with 1 × 10-7 M C-6 
HSL. 
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Figure 8. Mice treatment with colitis inducing agent dextran sulphate sodium (DSS). (A) 
Comparison of long chain AHL levels in serum samples before DSS treatment (green) 
and after a 7 day DSS treatment (red). The plotted values are blank-subtracted. 
Horizontal lines indicate the cutoff for each set of values. The cutoff is determined as 
the signal corresponding to 3 standard deviations of the blank. (B) Comparison of long 
chain AHL levels in stool samples before DSS treatment (green) and after a 7 day DSS 
treatment (red). The plotted values are blank-subtracted. Horizontal lines indicate the 
cutoff for each set of values. The cutoff is determined as the signal corresponding to 3 
standard deviations of the blank. 
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Table 1. LC-tandem MS detection of AHLs 
 
AHLs [M + H-101]+ (m/z) [M – H2O]
+ (m/z) 
C-7 HSL 113 196 
3-oxo-C-8 HSL 141 224 
C-8 HSL 127 210 
C-10 HSL 155 238 
C-12 HSL 183 266 
C-14 HSL 211 294 
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CHAPTER FOUR 
DETECTION OF BACTERIAL QUORUM SENSING MOLECULES IN FOOD MATRICES 
Introduction 
 Foodborne illnesses are a major health issue affecting over 15% of the US 
population and resulting in 3000 deaths each year139.  Most of these diseases are due to 
infections caused by viruses, bacteria, and parasites, which enter into the 
gastrointestinal tract by consumption of contaminated food. While diseases caused by 
pathogens, such as Yersinia, Escherichia coli O157:H7, and Listeria have decreased over 
the past few years, those caused by Salmonella and Vibrio have been on the rise140. 
None of these bacterial-related foodborne illnesses have been eradicated, and rather, 
multistate foodborne outbreaks have increased consistently over the past several 
years10. 
 Food contamination can occur at any stage, from farms and slaughter houses to 
distribution at restaurants and shopping centers. The list of edibles that are known to 
carry bacterial contamination includes milk and milk products (such as cheese, yogurt, 
and ice cream), meat products (such as beef, pork, chicken, and turkey), vegetables 
(such as broccoli, lettuce, tomato, and sprouts), eggs, and sea products. In the past, the 
time lag between food production and consumption was relatively short, and therefore, 
chances of food contamination were limited.  Current market demands that food be 
stored for longer durations of time.  To limit bacterial growth, a number of food 
preservation techniques have emerged. For example, milk is pasteurized by heating to 
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high temperatures for short periods of time, and vegetables and meat are packaged 
under a variety of controlled conditions.  
 Initial processing by heat treatments reduces the initial bacterial content 
considerably, and the recontamination thereafter determines shelf-life. The most 
commonly employed approach to improve shelf-life of foods involves focusing on 
packaging techniques that extend the viability of the food. Various methods are 
employed that utilize air, vacuum, or modified atmosphere packaging of food. A method 
is chosen depending on the food product and market requirements. For example, 
packaging with high oxygen content helps preserve the color of retail cut meat; 
however, shelf-life is only slightly improved141. On the contrary, storage of meat 
products in 100% carbon dioxide ensures maximum shelf life, but can cause 
discoloration142. Furthermore, different packaging methods differently affect the growth 
of various species of bacteria. In aerobic packaging a variety of bacteria can grow, 
including Pseudomonas spp., Brochothrix thermosphacta, Lactobacillus spp., and many 
Enterobacteriaceae, while in vacuum and anaerobic packaging a few bacteria can 
survive, the most common being Lactobacillus spp. Other factors impacting the growth 
of bacteria include temperature and pH. Many foods are amenable to storage at low 
temperatures, which, in most cases, extends the shelf-life by decreasing the rate of 
bacterial growth. Temperature studies involving Jalapeño peppers143, shell eggs144, 
pork145, and minced beef146 have shown that the bacterial count was lower when food 
was stored at low temperature as compared to when it was stored at higher 
temperatures. Moreover, while a decrease in pH may favorably reduce the growth of 
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certain bacteria, that is not the case for the Lactobacillus spp. , which produce lactic 
acid, and thus, contribute to a reduction of the pH147.  
 The economic and health consequences, caused by food spoilage, have fueled 
efforts to detect early food spoilage and contamination. The bacterial count is one of 
the indicators that food may either be spoiled or prone to spoilage. The number of 
bacteria is often counted by determining the colony forming units (cfu) per gram of food 
under consideration; when the cfu value from a food sample is higher than that of 
standard/unspoiled food, it is indicative of potential food spoilage. The determination of 
cfu has been used in a number of applications, ranging from evaluation of food spoilage 
to assessment of the effectiveness of an agent for prevention of food spoilage148,149. 
However, cfu determination cannot be considered accurate as it neglects the bacterial 
population that cannot grow under the conditions of the cfu assay. Hence, other ways 
to count bacteria are employed, which include epifluorescence, an ATP bioluminescence 
assay, impedance measurements, and spectroscopic methods. When using 
epifluorescence, bacteria present in the food sample are concentrated on a filtration 
membrane, stained with a fluorescent dye, and enumerated using epifluorescence 
microscopy150,151. Indirect measurement of bacterial load in the sample can be obtained 
by measuring ATP concentration. Highly sensitive ATP determination is achieved using 
firefly luciferase, which in the presence of adenosine 5’-triphosphate (ATP), converts the 
substrate luciferin to oxyluciferin emitting a photon of light. Non-microbial ATP present 
in food is first removed either by enzymatic degradation152 or by filtration153, and 
microbial ATP is then detected.  
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The bacterial load can also be estimated by measuring the change in current in 
the microbiological media as bacteria grow, consume nutrients, and release such highly 
charged molecules as fatty acids, amino acids, and organic acids. Impedance 
measurements have been used to measure bacteria in raw milk154, frozen vegetables155, 
meat156, and fish157.  Bacteria also release a range of volatile compounds during their 
growth that are different depending on the bacterial species.  Thus, the volatile 
compounds can be considered a fingerprint of the type of bacteria present in a sample; 
by using an array of sensors responsive to various volatile compounds, Blixt et al. 
evaluated the degree of spoilage of vacuum packaged beef158. Methods such as Fourier 
transform infrared (FT-IR) and short-wavelength-near-infrared (SW-NIR) spectroscopy 
have been used to discriminate among pathogens159 and to detect overall food 
spoilage160, respectively. Furthermore, molecular methods, such as the polymerase 
chain reaction (PCR)161 and real-time PCR162, have been employed to detect food 
spoilage caused by specific microorganisms.  
 Bacteria are known to communicate with one another by producing, releasing, 
and responding to small signaling molecules14. When these molecules reach a critical 
threshold concentration corresponding to a given cell density, certain specialized genes 
are expressed. This type of cell-to-cell communication, termed quorum sensing (QS), 
enables bacteria to regulate specialized phenotypes, including virulence factors 
production and biofilm formation, depending on their population size. Among the 
quorum sensing molecules (QSMs) employed for bacterial chatter are N-acyl 
homoserine lactones in Gram-negative bacteria, autoinducing peptides (AIPs) in Gram-
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positive bacteria, and autoinducer-2 (AI-2) in both Gram-negative and Gram-positive 
bacteria. 
Bacteria are involved in the spoilage of food by producing food degrading 
enzymes, whose synthesis and release are regulated by the QS circuitry in many 
bacteria. Hence, bacterial QS might play a crucial role in food spoilage. Another 
significant QS regulated function is biofilm formation, which enables bacteria to 
propagate and establish themselves on the contaminated surfaces by generating 
complex three-dimensional structures where bacteria are included and protected from 
other bacteria and antibiotics163. A biofilm is defined as “microbially derived sessile 
community characterized by cells that are irreversibly attached to a substratum or 
interface or to each other, are embedded in a matrix of extracellular polymeric 
substances that they have produced, and exhibit an altered phenotype with respect to 
growth rate and gene transcription”164. In the biofilm mature state, the extracellular 
matrix is composed of exopolysaccharides, proteins, dead bacteria, and DNAs. Biofilms 
can be comprised of single bacterial species; however, mixed species biofilms dominate 
under most environmental conditions165,166. Some features of biofilms include primitive 
homeostasis, metabolic cooperation, exchange of genetic material, and circulatory 
systems to facilitate waste disposal. Such biofilms can be present on the surface of 
foods as well as on food processing surfaces and equipment. Examples of food-related 
biofilm-forming bacteria include Bacillus spp. from dairy processing plants167 and 
Salmonella from poultry processing plants168, among others. In few foodborne 
pathogens, biofilm formation has been linked to quorum sensing. Specifically, wild type 
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Hafnia alvei, a milk and meat pathogen that employs the AHL-based QS signaling for 
communication, regularly forms biofilms, while a mutant from the same bacterial 
species Hafnia alvei that is unable to synthesize AHLs, cannot form biofilms169. 
In light of the evident important role that QS plays in food contamination and 
spoilage, we deemed necessary to further explore the relationship between food 
spoilage and QS. Methods that can detect QSMs in food samples should allow for the 
early detection and prevention of food contamination. Conventional physical-chemical 
methods, such as separation techniques coupled to various detection principles, are 
cumbersome, time-consuming, and often not sufficiently sensitive to detect QSMs at 
low concentrations.  In addition, most of these techniques require extensive sample 
preparation, expensive instrumentation, and specialized technical personnel170. On the 
other hand, whole-cell biosensing systems are sensitive, with limits of detection in the 
micromolar to nanomolar ranges27, rapid, easy to use, cost-effective, and require simple 
instrumentation and minimal or no sample preparation. Furthermore, they are 
amenable to multiplexing and high-throughput analysis, as well as on-site monitoring 
when incorporated into portable devices. 
To that end, we utilized cell-based biosensing systems to develop an analytical 
method for the quantitative detection of QSMs in food matrices such as milk and 
ground beef. Specifically, we employed Vibrio harveyi MM32-based whole-cell 
biosensing system for the detection of AI-2, and two E. coli-based whole-cell biosensing 
systems, one containing plasmid pSB406 and the other containing plasmid pSB1075, for 
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the detection of short chain AHLs and long chain AHLs, respectively. Most food products 
are either in liquid or solid form. We chose milk as an example of a liquid food, and 
ground beef as an example of a solid food. Initially, the whole-cell biosensing systems 
were optimized for use in these food matrices. The effect of the sample matrix on the 
performance of the sensing system’s response was evaluated by performing recovery 
studies.  In addition, the limit of detection, dynamic range, and reproducibility afforded 
by the sensing system in the two food samples were determined. In order to simulate 
food spoilage conditions, we employed food contaminating bacteria that naturally 
produce QSMs. For this purpose, we contaminated milk and ground beef samples with 
Escherichia coli AB1157 strain and Hafnia alvei 718 strain. The former communicates 
through and produces AI-2, while the latter employs the short chain AHL regulatory 
system. To demonstrate the validity of our proposed method in the detection of 
bacterial contamination, we then employed our cell-based biosensing systems in the 
quantitative determination of both types of quorum sensing molecules in milk and 
ground beef. 
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EXPERIMENTAL SECTION 
Materials. AHLs, N-hexanoyl-DL-homoserine lactone (C-6 HSL) and N-dodecanoyl-DL-
homoserine lactone (C-12 HSL), ampicillin, and kanamycin were purchased from Sigma 
(St. Louis, MO). AI-2 was purchased from Omm Scientific (Dallas, TX). Luria Bertani (LB) 
broth, nutrient broth, and vitamin free casamino acids were purchased from Difco 
(Sparks, MD). Acetonitrile used in all experiments was of HPLC grade and was from VWR 
Scientific (Pittsburgh, PA). The 96-well microtiter plates were purchased from Costar 
(Corning, NY). Lean ground beef (93% lean), fat free milk (skim milk), 2% fat milk, and 
whole milk were purchased from a local grocery store. Reverse osmosis (RO) filtered 
water (Milli-Q water purification system, Millipore, Bedford, MA) was utilized in all 
experiments as needed. 
The microcentrifuge was purchased from Eppendorf (Westbury, NY). The orbital 
shaker incubator was purchased from Fisher Scientific (Fair Lawn, NJ). Bioluminescent 
measurements were performed using the FLUOstar OPTIMA microplate reader (BMG 
Labtech, Durham, NC). The Spectronic 21D spectrophotometer used to measure optical 
density of the bacterial cultures was purchased from Artisan Scientific (Champaign, IL). 
Plasmids, bacterial strains, and culture conditions. The plasmids pSB406 and pSB1075 
were originally provided by Dr. Paul Williams (University of Nottingham, Nottingham, 
UK) and previously transformed in E. coli JM109 cells. The transformed AHL-sensing cells 
were then stored at -80 °C as glycerol stocks. Fresh cell cultures were obtained from the 
glycerol stocks, grown in LB media (100 µg/mL ampicillin) overnight, in the orbital 
shaker at 37 °C, 250 rpm, and then refreshed and allowed to grow until an optical 
119 
 
density at 600 nm (OD600nm) of 0.45-0.50 was reached. V. harveyi MM32 (AI-2-sensing 
strain), E. coli AB1157 (AI-2-producing strain), and H. alvei 718 (AHL-producing strain) 
were purchased from American Type Culture Collection (Manassas, VA). Cultures of V. 
harveyi MM32 cells were setup in autoinducer bioassay (AB) media containing 30 µg/mL 
kanamycin and grown overnight in the orbital shaker at 30 °C, 250 rpm. Overnight 
cultures were then diluted 1:100 to obtain an OD600nm of 0.01-0.02. The procedure to 
prepare AB media has been described elsewhere129. E. coli AB1157 cells were grown in 
LB media (no antibiotic) at 37 °C, 250 rpm, while H. alvei 718 cells were grown in 
nutrient media (no antibiotic) at 30 °C, 250 rpm, in the orbital shaker. 
Dose-response curves. Commercially available N-acyl-homoserine lactones were 
dissolved in acetonitrile to obtain 1 x 10-2 M stock solutions, which were serially diluted 
with RO filtered water to obtain standard solutions at concentrations ranging from 1 x 
10-4 M to 1 x 10-8 M. A 1% solution of acetonitrile in RO filtered water was used as blank 
(upon addition to the bacterial culture, the acetonitrile final concentration of 0.1% did 
not result toxic for the sensing cells). A volume of 10 μL of each of these solutions was 
added in triplicate to a 96-well white polystyrene microtiter plate containing 90 µL/well 
of cell culture grown to an OD600nm of 0.45-0.50. C-6 HSL solutions were employed for 
the whole-cell sensor with pSB406, while C-12 HSL solutions were employed for the 
whole-cell sensor with pSB1075. The microtiter plate was then incubated in the orbital 
shaker at 37 °C, 175 rpm for two hours. The produced bioluminescence was then 
measured using the microplate reader. The light intensity was expressed in relative light 
units (RLU). 
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AI-2 aqueous stock solution (3.7 × 10-3 M) was serially diluted with RO filtered 
water to prepare AI-2 standard solutions at concentrations ranging from 1 × 10-4 M to 1 
× 10-8 M. RO filtered water was used as blank. A volume of 10 μL of each of these 
standard solutions and blank was added in triplicate to a 96-well black polystyrene 
microtiter plate containing 90 µL/well of V. harveyi MM32 cell culture at an OD600 nm of 
0.01-0.02. The microtiter plate was then incubated in the orbital shaker at 30 °C, 175 
rpm for three hours. The produced bioluminescence was then measured using the 
microplate reader. The light intensity was expressed in relative light units (RLU). 
Food sample collection and processing. Food samples used in this study were lean 
ground beef (93% lean), fat free milk, milk with 2% fat, and whole milk. They were 
purchased from a local grocery store. The ground beef sample was further ground, with 
slow addition of water, using a high performance blender to form a uniform suspension. 
The volume of water was then adjusted to prepare a 10% w/v suspension, which was 
stored as 20 mL aliquots at -80 °C. When needed, beef suspension aliquots were thawed 
at room temperature and diluted using RO filtered water. For simplicity, 10% w/v beef 
suspension is referred to as beef suspension in the rest of the manuscript. All milk 
samples were stored at -80 °C in 15 mL aliquots. When needed, milk aliquots were 
thawed at room temperature and diluted using RO filtered water. 
Food sample dilution study. To test for potential matrix effect of the food samples on 
the whole-cell sensing systems response, an aliquot of 10% w/v beef suspension was 
serially diluted with RO filtered water to obtain 1:10, 1:100, and 1:1000 dilutions. At 
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each dilution step, proper care was given to vortex the suspensions thoroughly to avoid 
settling of meat particles. Similarly, a fat free milk aliquot was serially diluted with RO 
filtered water to obtain 1:10, 1:100, and 1:1000 dilutions. To test the beef and skim milk 
samples with the E. coli whole-cell biosensing systems containing plasmids pSB406 or 
pSB1075, a 10 µL volume of the above beef suspensions and milk solutions was added in 
triplicate to a microtiter plate followed by addition of 90 µL/well of the sensing bacterial 
cells grown to an OD600nm of 0.45-0.50. Similarly, to test the beef and skim milk samples 
with the V. harveyi MM32 whole-cell biosensing system, a 10 µL volume of the above 
beef suspensions and milk solutions was added in triplicate to a microtiter plate 
followed by addition of 90 µL/well of the sensing bacterial cells at an OD600nm of 0.01-
0.02. A reference dose-response curve with the respective QSM was included in each 
analytical run. The assays were performed as described above for standard dose-
response curves. 
Evaluation of food matrix effects in the presence of QSMs. Beef suspensions and skim 
milk solutions at various dilutions, prepared as described above, were spiked with a 
fixed concentration of QSM, namely 1 × 10-6 M C-6 HSL, 1 × 10-6 M C-12 HSL, or 1 × 10-5 
M AI-2. A 10 µL volume of each of these spiked samples was added in triplicate to a 
microtiter plate followed by addition of 90 µL/well of the corresponding sensing cell 
suspension. The assays were then performed as described above.  
Dose-response curves in sample matrix. Acetonitrile 1 × 10-2 M stock solutions of C-6 
HSL and C-12 HSL were serially diluted with 1:10 beef suspension or undiluted skim milk 
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to obtain AHL solutions of concentrations ranging from 1 × 10-4 to 1 × 10-9 M. A 1% 
acetonitrile solution in each of the above food sample dilution was used as blank. 
Similarly, 3.7 × 10-3 M aqueous stock solution of AI-2 was serially diluted with 1:10 beef 
suspension or undiluted skim milk to obtain AI-2 solutions of concentrations ranging 
from 1 × 10-4 to 1 × 10-9 M. 1:10 beef suspension and undiluted skim milk served as 
blanks. A 10 µL volume of each of the obtained solutions and blanks was added in 
triplicate to a microtiter plate followed by addition of 90 µL/well of cell culture of the 
respective biosensing system. The assays were performed as described above. A 
reference dose-response curve was included in each analytical run.  
Monitoring of QSM production by E. coli AB1157 and H. alvei 718. E. coli AB1157 was 
grown in LB media (no antibiotic) overnight, in the incubator shaker at 37 °C, 250 rpm. 
H. alvei 718 was grown in nutrient media (no antibiotic) overnight, in the incubator 
shaker at 30 °C, 250 rpm. Overnight cultures were diluted 1:100 and 1:15, respectively, 
with fresh media and allowed to grow in the above conditions. One-milliliter fractions of 
culture media were collected at each hour for 8 hours, followed by collection of an 
overnight fraction. The collected fractions were centrifuged at 13,000 rpm for 5 minutes 
at room temperature and the supernatants were stored at -20 °C until analyzed. To 
measure the QSMs produced, 10 µL of each supernatant sample was added in triplicate 
to the wells of a microtiter plate followed by addition of 90 µL of the proper sensing cell 
suspension, prepared as described above. For E. coli AB1157 culture media fractions, V. 
harveyi MM32 sensing cells were used, while for H. alvei 718 culture media fractions, 
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the whole-cell sensing systems containing pSB406 and pSB1075 were employed. The 
assays were performed as described above.  
Food contamination study. To investigate QSM production in food matrices, we 
contaminated beef and skim milk with AHL producing H. alvei 718 and AI-2 producing E. 
coli AB1157, respectively. An overnight grown culture of E. coli AB1157 was added into 
10% w/v beef suspension to obtain a 1:100 dilution of the original culture and allowed 
to grow in the incubator shaker at 37 °C, 250 rpm.  Similarly, an overnight grown culture 
of H. alvei 718 was added into 10% w/v beef suspension to obtain a 1:15 dilution of the 
original culture and allowed to grow in the incubator shaker at 30 °C, 250 rpm. 
Procedures similar to those used for contaminating beef suspension were employed to 
contaminate skim milk. One-milliliter fractions of media from each of the contaminated 
food samples were collected at each hour for 8 hours, followed by collection of an 
overnight fraction. The collected fractions were centrifuged at 13,000 rpm for 5 minutes 
at room temperature and the supernatants were stored at -20 °C until analyzed. To 
measure the QSMs produced, the supernatant samples were assayed using the 
respective whole-cell biosensing systems as described above.  
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Results and discussion 
The purpose of our work was to demonstrate the feasibility of employing whole-
cell biosensing systems to detect bacterial presence as a measure of spoilage and 
contamination of foods.  Three different specific biosensing systems were employed in 
the determination of two different classes of quorum sensing molecules, AI-2 and AHLs 
(long and short chain), in ground beef and milk. The AI-2 quorum sensing regulatory 
system is used by both Gram-negative and Gram-positive bacteria, while AHL-based 
communication is employed by Gram-negative bacteria.  The role of QS in food spoilage 
was validated by identification of QSMs in spoiled foods171,172. For example, bacterial 
presence and AHL molecules were detected in vacuum packed meat samples171. In 
addition, AI-2 has been identified in food samples such as fish, tomato, carrots, tofu, and 
milk172. The methods employed in both of the above studies were qualitative and time 
consuming due to a need for processing steps and the fact that detection relied on color 
development by reporter cells upon exposure to AHLs171. To the best of our knowledge, 
this is the first application of cell-based biosensing systems in the quantitative detection 
of QSMs in food samples aimed at aiding in the early detection of food contamination 
and prevention of food spoilage. 
In this work, we employed E. coli whole-cell biosensing systems containing 
plasmids pSB406 and pSB1075 to detect short and long chain AHLs, respectively.  For AI-
2 detection, we used a whole-cell biosensing system that is based on V. harveyi MM32. 
The plasmids pSB406 and pSB1075 bear recognition and regulatory elements that are 
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originally derived from Pseudomonas aeruginosa AHL-dependent RhlR/RhlI and 
LasR/LasI QS systems23. Plasmids pSB406 and pSB1075 carry the promoters PrhlI and PlasI, 
respectively, as well as the genes rhlR and lasR, encoding for the recognition/regulatory 
proteins RhlR and LasR, respectively. In addition, both plasmids contain the luxCDABE 
cassette that is under transcriptional control of the respective promoters. The luxCDABE 
genes encode for bioluminescent bacterial luciferase and the enzymes catalyzing the 
synthesis of the luciferase substrate (Figure 1a). The plasmids are lacking the rhlI and 
lasI genes that code for the AHL synthase enzymes, thus, exogenous AHLs need to be 
supplied in order for the sensing cells to produce bioluminescence. When AHLs are 
present in the environment of the sensing cells, they bind to the recognition/regulatory 
proteins, triggering the expression of luciferase and other enzymes part of the luxCDABE 
cassette.  This results in the production of bioluminescence in a manner proportional to 
the concentration of AHLs present. The whole-cell biosensing systems based on plasmid 
pSB406 and pSB1075 had been previously characterized in our laboratory and employed 
to detect AHLs in saliva and stool samples27. V. harveyi MM32 is a mutant of wild-type V. 
harveyi BB120, a marine bioluminescent bacterium that controls light emission through 
multiple QS systems. Strain MM32 was genetically modified to only emit 
bioluminescence in response to AI-2 and not to produce its own AI-215; therefore, light 
emission is only triggered by AI-2 present in the environment of the cells. When AI-2 
binds to its recognition element, the periplasmic binding protein LuxP, the binding event 
triggers a cascade of phosphorylation and de-phosphorylation processes in a number of 
proteins that control the expression of luxCDABE, responsible for bioluminescence, 
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along with other genes (Figure 1b). Thus far, V. harveyi MM32 has been used as a 
reporter strain in bioassays for a number of applications – to evaluate QS regulated 
functions173, to screen compounds for agonistic and antagonistic activities57, and to 
identify bacteria that produce AI-2174. Herein, we employed V. harveyi MM32 to develop 
a whole-cell biosensing system for quantitative detection of AI-2. Due to the high 
sensitivity and selectivity demonstrated by the above whole-cell biosensing systems for 
AHL and AI-2 detection, we utilized them as sensitive and rapid tools for the analysis of 
QSMs in various food matrices. The levels of QSMs should correlate with the extent of 
bacterial contamination and serve as indicators of food spoilage. 
In our study, milk and ground beef were chosen as food representative models 
to investigate whether whole-cell biosensing systems could be used with liquid as well 
as solid foods. Initially, the analytical parameters of the biosensing systems were 
determined using standard solutions of QSMs in RO water (Table 1). The limits of 
detection for each analyte were found to be 1 × 10-9 M. In addition, dynamic ranges of 
at least three orders of magnitude were obtained with all biosensing systems. At least 
three sets of experiments were performed to verify reproducibility, both with standard 
solutions and in food matrix.  
Next, we evaluated the effect exerted by the food sample matrices on the 
whole-cell biosensing systems response. Being solid, ground beef was mixed with RO 
filtered water and using a grinder, a 10% w/v suspension (referred to as beef 
suspension) was prepared. As can be seen from Figure 2a-2c, when beef suspension was 
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incubated with whole-cell biosensing systems, bioluminescence signals lower than those 
of the controls were observed. Such decrease was probably due to components of the 
sample matrix diminishing the ability of the system to emit bioluminescence. The matrix 
effect was eliminated when beef suspension was diluted 1:10, 1:100, and 1:1000. At 
these dilutions, bioluminescence signals were similar to those of the controls, 
confirming that dilution was necessary and that a 1:10 dilution was sufficient to 
eliminate the matrix effect. Recovery studies were performed by spiking the beef 
suspension with a known concentration of a QSM standard solution. A complete signal 
recovery was observed when employing a 1:10 dilution of beef suspension (Figure 3a-
3c).  
To evaluate the performance of the biosensing systems in the beef matrix at 
various concentrations of QSMs, dose-response curves using a 1:10 dilution of the beef 
suspension were obtained and compared to the dose-response curves obtained in water 
during the same analytical run (Figure 4). The slopes of the dose-response curves 
obtained in the 1:10 beef suspension were nearly identical to those of the reference 
dose-response curves for all three sensing systems. Therefore, we concluded that short 
chain AHLs in the range of 1 × 10-5 M to 1 × 10-9 M, long chain AHLs in the range of 1 × 
10-6 M to 1 × 10-9 M, and AI-2 in the range of 1 × 10-5 M to 1 × 10-9 M can be detected in 
1:10 beef suspension using our whole-cell biosensing systems. The results obtained 
prove that these biosensing systems could be employed to detect QSMs in solid foods, 
such as beef, with minimal sample processing.  
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Similar studies were carried out to investigate the effect of matrix on QSM 
detection in skim milk.  When undiluted skim milk was incubated with the whole-cell 
biosensing systems, we observed an emission of bioluminescence signal similar to that 
of the controls. Further, dilutions of skim milk did not alter the bioluminescence signals 
(Figure 5). However, when milk was spiked with fixed concentrations of QSMs, followed 
by incubation with the respective sensing cells, increases in bioluminescence were 
observed in spiked milk samples as compared to the controls; the controls consisted of 
aqueous solutions with the same fixed QSM concentrations (data not shown). Dose-
response curves obtained in skim milk also showed higher bioluminescence emission 
than those obtained with reference dose-response curves in the same analytical run 
(Figure 6). The observed increase in bioluminescence could be due to the presence of 
very small amounts of fat (<0.5%) and slight acidity of the skim milk, which might 
increase the solubilization and stability of the QSMs. Fatty acids present in the milk may 
help better solubilize AHLs, thus enhancing their bioavailability to the sensing cells. This 
effect would be more pronounced as the hydrophobicity of AHLs increases. This 
conforms to our observation that a larger increase in bioluminescence was observed 
with long chain AHLs than with short chain AHLs.  
To further evaluate the effect of fat content in milk, we spiked and analyzed two 
additional types of milk (whole milk, 2% fat milk), along with skim milk, which differ in 
fat content. We observed that as the fat percentage increased, bioluminescence also 
increased, thus supporting improved AHL solubility and bioavailability in the presence of 
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fat. As the pH effect is concerned, lower pH values are known to enhance the stability of 
AHLs, by reducing lactonolysis175.  
To further prove that our whole-cell biosensing systems can be employed in food 
analysis, the next step of the study was to detect QSMs in simulated spoiled food 
samples that were subjected to bacterial contamination. We chose E. coli AB1157 and H. 
alvei 718 as model organisms, given that they produce AI-2 and AHLs, respectively, to 
artificially contaminate skim milk and beef suspension. First, we characterized the two 
bacterial strains in order to find out the amount of time required for maximum 
production of QSMs. When grown in LB media at 37 °C, E. coli AB1157 produces 
maximum concentration of AI-2s in six hours, while maximum production of AHLs in H. 
alvei 718 was observed after five hours growth in nutrient media at 30 °C.  
To perform spoilage studies, overnight separate cultures of E. coli AB1157 and H. 
alvei 718 were added into a beef suspension and skim milk, respectively. A 1 mL-volume 
sample was collected hourly, centrifuged to remove debris, and the supernatant 
analyzed for the presence of QSMs using the whole-cell biosensing systems. The results 
obtained with beef suspension contaminated with H. alvei 718 indicating the ability of 
the employed sensing system to detect the produced short chain AHLs are shown in 
Figure 7a. Only minor production of long chain AHLs was observed, which is consistent 
with the fact that H. alvei produces and uses short chain AHLs as QSMs171. Similarly, 
when the beef was contaminated with AI-2 producing E. coli AB1157, our V. harveyi 
MM32 whole-cell biosensing system was able to detect the AI-2 produced in beef 
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(Figure 7b). The same trend was observed when skim milk was contaminated with E. coli 
AB1157 and H. alvei 718, respectively. In sum, these data demonstrate that the whole-
cell biosensing systems can be successfully utilized to detect different QSMs in various 
contaminated food matrices. 
 
Conclusion 
 The incidences of food spoilage and foodborne illnesses have been on the rise, 
with more multistate outbreaks reported each year. There are numerous bacteria 
responsible for the outbreaks and foods that spread the illnesses, thus making the 
source of contamination difficult to identify. However, a feature common to many 
bacteria, including foodborne pathogens, is the production of QSMs. Herein, we 
investigated the feasibility of employing QSMs as quantitative markers of bacterial 
presence in foods. To that end, we have developed an analytical method to detect 
QSMs for early detection of food contamination and prevention of food spoilage in two 
different food matrices, namely beef and milk.  The proposed method is based on the 
use of whole-cell biosensing systems that are sensitive, easy to use, rapid cost-effective, 
and amenable to miniaturization, thus exhibiting potential for high throughput and on-
site analysis.  The optimized method allowed for detection of QSMs in a sensitive 
manner with limits of detection down to nanomolar levels. Additionally, food spoilage 
studies proved that our whole-cell biosensing systems can be successfully employed to 
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detect QSMs in spoiled food, thus suggesting potential usefulness in the early detection 
of food spoilage and prevention of foodborne illnesses.  
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Figure 1. (A) Plasmids pSB406 and pSB1075 contained in E. coli-based whole-cell sensing 
systems for detection of short and long chain AHLs, respectively. (B) V. harveyi AI-2-
based quorum sensing regulatory pathway. V. harveyi MM32 lacks LuxS, thus not 
producing its own AI-2 and only responding to exogenous AI-2.  
(A) 
 
(B)  
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Figure 2. Beef suspension (BS) and its dilutions were incubated with whole-cell based 
biosensing systems. Data shown is the average ± one standard deviation (n=3). 
(A) Whole-cell biosensing system containing plasmid pSB406 for detection of short chain 
AHLs. 
 
(B) Whole-cell biosensing system containing plasmid pSB1075 for detection of long 
chain AHLs.  
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(C) V. harveyi MM32-based whole-cell biosensing system for detection of AI-2. 
 
 
C
on
tr
ol
U
nd
ilu
te
d 
B
S
1:
10
 B
S
1:
10
0 
B
S
1:
10
00
 B
S
0
200
400
600
B
io
lu
m
in
e
s
c
e
n
c
e
 I
n
te
n
s
it
y
(R
L
U
)
135 
 
Figure 3. Effect of beef matrix on the whole-cell sensing systems response in the 
presence of QSMs. Beef suspension and its dilutions containing 1 × 10-6 M of C-6 HSL, 1 
× 10-6 M of C-12 HSL, or 1 × 10-5 M of AI-2 were incubated with whole-cell biosensing 
system containing pSB406, whole-cell biosensing system containing pSB1075, or V. 
harveyi MM32 biosensing system, respectively. Data shown is the average ± one 
standard deviation (n=3).  
(A) Whole-cell biosensing system containing plasmid pSB406 for detection of short 
chain AHLs. 
 
(B) Whole-cell biosensing system containing plasmid pSB1075 for detection of long 
chain AHLs. 
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(C) V. harveyi MM32-based whole-cell biosensing system for detection of AI-2. 
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Figure 4. Standard dose-response curve (black) compared with dose-response curve in 
1:10 beef suspension (red) obtained using (A) whole-cell biosensing system containing 
plasmid pSB406, (B) whole-cell biosensing system containing plasmid pSB1075, and (C) 
V. harveyi MM32-based whole-cell biosensing system. 
(A) 
 
(B) 
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Figure 5. Skim milk and its dilutions were incubated with whole-cell based biosensing 
systems. Data shown is the average ± one standard deviation (n=3). 
(A) Whole-cell biosensing system containing plasmid pSB406 for detection of short 
chain AHLs. 
 
(B) Whole-cell biosensing system containing plasmid pSB1075 for detection of long chain 
AHLs. 
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(C) V. harveyi MM32-based whole-cell biosensing system for detection of AI-2. 
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Figure 6. Standard dose-response curve (black) compared with dose-response curve in 
undiluted skim milk (red) obtained using (A) whole-cell biosensing system containing 
plasmid pSB406, (B) whole-cell biosensing system containing plasmid pSB1075, and (C) 
V. harveyi MM32-based whole-cell biosensing system.  
(A) 
 
(B) 
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(C) 
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Figure 7. Contamination of food matrix with QSM producing bacteria. 
(A) Short chain AHL production in beef suspension contaminated with H. alvei 718, 
as monitored with whole-cell biosensing system containing plasmid pSB406. 
 
(B) AI-2 production in beef suspension contaminated with E. coli AB1157, as 
monitored with V. harveyi MM32 whole-cell biosensing system.  
 
 
  
0 1 2 3 4 5 6
0
5000
10000
15000
Time (h)
B
io
lu
m
in
e
s
c
e
n
c
e
 I
n
te
n
s
it
y
(R
L
U
)
0 1 2 3 4 5 6
0
5000
10000
15000
20000
Time (h)
B
io
lu
m
in
e
s
c
e
n
c
e
 I
n
te
n
s
it
y
(R
L
U
)
144 
 
Table 1. Analytical parameters of the whole-cell biosensing systems. 
Biosensing system Limit of detection (M) Dymanic range (M) 
E. coli pSB406 1 × 10-9 1 × 10-5 - 1 × 10-9 
E. coli pSB1075 1 × 10-9 1 × 10-6 - 1 × 10-9 
V. harveyi MM32 1 × 10-9 1 × 10-5 - 1 × 10-9 
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CHAPTER FIVE 
INTERFERENCE OF GENERALLY RECOGNIZED AS SAFE (GRAS) COMPOUNDS WITH 
BACTERIAL QUORUM SENSING 
Introduction 
The discovery of bacterial communication was paradigm shifting in terms of 
bacteria being viewed as organisms that exert their effects as a community, not as 
independent single cell organisms. Cell-to-cell communication occurs via the synthesis 
and release of small signaling molecules, termed quorum sensing molecules (QSMs) that 
are transported out of the cell and can be detected by bacteria of the same (intra-
species communication) or different species (inter-species communication). Such QSMs 
include N-acyl homoserine lactones (AHLs), autoinducing peptides (AIPs), and 
autoinducer-2 (AI-2), which are utilized by Gram-negative, Gram-positive, and both 
Gram-negative and Gram-positive bacteria, respectively.  This system of communication, 
which bacteria employ to modulate their behavior in a cell-density dependent manner, 
is termed quorum sensing (QS). Specifically, when the cell population reaches a critical 
size reflected by a critical threshold QSM concentration in the environment surrounding 
the cells, certain specialized genes are expressed. Hence, this communication process 
allows a population of bacteria to change the community behavior in response to 
changes in its size. More recently, it has been reported that certain QSMs not only 
mediate bacterial communication, but also interkingdom communication – 
communication between microorganisms and their hosts17,103. Figure 1(a) depicts the 
aforementioned QS phenomenon. QS is utilized by both pathogenic and non-pathogenic 
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Gram-positive and Gram-negative bacteria25,176,177. Employing QS, bacteria regulate 
various functions such as sporulation, swarming motility, biofilm formation, and 
production of virulence factors and antibiotics. Among these phenomena, QS regulation 
of virulence in human pathogens such as Staphylococcus aureus, Pseudomonas 
aeruginosa, and enterohaemorrhagic Escherichia coli, has been well documented178. 
Bacterial infections are generally treated with antibiotics; however abuse of use 
of antibiotics in humans and animals that humans consume has caused the emergence 
of a number of antibiotic resistant bacteria179. This has created the need for the 
identification of classes of new antibacterial compounds that are efficient in attacking 
the aforementioned resistant bacteria.   To that end, the discovery of compounds that 
may interfere with bacterial communication may provide with a potential alternative to 
current classes of antibacterial drugs52,180. Molecules that can interfere with QS should 
be able to mislead the bacteria about their surrounding environmental conditions, and 
therefore, affect their growth and behavior181. In the past few years, a number of such 
molecules have been identified. For instance, some synthetic analogs of AI-2 were found 
to act as agonists in Vibrio harveyi, while others were antagonists in P. aeruginosa182. 
More recently, modified imidazolines have been reported to inhibit QS33. The list of such 
interfering compounds is extensive and there are several possible mechanisms of 
interference as pointed out in  a recent review by Ni et al.52 One of the most significant 
advantages of using QS interfering molecules as a means to limit bacterial growth and 
pathogenicity is that QS interfering molecules, unlike antibiotics, do not directly kill the 
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bacteria and, therefore, do not add evolutionary pressure to develop resistance against 
interfering molecules183,184. 
 To date several molecules that interfere with QS have been identified, but their 
use in practical applications is limited because of potential side-effects on human 
health. An approach to address this issue is to test compounds that are safe to consume, 
or known to improve the quality of food products, as QS interfering agents185-187. The 
United States Department of Food and Drug Administration maintains a list of food 
additives that are considered safe and approved suitable for consumption. These 
substances are classified as Generally Recognized As Safe (GRAS). Sources of GRAS 
substances include angelica, basil, bergamot, chamomile roman, chamomile german, 
cinnamon bark, citrus rind (all), clary sage, clove, coriander, dill, eucalyptus, 
frankincense, galbanum, geranium, ginger, grapefruit, hyssop, juniper, jasmine, bay 
laurel, lavender, lemon, lemongrass, lime, melissa (lemon balm), marjoram, myrrh, 
myrtle, nutmeg, orange, oregano, patchouly, pepper, peppermint, petitgrain, pine, 
rosemary, rose, savory, sage, sandalwood, spearmint, spruce, tarragon, tangerine, 
thyme, valerian, vetiver, and ylang ylang, among others. 
Phenolic compounds, which are known to protect the plants from pathogens188, 
constitute a key ingredient of a number of GRAS substances. The three major classes of 
phenolic compounds are tannins, flavonoids, and lignins. Among them, flavonoids have 
a variety of beneficial biological properties and, therefore, are the most studied among 
all189. To date, a limited number of compounds originating from GRAS substances have 
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been shown to affect QS. For example, Niu et al. have reported that cinnamaldehyde, an 
ingredient of cinnamon, inhibited the bacterial growth in sub-millimolar ranges36. In 
addition, tannic acid, which is abundant in oak bark, antagonized QS in 
Chromobacterium violaceum as well as reduced biofilm formation in Proteus mirabilis190. 
In another study, garlic extract and p-coumaric acid were proven to act as antagonists in 
the QS systems of various bacteria such as Escherichia coli, Chromobacterium violaceum, 
Agrobacterium tumefaciens, Pseudomonas putida, and Pseudomonas chlororaphis191.  
Phenolic compounds originating from GRAS substances are under investigation 
at the College of Agriculture of the University of Kentucky; some of them have been 
shown to possess antimicrobial properties192 and are being considered for use as food 
preservatives. However, the mechanism of action of these compounds is not known. We 
postulated that they may act by interfering with bacterial QS. There are a number of 
ways in which a molecule can interfere with QS; Figure 2 represents some of them. 
Specifically, we hypothesized that test GRAS compounds 1) may affect the 
concentration of QSMs produced by food contaminating bacteria or 2) may act as 
agonists or antagonists in the QS systems of bacteria. The former may occur if QSM 
synthesis is inhibited. In order to test this hypothesis, we selected 12 compounds that 
had shown antimicrobial effect, and incubated each of them with cultures of QSM 
producing bacteria. QSM production was then monitored in the culture media at 
different time intervals using a panel of bacterial whole-cell sensing systems designed to 
quantitatively respond to AI-2, short chain AHLs, and long chain AHLs, respectively. 
These experiments allowed us to detect the amount of QSMs that the cultured bacteria 
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produced and verify if GRAS compounds affected the QSM synthesis. To test the latter, 
we performed experiments to determine if the GRAS compounds had an effect on the 
QS response of the above sensing bacteria, both, in the presence and absence of QSMs. 
These studies provided insight into the mode of action of GRAS compounds based on 
their effects on the QS sensing/regulatory elements of the whole-cell biosensing 
systems.  
 
Materials and methods 
Materials. AHLs, N-hexanoyl-DL-homoserine lactone (C-6 HSL) and N-dodecanoyl-DL-
homoserine lactone (C-12 HSL), ampicillin, kanamycin, and compounds originating from 
GRAS substances, namely curcumin, capsaicin, thymol, thymoquinone, coumarin, 
ascorbic acid, p-coumaric acid, t-cinnamic acid, tannic acid, eugenol, quercetin, and o-
dianisidine, were purchased from Sigma (St. Louis, MO). AI-2 was purchased from Omm 
Scientific (Dallas, TX). Luria Bertani (LB) broth, nutrient broth, and vitamin free casamino 
acids were purchased from Difco (Sparks, MD). Acetonitrile used in the experiments was 
of HPLC grade and was purchased from VWR Scientific (Pittsburgh, PA). The 96-well 
microtiter plates were purchased from Costar (Corning, NY). The microcentrifuge was 
purchased from Eppendorf (Westbury, NY). The orbital shaker incubator was purchased 
from Fisher Scientific (Fair Lawn, NJ). Bioluminescent measurements were performed 
using the FLUOstar OPTIMA microplate reader (BMG Labtech, Durham, NC). 
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Plasmids, bacterial strains, and culture conditions. The plasmids pSB406 and pSB1075 
were originally provided by Dr. Paul Williams (University of Nottingham, Nottingham, 
UK) and previously transformed in E. coli JM109 cells. The transformed AHL-sensing cells 
were then stored at -80 °C as glycerol stocks. Fresh cell cultures were obtained from the 
glycerol stocks, grown in LB media (100 µg/mL ampicillin) overnight, in the orbital 
shaker at 37 °C, 250 rpm, and then refreshed and allowed to grow until an optical 
density (OD) at 600 nm of 0.45-0.50 was reached. V. harveyi MM32 (AI-2-sensing strain), 
E. coli AB1157 (AI-2-producing strain), and Hafnia alvei 718 (AHL-producing strain) were 
purchased from American Type Culture Collection (Manassas, VA). Cultures of V. harveyi 
MM32 cells were setup in autoinducer bioassay (AB) media containing 30 µg/mL 
kanamycin  and grown overnight in the orbital shaker at 30 °C, 250 rpm. Overnight 
cultures were then diluted 1:100 to obtain an OD (600 nm) of 0.01-0.02. The procedure 
to prepare AB media has been described elsewhere129. E. coli AB1157 cells were grown 
in LB media (no antibiotic) at 37 °C, 250 rpm, while H. alvei 718 cells were grown in 
nutrient media (no antibiotic) at 30 °C, 250 rpm, in the orbital shaker. 
Dose-response curves. Commercially available N-acyl homoserine lactones were 
dissolved in acetonitrile to obtain 1 x 10-2 M stock solutions, which were serially diluted 
with RO filtered water to obtain standard solutions at concentrations ranging from 1 x 
10-4 M to 1 x 10-8 M. A 1% solution of acetonitrile in RO filtered water was used as blank 
(upon addition to the bacterial culture, the acetonitrile final concentration of 0.1% did 
not result toxic for the sensing cells). A volume of 10 μL of each of these solutions was 
added in triplicate to a 96-well white polystyrene microtiter plate containing 90 µL/well 
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of cell culture grown to an OD (600 nm) of 0.45-0.50. C-6 HSL solutions were employed 
for the whole-cell sensor with pSB406, while C-12 HSL solutions were employed for the 
whole-cell sensor with pSB1075. The microtiter plate was then incubated in the orbital 
shaker at 37 °C, 175 rpm for two hours. The produced bioluminescence was then 
measured using the microplate reader. The light intensity was expressed in relative light 
units (RLU). 
 AI-2 aqueous stock solution (3.7 × 10-3 M) was serially diluted with RO filtered 
water to prepare AI-2 standard solutions at concentrations ranging from 1 × 10-4 M to 1 
× 10-8 M. RO filtered water was used as blank. A volume of 10 μL of each of these 
standard solutions and blank was added in triplicate to a 96-well black polystyrene 
microtiter plate containing 90 µL/well of V. harveyi MM32 cell culture grown to an OD 
(600 nm) of 0.01-0.02. The microtiter plate was then incubated in the orbital shaker at 
30 °C, 175 rpm for three hours. The produced bioluminescence was then measured 
using the microplate reader. The light intensity was expressed in relative light units 
(RLU). 
Monitoring of QSM production by E. coli AB1157 and H. alvei 718. E. coli AB1157 was 
grown in LB media (no antibiotic) overnight, in the incubator shaker at 37 °C, 250 rpm. 
H. alvei 718 was grown in nutrient media (no antibiotic) overnight, in the incubator 
shaker at 30 °C, 250 rpm. Overnight cultures were diluted 1:100 and 1:15, respectively, 
with fresh media and allowed to grow in the above conditions. One-milliliter fractions of 
culture media were collected at each hour for 8 hours, followed by collection of an 
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overnight fraction. The collected fractions were centrifuged at 13,000 rpm for 5 minutes 
at room temperature and the supernatants were stored at -20 °C until analyzed. To 
measure the QSMs produced, 10 µL of each supernatant sample was added in triplicate 
to the wells of a microtiter plate followed by addition of 90 µL of the proper sensing cell 
suspension, prepared as described above. For E. coli AB1157 culture media fractions, V. 
harveyi MM32 sensing cells were used, while for H. alvei 718 culture media fractions, 
the whole-cell sensing systems containing pSB406 and pSB1075 were employed. The 
assays were performed as described above. 
Solubility study and preparation of GRAS compounds solutions. While the selected 
GRAS compounds are soluble in several solvents, the cell based biosensing systems 
employed in this work have been characterized in terms of behavior in the presence of 
water and acetonitrile. Therefore, when solubility properties allowed, we prepared 
solutions of GRAS compounds in either of the two solvents. Tannic acid, eugenol, and 
ascorbic acid were dissolved in RO filtered water to obtain 10 mg/mL stock solutions. A 
set of 10 mg/mL stock solutions of coumarin, p-coumaric acid, t-cinnamic acid, 
capsaicin, thymoquinone, and thymol were prepared in acetonitrile. Curcumin was not 
completely soluble either in water or acetonitrile at 10 mg/mL; therefore, a 1 mg/mL 
stock solution in acetonitrile was prepared. A 10 mg/mL stock solution of o-dianisidine 
was prepared in dimethyl sulfoxide (DMSO). Quercetin was dissolved in 0.1 N NH4OH to 
obtain a 10 mg/mL stock solution. The GRAS compound stock solutions were serially 
diluted with RO filtered water to obtain the desired range of concentrations. Table 1 
lists the GRAS compounds, their structures, solvents used to dissolve them, and the 
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concentration ranges that were tested. All of the GRAS compound solutions were 
evaluated in the experiments described below along with the respective controls. For 
each compound, the control was comprised of a RO filtered water solution containing 
an amount of solvent equivalent to that present in the solution of GRAS compound at 
the highest concentration tested. 
Effect of GRAS compounds on the response of the bacterial sensing systems in the 
absence of QSMs. A 10 µL volume of the GRAS compound solutions at various 
concentrations and of the respective controls was added in triplicate to 90 µL of cell 
culture of each of the sensing systems, prepared as described above, in a microtiter 
plate. The assays were performed as described above for standard QSM solutions. A 
matched standard dose-response curve was included in each analytical run. 
Effect of GRAS compounds on the response of the bacterial sensing systems in the 
presence of QSMs. A fixed concentration of QSM was added to each of the GRAS 
compound solutions at various concentrations and to the respective controls. 
Specifically, 2 × 10-6 g/mL C-6 HSL, 2.8 × 10-7 g/mL C-12 HSL, or 1.9 × 10-6 g/mL AI-2 was 
added to each sample. A 10 µL volume of the obtained GRAS compound solutions at 
various concentrations and of the respective controls, containing a fixed concentration 
of QSM, was added in triplicate to 90 µL of cell culture of the corresponding sensing 
system, prepared as described above, in a microtiter plate. The assays were performed 
as described above for standard QSM solutions. A matched standard dose-response 
curve was included in each analytical run. 
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Effect of GRAS compounds on the production of QSMs by E. coli AB1157 and H. alvei 
718. E. coli AB1157 produces AI-2 molecules, while H. alvei 718 produces AHL 
molecules. The two bacterial strains were grown overnight, and the overnight cultures 
were then diluted 1:100 with fresh LB media (E. coli AB1157) and 1:15 with fresh 
nutrient media (H. alvei 718), respectively, as described above. Volumes of 100 µL of 
GRAS compound solutions at various concentrations and of the respective controls were 
added in triplicate to 1-mL aliquots of diluted cell cultures in 14 mL culture tubes; cells 
were then allowed to grow in proper conditions, as described above, for a period of six 
hours (time needed for maximum production of QSMs by bacteria). At the end of this 
time period, the cultures were centrifuged at 12,000 rpm for 5 minutes at room 
temperature. The supernatants were stored at -20 °C until analyzed. The QSMs 
produced were measured in the supernatant samples following the protocol described 
above for monitoring of QSM production by bacteria. 
  
155 
 
Results and discussion 
 Bacterial QS plays a major role in the survival of bacteria and their success in 
colonizing various environments. Since QS is utilized by a number of bacteria, 
interference with QS could be employed as a general tool to mitigate bacterial growth 
and pathogenicity. To that end, a variety of natural and synthetic compounds have been 
investigated and shown to be able to disrupt the bacterial chatter52. The compounds 
that we selected in our study were initially evaluated for antimicrobial properties at the 
College of Agriculture of the University of Kentucky. Specifically, phenolic compounds of 
GRAS origin were tested against some of the most common Gram-positive and Gram-
negative foodborne pathogens to determine their minimum inhibitory concentration 
(MIC) values192. Compounds that exhibited antimicrobial properties were chosen to be 
tested as QS interferants (Table 1). For that, we utilized whole-cell based biosensing 
systems that can quantitatively detect QS signaling molecules, namely AHLs and AI-2. E. 
coli based whole-cell biosensing systems either containing plasmid pSB406 or plasmid 
pSB1075 detect short-chain AHLs and long-chain AHLs, respectively. These 
bioluminescent cell-based sensors have been previously optimized, characterized, and 
employed as analytical tools in our lab to detect AHLs in physiological samples27 and to 
assess QS-interfering characteristics of antibiotics193. V. harveyi MM32 is derived from 
spontaneously bioluminescent marine bacterium V. harveyi, which controls light 
emission by means of various QS systems; in strain MM32, bioluminescence is only 
triggered by AI-2 since the other QS regulatory systems have been silenced15. Recently, 
we developed a whole-cell biosensing system based on V. harveyi MM32 for 
156 
 
quantitative detection of AI-2 (this dissertation, Chapter 5). All three biosensing systems 
contain genetic modifications so that the sensing cells cannot produce their own QSMs 
and, therefore, emit bioluminescence only in response to the QSMs present in the 
environment. Examples of QSMs detected by these biosensing systems are shown in 
Figure 1(b). 
Initial solubility tests were performed to select a suitable solvent for each of the 
GRAS compounds, while making sure that it did not have harmful effects on the 
bacterial sensing cells.  A range of solutions of GRAS compounds were prepared after 
dissolving each compound in appropriate solvent by serially diluting the stock solution 
with RO filtered water.  In order to test the effect of GRAS compounds on the response 
of the whole-cell biosensing systems, these solutions were then incubated with the 
biosensing cells in the absence as well as in the presence of a fixed concentration of the 
respective QSM.  
GRAS compounds, curcumin, capsaicin, eugenol, quercetin, p-coumaric acid, 
thymol, and o-dianisidine did not alter the bioluminescence emitted by all of the sensing 
cells, both, in the absence and presence of the QSM. Namely, the compounds alone did 
not trigger a response in the sensing systems and, when incubated along a fixed 
concentration of QSM, they did not affect the sensing systems’ responses to the 
respective QSMs. As an example, Figure 3 shows the response of the whole-cell sensing 
system that harbors pSB406 to various concentrations of p-coumaric acid (from 1 × 10-4 
g/mL to 1 × 10-9 g/mL), in the absence and presence of 2.0 × 10-7 g/mL C-6 HSL. 
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Decreased signal intensities with 1 × 10-4 g/mL p-coumaric acid were likely due to the 
cell toxicity of the compound. In addition, when the above mentioned GRAS compounds 
were incubated with AHL producing H. alvei 718 cells and AI-2 producing E. coli AB1157 
cells, no change in the QSM production profile of these bacteria was observed. Hence, 
we concluded that these compounds did not interfere with QS, at least through the 
investigated mechanisms, that is, interaction with QS recognition/regulatory proteins 
and effect on QSM synthesis. 
Thymoquinone is known to inhibit the formation of bacterial biofilms194; 
however, its mechanism of action is not known. A potential mechanism may involve 
interference with bacterial QS. Therefore, we employed whole-cell biosensing systems 
to investigate if thymoquinone interferes with QS. In our study, we found that 
thymoquinone affected the bioluminescence response of the biosensing system 
harboring plasmid pSB1075, both, in the absence and presence of C-12 HSL (Figure 4). 
The increase in bioluminescence observed with 1 × 10-5 g/mL of thymoquinone alone 
(Figure 4a) indicates that the compound induces a response in the sensor and may be 
recognized by the LasR QS recognition/regulatory protein present in the sensing cells, 
thus suggesting potential for interference with QS. The observed decrease in 
bioluminescence, when both 1 × 10-5 g/mL thymoquinone and C-12 HSL are present 
(Figure 4b), suggests that thymoquinone may interfere with the binding between C-12 
HSL and the receptor protein LasR. Based on the overall results, one could speculate 
that thymoquinone may bind to LasR, although causing a less effective response as 
compared to C-12 HSL. The hydrophobic binding pocket of LasR, being more 
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hydrophobic than that of RhlR, may interact with thymoquinone. This might help explain 
the effect on the pSB1075 based whole-cell biosensing system. Further experiments and 
molecular modeling studies are underway to investigate and elucidate the observed 
effects. Thymoquinone did not alter the bioluminescence emitted by the E. coli pSB406-
based and V. harveyi MM32-based whole-cell biosensing systems, both, in the absence 
and presence of the respective QSMs. Additionally, when thymoquinone was incubated 
with AHL and AI-2 producing bacteria, no effect was observed on the QSM production. 
Ascorbic acid has been previously reported to reduce bioluminescence of the AI-
2 reporter strain V. harveyi BB170195. Therefore, we studied ascorbic acid with the V. 
harveyi MM32-based whole-cell biosensing system. In our study, ascorbic acid solutions 
were incubated with V. harveyi MM32 sensing cells in the presence and absence of AI-2. 
We observed that, in both conditions, ascorbic acid at concentrations from 1 × 10-3 g/mL 
to 1 × 10-8 g/mL did not influence the bioluminescence response of the biosensing cells. 
Similarly, ascorbic acid did not induce a response in the developed FRET biosensing 
system for AI-2 detection (this dissertation, Chapter 6). Therefore, we may conclude 
that ascorbic acid does not bind to the LuxP protein. On the other hand, in both 
experiments, with and without AI-2, a sharp decrease in bioluminescence signal was 
observed with 1 × 10-2 g/mL of ascorbic acid, which may be attributed to general toxicity 
of ascorbic acid to the sensing cells (data not shown). Next, ascorbic acid solutions (1 × 
10-2 g/mL to 1 × 10-8 g/mL) were incubated with AI-2 producing E. coli AB1157 cells, and 
cell culture supernatants were analyzed with V. harveyi MM32 sensing cells to measure 
the levels of AI-2 produced. Increased levels of bioluminescence, corresponding to 
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increased AI-2 concentrations, were detected in supernatant samples derived from E. 
coli AB1157 cultures incubated with ascorbic acid at concentrations from 1 × 10-5 g/mL 
to 1 × 10-3 g/mL (Figure 5). These data suggest that ascorbic acid seems to enhance the 
production of AI-2 by E. coli AB1157 cells, although there are currently no clear 
indications that the ascorbic acid metabolic pathway is linked to the AI-2 synthetic 
pathway. Further studies are required to clarify if ascorbic acid acts through a specific 
effect on the QS regulatory system or a general effect on the cell metabolism. Ascorbic 
acid at the concentrations tested did not affect the response of the whole-cell 
biosensing systems containing plasmids pSB406 or pSB1075, both, in the absence and 
presence of the respective AHLs. In addition, ascorbic acid did not influence the AHL 
production by H. alvei 718.  
When t-cinnamic acid at concentrations of 1 × 10-3 g/mL to 1 × 10-9 g/mL was 
incubated with the whole-cell biosensing systems containing pSB406 or pSB1075, in the 
absence of AHLs, a significant increase in bioluminescence was observed at 1 × 10-4 
g/mL and 1 × 10-5 g/mL of t-cinnamic acid (Figure 6). The effect was dose-dependent, at 
least for the sensor bearing pSB1075. These data indicate that t-cinnamic acid may be 
able to bind to the AHL receptors. No data are available at this time to confirm whether 
t-cinnamic acid binds to the AHL-binding site or to other binding pockets on the AHL 
receptors. If the binding was to occur in the AHL-binding site, the fact that the receptors 
have higher affinity for their cognate AHLs would explain why a much higher 
concentration of t-cinnamic acid (1 × 10-5 g/mL) is needed to obtain a detectable 
response, as compared to the cognate AHLs that induce a response at nanomolar levels. 
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t-Cinnamic acid at the concentrations tested did not affect the response of the whole-
cell biosensing systems containing plasmids pSB406 or pSB1075 in the presence of the 
respective AHLs, as well as the response of V. harveyi MM32 sensing system, both, in 
the presence and absence of AI-2. In addition, t-cinnamic acid did not influence either 
the AHL production by H. alvei 718 or AI-2 production by E. coli AB1157. 
Recently, the anti QS activity of tannic acid was reported by Taganna et al.196, 
who demonstrated that tannin-rich methanolic leaf extract of Terminalia catappa 
(tropical almond) inhibited AHL-dependent QS regulated violacein production in 
Chromobacterium violaceum. The same extract also inhibited AHL-dependent biofilm 
maturation in P. aeruginosa. Further, tannic acid and its derivatives are known to inhibit 
biofilm formation in E. coli139 and Proteus mirabilis190. Our studies have confirmed that 
tannic acid interferes with AHL based quorum sensing; however, we observed that the 
sensors bioluminescence response increased as the concentration of tannic acid 
increased. This trend was observed when tannic acid solutions were incubated with 
whole-cell biosensing systems containing plasmid pSB406 or pSB1075 (Figure 7), both, in 
the presence and absence of C-6 HSL or C-12 HSL, respectively. In addition, tannic acid 
also interfered with the AI-2 based QS system as evident by increased bioluminescence 
signals obtained when tannic acid was incubated with V. harveyi MM32-based whole-
cell biosensing system, both, in the presence and absence of AI-2 (data not shown). 
Tannic acid does not have any structure similarities with either AHLs or AI-2. However, it 
has been shown that certain compounds can interfere with QS by binding to the QSM 
recognition proteins in a non-agonistic manner52,140. Therefore, we speculate that tannic 
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acid may interact with the AHL or AI-2 recognition proteins by binding to a site other 
than the ligand binding pocket. No effect was observed on the AHL production by H. 
alvei 718 or AI-2 production by E. coli AB1157. Since tannic acid interferes with QS 
systems of both Gram-negative and Gram-positive bacteria, it may potentially be used 
as a universal molecule to fight bacterial infections. 
Although coumarin is not a GRAS compound, we analyzed it due to its known 
antimicrobial properties. In a study by Ojana et al., coumarin exhibited antimicrobial 
activity against E. coli, P. aeruginosa, and S. aureus197. In addition, coumarin, alone and 
in combination with antibiotics, significantly reduced incidence of local peritoneal 
infections in animal models198. In our study, coumarin did not show any effect on the 
biosensing system with plasmid pSB406, both, in the presence and absence of C-6 HSL, 
as well as on the biosensing system with plasmid pSB1075, both, in the presence and 
absence of C-12 HSL. However, when coumarin solutions were incubated with V. harveyi 
MM32-based whole-cell biosensing system, both, in the presence and absence of AI-2, 
bioluminescence signals higher than those of the controls (no coumarin) were obtained 
between 1 × 10-4 g/mL and 1 × 10-5 g/mL of coumarin (Figure 8). Additionally, when 
coumarin was incubated with E. coli AB1157, higher levels of bioluminescence, 
corresponding to higher AI-2 concentrations, were measured in supernatant samples 
from cultures of E. coli AB1157 exposed to 1 × 10-8 g/mL to 1 × 10-6 g/mL of coumarin. 
No effect on AHL production by H. alvei 718 was observed. The data obtained supports 
that coumarin is capable of interfering with AI-2 dependent bacterial QS, both, by 
interacting with the QS regulatory system and affecting the synthesis of AI-2. 
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Conclusion 
We evaluated twelve compounds for their effect on bacterial QS. Although some 
of them did not exert an effect that we could measure using our whole-cell biosensing 
systems, other compounds, such as, thymoquinone, t-cinnamic acid, ascorbic acid, 
tannic acid, and coumarin affected the bioluminescence response of the bacterial 
biosensing systems. In these biosensing systems, bioluminescence depends on 
activation of QS regulated circuits; therefore, a molecule that causes a change in 
bioluminescence in the sensors may have an effect on the QS systems of naturally 
occurring bacteria. While some of the compounds that influenced bioluminescence are 
structurally related to QSMs, for instance, ascorbic acid and AI-2 are both furanones, 
others are not. Therefore, there must be various ways by which these compounds 
interfere with QS. Further investigation is essential to elaborate on the mechanisms of 
action of the tested compounds. Moreover, animal studies using these GRAS 
compounds should provide further insight into the feasibility of employing them as 
alternatives to antibiotic treatment and as food preservatives. 
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Figure 1. (a) General schematic of quorum sensing in bacteria. For intra-species 
communication, Gram-negative bacteria utilize AHLs and Gram-positive bacteria utilize 
AIPs. For inter-species communication, AI-2 molecules are utilized by both Gram-
negative and Gram-positive bacteria. (b) Chemical structures of AI-2, C-6 HSL, and C-12 
HSL.  
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(b) 
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Figure 2. Interference with QS. Possible interference mechanisms include (1) 
interference with the binding between QSM and its cognate recognition protein, (2) 
interference with activation of gene expression, including genes encoding QSM 
synthases, and (3) degradation of QSM. 
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Figure 3. (a) p-Coumaric acid solutions were incubated with the whole-cell biosensing 
system containing plasmid pSB406 for 2 h at 37 °C, 175 rpm. Blank (0 mg/mL p-coumaric 
acid) contains 1% acetonitrile (v/v). (b) p-Coumaric acid solutions containing 2.0 × 10-6 
g/mL C-6 HSL were incubated with the whole-cell biosensing system containing plasmid 
pSB406 for 2 h at 37 °C, 175 rpm. Blank (0 mg/mL p-coumaric acid) contains 1% 
acetonitrile (v/v), along with 2.0 × 10-6 g/mL C-6 HSL. Upon addition to the biosensing 
cells, the final concentration of C-6 HSL is 2.0 × 10-7 g/mL. 
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Figure 4. (a) Thymoquinone solutions were incubated with the whole-cell biosensing 
system containing plasmid pSB1075 for 2 h at 37 °C, 175 rpm. Blank (0 mg/mL 
thymoquinone) contains 1% acetonitrile (v/v). (b) Thymoquinone solutions containing 
2.8 × 10-7 g/mL C-12 HSL were incubated with the whole-cell biosensing system 
containing plasmid pSB1075 for 2 h at 37 °C, 175 rpm. Blank (0 mg/mL thymoquinone) 
contains 1% acetonitrile (v/v), along with 2.8 × 10-7 g/mL C-12 HSL. Upon addition to the 
biosensing cells, the final concentration of C-12 HSL is 2.8 × 10-8 g/mL. 
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Figure 5. Ascorbic acid solutions, from 1 × 10-2 g/mL to 1 × 10-8 g/mL, were added to 
cultures of AI-2 producing E. coli AB1157 cells. After 6 hours (time required for 
maximum AI-2 production) the cell cultures were centrifuged, and the supernatants 
were analyzed for AI-2 content using the V. harveyi MM32 based whole-cell biosensing 
system. Blank (0 mg/mL ascorbic acid) contained RO filtered water. 
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Figure 6. (a) t-Cinnamic acid solutions were incubated with the whole-cell biosensing 
system containing plasmid pSB406 for 2 h at 37 °C, 175 rpm. Blank (0 mg/mL t-cinnamic 
acid) contains 1% acetonitrile (v/v). (b) t-Cinnamic acid solutions were incubated with 
the whole-cell biosensing system containing plasmid pSB1075 for 2 h at 37 °C, 175 rpm. 
Blank (0 mg/mL t-cinnamic acid) contains 1% acetonitrile (v/v).  
(a) 
0 -5
 1
0

1 
-4
 1
0

1 
-3
 1
0

1 
-3
 1
0

2.
5 
0
200000
400000
600000
t-Cinnamic acid (g/mL)
B
io
lu
m
in
e
s
c
e
n
c
e
 I
n
te
n
s
it
y
(R
L
U
)
 
(b) 
0 -5
 1
0

1 
-4
 1
0

1 
-3
 1
0

1 
-3
 1
0

2.
5 
0
50000
100000
150000
200000
250000
t-Cinnamic acid (g/mL)
B
io
lu
m
in
e
s
c
e
n
c
e
 I
n
te
n
s
it
y
(R
L
U
)
 
 
 
170 
 
Figure 7. (a) Tannic acid solutions were incubated with the whole-cell biosensing system 
containing plasmid pSB1075 for 2 h at 37 °C, 175 rpm. Blank (0 mg/mL tannic acid) 
contains RO filtered water. (b) Tannic acid solutions containing 2.8 × 10-7 g/mL C-12 HSL 
were incubated with the whole-cell biosensing system containing plasmid pSB1075 for 2 
h at 37 °C, 175 rpm. Blank (0 mg/mL tannic acid) contains RO filtered water, along with 
2.8 × 10-7 g/mL C-12 HSL. Upon addition to the biosensing cells, the final concentration 
of C-12 HSL is 2.8 × 10-8 g/mL. 
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Figure 8. (a) Coumarin solutions, from 1 × 10-6 g/mL to 1 × 10-2 g/mL, were incubated 
with the V. harveyi MM32 based whole-cell biosensing system for 3 h at 30 °C, 175 rpm. 
Blank (0 mg/mL t-cinnamic acid) contains 1 % acetonitrile (v/v). (b) Coumarin solutions, 
from 1 × 10-6 g/mL to 1 × 10-2 g/mL, containing 2.0 × 10-6 g/mL AI-2 were incubated with 
the V. harveyi MM32 based whole-cell biosensing system for 3 h at 30 °C, 175 rpm. 
Blank (0 mg/mL t-cinnamic acid) contains 1 % acetonitrile (v/v), along with 2.0 × 10-6 
g/mL AI-2. Upon addition to the biosensing cells, the final concentration of AI-2 is 2.0 × 
10-7 g/mL. 
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Table 1. GRAS compounds and their properties. 
GRAS 
compounds 
Structure Solubility 
Curcumin 
 
Acetonitrile 
Capsaicin 
 
Acetonitrile 
Thymol 
 
Water 
Thymoquinon
e 
 
Acetonitrile 
Coumarin 
 
Acetonitrile 
Ascorbic acid 
 
Water 
p-Coumaric 
acid 
 
Acetonitrile 
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Table 1 (continued) 
 
t-Cinnamic 
acid 
 
Acetonitrile 
Eugenol 
 
Water 
Quercetin 
 
0.1 N ammonium 
hydroxide 
o-Dianisidine 
 
DMSO 
Tannic acid 
 
Water 
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CHAPTER SIX 
BREAKING INTO THE BACTERIAL QUORUM SENSING CIRCUITS: DETECTION OF THE 
AUTOINDUCER-2 VIA A FLUORESCENCE BIOSENSING SYSTEM 
 
Introduction 
 
 Bacteria, both Gram-positive and Gram-negative modulate the expression of 
certain genes in a cell-density dependent manner via the production, release, and 
sensing of small signaling molecules known as quorum sensing molecules (QSMs).  This 
phenomenon, termed quorum sensing (QS), is known to regulate a diverse array of 
functions including the production of virulence factors9,199,200 and antibiotics142,201, 
biofilm formation202, and motility203. Specifically, specialized genes involved in the above 
functions are expressed when a QSM threshold concentration representative of a 
certain population size is reached. The most common types of QSMs are N-acyl 
homoserine lactones (AHLs), autoinducing peptides (AIPs), and autoinducer-2 (AI-2). 
Gram-negative and Gram-positive bacteria employ AHLs and AIPs, respectively, for 
communicating with members of the same species. AI-2 molecules are used by both 
types of bacteria and also involved in communication between species204.  Bacteria are 
not limited to the use of just one type of QSM or QS circuit, and many bacteria utilize 
multiple QS circuits to regulate their various functions205-207. In that regard, Vibrio 
harveyi, a marine bacterium, employs multiple QS systems to regulate multiple 
functions, such as siderophores208 and metalloproteases production209, type III 
secretion210, biofilm formation211, and bioluminescence205. These QS circuits are based 
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on the use of different QSMs (Figure 1A), namely, N-(3-hydroxybutanoyl) homoserine 
lactone (HAI-1), (Z)-3-aminoundec-2-en-4-one (CAI-1), (2S, 4S)-2-methyl-2,3,3,4-
tetrahydroxytetrahydrofuran-borate (BAI-2), and nitric oxide (NO), which was recently 
shown to participate in QS regulation of bioluminescence through a newly discovered 
QS pathway212. HAI-1 is found only in V. harveyi and its close relative Vibrio 
parahaemolyticus, CAI-1 is mostly present in the Vibrio species, while the class of AI-2 
molecules is found in a wide variety of bacterial species and genera211. This suggests 
that HAI-1 is involved in intra-species communication, CAI-1 in intra-genera 
communication, and AI-2 in inter-bacterial communication amongst different species 
and genera. 
 The class of AI-2 molecules, including borated autoinducer-2 (BAI-2), is 
composed by a family of compounds that originate from the precursor 4,5-dihydroxy-
2,3-pentanedione (DPD). In V. harveyi, DPD is formed as a by-product of an enzymatic 
reaction part of a bacterial metabolic pathway.  Specifically, the essential coenzyme S-
adenosyl methionine (SAM) is converted into S-adenosyl homocysteine (SAH) upon 
transfer of methyl groups to DNA, RNA, and proteins48. SAH is toxic to cells as it inhibits 
SAM-dependent methyltransferases213 and is metabolized to S-ribosyl homocysteine 
(SRH) by 5′-methylthioadenosine-SAH nucleosidase as a first step to dampen its toxic 
effects. SRH is subsequently converted into homocysteine by the enzyme LuxS, with 
DPD being formed as a by-product of this enzymatic reaction. DPP is then employed by 
the bacterial quorum sensing circuit to produce AI-2.  The biosynthesis of AI-2 from DPD 
is illustrated in Figure 1B. Under aqueous conditions, DPD undergoes spontaneous 
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cyclization to generate various interconverting hydrated forms, (2R,4S)- and (2S,4S)-2,4-
dihydroxy-2-methyldihydrofuran-3-one (R- and S-DHMF, respectively), as well as 
(2R,4S)- and (2S,4S)-2-methyl-2,3,3,4-tetrahydroxytetrahydrofuran (R- and S-THMF, 
respectively). In the presence of borate, S-THMF is converted into (2S,4S)-2-methyl-
2,3,3,4-tetrahydroxytetrahydrofuran-borate (S-THMF-borate), i.e., BAI-2104. Two of 
these AI-2 molecules, BAI-2 and R-THMF, are known to be utilized as QSMs by Vibrio 
harveyi and Salmonella typhimurium, respectively, while other forms of AI-2 are used by 
other bacterial species15.   
AI-2 serves a vital role in QS-regulated pathways in a number of human and 
foodborne pathogens, including S. typhimurium and various pathogenic E. coli 
strains15,214.  Thus, detection of AI-2 in physiological samples may be critical in the early 
detection of bacterial infections and monitoring of the efficacy of antibacterial therapy. 
To that end, we have developed a rapid, highly sensitive, and selective protein-based 
biosensing system aimed at the detection of AI-2 molecules in physiological samples. 
In V. harveyi, the periplasmic binding protein LuxP is responsible for recognition 
and binding of the BAI-2 molecule. Similar to other periplasmic binding proteins94,215, 
LuxP undergoes a change in conformation when it binds BAI-2, a property that has been 
employed by researchers to create protein biosensing systems for AI-2 detection. For 
example, Rajamani et al. developed a Förster Resonance Energy Transfer (FRET)-based 
system128 in which the gene sequence of the LuxP protein was inserted between that of 
two different variants of the Green Fluorescent Protein, Cyan Fluorescent Protein (CFP) 
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and Yellow Fluorescent Protein (YFP) to create a hybrid CFP-LuxP-YFP fusion protein. 
Upon excitation at 440 nm, CFP emits at 485 nm, while YFP excitation and emission 
wavelengths are 485 nm and 527 nm, respectively.  Thus, excitation of the CFP-LuxP-YFP 
fusion protein at 440 nm causes emission of CFP at 485 nm, which, in turn leads to 
fluorescence resonance energy transfer (FRET) from CFP to YFP, resulting in YFP 
fluorescence emission at 527 nm.  When BAI-2 is present in the environment, it binds to 
the LuxP part of the fusion protein, changes its conformation, and alters the 
fluorescence emission at 527 resulting from the FRET between CFP and YFP.  
Specifically, addition of BAI-2 caused a dose-dependent decrease in FRET of the sensing 
CFP-LuxP-YFP fusion protein that was used to detect the levels of the QSM.  This 
biosensing system responded selectively to BAI-2 with an apparent Kd of 270 nM. In 
another approach, Zhu et al. modified the LuxP protein with environmentally sensitive 
fluorophores216, such as, 6-acryloyl-2-dimethylaminonaphthalene (acrylodan), 6-
bromoacetyl-2-(dimethylamino) naphthalene (badan), N,N’-didansyl-L-cystine (DDC), 
and Dapoxyl (2-bromoacetamidoethyl)sulfonamide (Dapoxyl). The fluorophores were 
chemically conjugated to Cysteines near the ligand binding site so that upon analyte 
binding, change in the microenvironment surrounding the fluorophore would lead to a 
change in the fluorescence emission. These systems were able to detect BAI-2 at 
micromolar levels.  
The biosensing systems developed by Rajamani et al. and Zhu et al. exhibited a 
selective response to BAI-2, but the detection limits were not sufficient for  their use in 
clinical samples, such as saliva and stool.  Data obtained by us (this dissertation, chapter 
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3) and others119,217, suggests that AI-2 is present in a sub-micromolar to low nanomolar 
range. Physicochemical methods, such as GC-MS124 and LC-MS-MS119, have also been 
employed to detect DPD with limits of detection of 5.6 nM and 0.23 nM, respectively. 
However, DPD must be derivatized with the proper chemical moiety before analysis can 
be performed, negating the usefulness of these methods for direct quantitative 
detection without prior pre-treatment of any physiological sample.  
In order to address the current need for systems that can detect QSMs in 
physiological samples in a quantitative manner, we designed and developed a 
fluorescecce-based sensing system that takes advantage of the exquisite molecular 
recognition properties of the LuxP protein to its ligand, AI-2, coupled with the sensitive 
detection afforded by fluorescence resonance energy transfer methods.  The design of 
our system is based on a combination of genetic fusion methods with site-selective 
incorporation of a fluorophore into selected the amino acids of LuxP.  Specifically, we 
prepared a fusion protein between LuxP and enhanced green fluorescent protein 
(EGFP).  This LuxP-EGFP fusion protein was capable of emitting fluorescent light upon 
excitation at 485 nm, and the fluorescence produced was not significantly altered by the 
presence of AI-2.  This characteristic of the system inspired us to design a FRET 
biosensing system for AI-2 detection that involved labeling the LuxP part of the LUxP-
EGFP fusion protein with a fluorophore. In particular we utilized the fluorophore 7-
diethylamino-3-[N-(2-maleimidoethyl)carbamoyl]coumarin (MDCC) and the fusion of 
the LuxP protein with EGFP as the donor-acceptor pair for FRET.  MDCC, when excited at 
425 nm, transferred energy to EGFP in the LuxP-EGFP fusion protein, causing EGFP 
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excitation and consequent emission with a peak at 507 nm.  Addition of BAI-2 caused a 
dose-dependent decrease in FRET, which translated in a lower fluorescence emission 
signal at 507 nm.  The biosensing system developed was selective to AI-2 molecules, had 
detection limits in the sub-micromolar range, and its utility was validated by 
determining the concentration of AI-2 molecules in human saliva and blood serum. 
 
Materials and Methods 
 
Materials 
Plasmid pGEX-4T-1-LuxP was kindly provided by Dr. Bonnie Bassler (Princeton 
University). Plasmid pEGFP and ExTaq DNA polymerase were purchased from Clontech 
(Mountain View, CA). Plasmid pET28a(+) was purchased from EMD Millipore (Billerica, 
MA). Chemically competent Escherichia coli cells BL21 (DE3) were purchased from 
American Type Culture Collection (Manassas, VA). Pfu DNA polymerase was purchased 
from Promega (Madison, WI). The TOPO TA cloning kit, MDCC, and Microcon YM-10 
centrifugal device were purchased from Invitrogen (Carlsbad, CA). Restriction 
endonuclease enzymes, NheI and BamHI, Calf Intestinal Alkaline Phosphatase, and T4 
DNA ligase were purchased from New England Biolabs (Ipswich, MA). The QIAprep 
Miniprep DNA extraction kit and Nickel-NitriloTriAcetic acid (Ni-NTA) agarose were 
purchased from Qiagen (Valencia, CA). Primers were purchased from Operon 
(Huntsville, AL). AI-2 was purchased from Omm Scientific (Dallas, TX). Isopropyl-β-D-
thiogalactoside (IPTG) was purchased from Gold Biotechnology (Houston, TX). The 
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Bradford protein assay kit was purchased from Bio-Rad Laboratories (Hercules, CA). 
Polystyrene petri dishes and culture tubes were purchased from BD Biosciences (Sparks, 
MD). Boric acid was purchased from Fisher Scientific (Pittsburgh, PA). Sodium Dodecyl 
Sulfate (SDS) was purchased from Curtin Mathesin Scientific (Houston, TX). Luria Bertani 
(LB) media and 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulphonic acid (HEPES) were 
purchased from VWR International (Bridgeport, NJ). Ampicillin, kanamycin, and sodium 
chloride were purchased from Sigma (St. Louis, MO). All solutions were prepared using 
deionized reverse osmosis filtered water (Milli-Q Water Purification System, Millipore, 
Bedford, MA).  
Apparatus 
Cell cultures were grown using an orbital shaker incubator purchased from 
Forma Scientific (Marietta, OH). Cells were harvested using a Beckman J2-MI centrifuge 
(Palo Alto, CA). DNA amplification and overlap Polymerase Chain Reaction (PCR) 
reactions were performed using an Eppendorf Mastercycler personal thermal cycler 
(Hauppauge, NY). Bacterial colonies were grown on agar plates using an Isotemp 
incubator from Fisher Scientific (Pittsburgh, PA). Fluorescence studies were performed 
using a PTI Laserstrobe™ Fluorescence Lifetime Spectrofluorometer (Birmingham, NJ). 
The optical density of bacterial cultures was measured using a Spectronic 21D 
spectrophotometer (Artisan Scientific, Champaign, IL).  
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Isolation and cloning of DNA 
The plasmids pGEX-4T-1-LuxP and pEGFP, respectively, were transformed and 
maintained in E. coli BL21 (DE3) cells. Cultures of pGEX-4T-1-LuxP and pEGFP containing 
cells were grown overnight in LB media supplemented with 100 µg/mL of ampicillin 
using an orbital shaker incubator set at 37 °C and 250 rpm. The DNA from each culture 
was harvested using the Qiagen DNA extraction kit. LuxP DNA was amplified from pGEX-
4T-1-LuxP by PCR using primers 5’-GCTAGCACACAAGTTTTGAATGGGTACTGG-3’ and 5’-
TATTCAGATAATTCAGGTGGAGGTGGATCA-3’. EGFP DNA was amplified from pEGFP by 
PCR using primers 5’-TCAGGTGGAGGTGGATCAGTGAGCAAGGGC-3’ and 5’-
CTCGGCATGGACGAGCTGTACAAGGGATCC-3’. By using these primers, a site for the 
nuclease NheI was introduced at the beginning of the LuxP DNA sequence and a site for 
the nuclease BamHI was introduced at the end of the EGFP DNA sequence. An overlap 
PCR reaction was then carried out using the primers 5’-
TATTCAGATAATTCAGGTGGAGGTGGATCA-3’ and 5’-
TCAGGTGGAGGTGGATCAGTGAGCAAGGGC-3’. A high fidelity Pfu polymerase was used 
for the above PCR reactions. The overlap PCR product was further incubated with ExTaq 
polymerase to introduce A (adenine) overhangs at the 3’ terminus of the amplified DNA. 
The obtained DNA product was then cloned into the TA vector using a TA cloning kit. 
The plasmid ligation product was transformed and maintained in the TOP10F’ cells 
supplied with the TA cloning kit.  The primers used enabled creation of a fusion between 
the DNAs of LuxP and EGFP connected by a linker corresponding to the peptide Ser-Hys-
Hys-Hys-Hys-Ser. Using the restriction enzymes, NheI and BamHI, the LuxP-EGFP DNA 
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was cloned into vector pET28a(+) to obtain plasmid pET28a(+)-LuxP-EGFP, which was 
transformed and maintained in E. coli BL21 (DE3) cells. 
Purification of LuxP-EGFP fusion protein 
A culture of E. coli BL21 (DE3) cells containing plasmid pET28a(+)-LuxP-EGFP was 
grown overnight in LB media supplemented with 30 µg/mL kanamycin using an orbital 
shaker incubator set at 37 °C and 250 rpm. A 4 mL volume of overnight grown culture 
was added to 500 mL of fresh LB media (30 µg/mL kanamycin) and allowed to grow at 
37 °C, 250 rpm until an optical density (600 nm) of 0.40 to 0.50 was reached. The culture 
was moved to an orbital shaker incubator that was set at 16 °C, 250 rpm, and protein 
expression was induced by adding IPTG at a final concentration of 10 mM. The following 
day, the fusion protein was harvested and purified using a Ni-NTA resin drip column. 
The purified protein was analyzed using SDS-PAGE and dialyzed extensively (16 buffer 
changes over 2 days) using a buffer containing 50 mM HEPES and 150 mM NaCL (pH 
7.0). The concentration of the purified protein was determined using the Bradford 
protein assay according to the manufacturer’s instructions. 
DNA and protein sequence analysis 
DNA was isolated from a culture of E. coli BL21 (DE3) cells containing plasmid 
pET28a(+)-LuxP-EGFP using QIAprep miniprep kit and sent for sequencing at the 
University of Kentucky Advanced Genetic Technologies Center. The fusion protein was 
expressed, purified, and analyzed by SDS-PAGE, as reported above. The gel band of the 
protein was digested with trypsin, and LC-ESI-MS-MS analysis was performed using a 
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ThermoFinnigan LTQ linear ion trap instrument at the University of Kentucky Mass 
Spectrometry Facility. The resulting MS-MS spectra were searched in the Swiss-Prot 
protein sequence database using the Mascot search engine to confirm the presence of 
both proteins, LuxP and EGFP.  
Method optimization for FRET signal detection 
The fluorophore MDCC was dissolved in anhydrous dimethyl sulfoxide (DMSO) to 
obtain a 1 × 10-4 g/mL stock solution, which was serially diluted with 50 mM HEPES, 150 
mM NaCl buffer (pH 7.0) to obtain 1 × 10-5 to 1 × 10-9 g/mL MDCC solutions. LuxP-EGFP 
solutions, ranging from 1 × 10-6 M to 1 × 10-10 M, were prepared by serial dilution of the 
purified fusion protein solution using 50 mM HEPES, 150 mM NaCl buffer (pH 7.0). The 
excitation and emission peak wavelengths of MDCC were 425 nm and 475 nm, 
respectively. The excitation and emission peak wavelengths of EGFP in the fusion 
protein were 488 nm and 507 nm, respectively. The overlap between the emission 
spectrum of MDCC and absorption spectrum of the fusion protein, which contained 
EGFP, was determined by using a Varian Cary Eclipse Spectrophotometer. A 900 µL 
volume of MDCC solution, at a fixed concentration, was incubated with 100 µL of fusion 
protein solutions at various concentrations for 15 minutes. The obtained solutions were 
excited at 425 nm and the emission spectra were recorded from 450 nm to 600 nm. The 
optimal FRET, i.e., the maximum transfer of energy from MDCC to the fusion protein, as 
demonstrated by the emission intensity at 507 nm, was observed when 2.5 × 10-7 M 
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MDCC was used in combination with 5 × 10-9 M fusion protein. The resulting FRET 
donor-acceptor solution was referred to as FRET complex.  
Dose-response curve using BAI-2 
The FRET complex contained 90% (v/v) MDCC at 2.5 × 10-7 M concentration and 
10% (v/v) fusion protein at 5 × 10-9 M concentration. A 1 × 10-3 M solution of boric acid 
was prepared in 50 mM HEPES, 150 mM NaCl buffer (pH 7.0). The commercially 
available AI-2 aqueous solution was serially diluted using the 1 × 10-3 M boric acid 
solution to obtain standards of the borate isomeric form (BAI-2) ranging in 
concentration from 1 × 10-4 M to 1 × 10-10 M. A 180 µL volume of the FRET complex was 
incubated with 1.8 µL of BAI-2 solutions at various concentrations in triplicate for a 
period of 3 minutes. The incubation was performed in a 300 µL quartz microcuvette. The 
samples were then excited at 425 nm and the emission spectra were recorded from 450 
nm to 600 nm. A 180 µL volume of the FRET complex with 1.8 µL volume of 1 × 10-3 M 
boric acid solution in 50 mM HEPES, 150 mM NaCl buffer (pH 7.0) served as blank.  
Selectivity studies 
The compounds tested included AI-2, ascorbic acid, and 4-hydroxy-2,5-dimethyl-
3(2H)-furanone (DMHF). AI-2 (3.7 × 10-3 M) and ascorbic acid (1 × 10-3 M) stock solutions  
were prepared in water, while DMHF stock solution (1 × 10-3 M) was prepared in 
ethanol. These stock solutions were serially diluted with 50 mM HEPES, 150 mM NaCl 
buffer (pH 7.0) to obtain 1 × 10-4 M to 1 × 10-10 M solutions. A 1.8 µL aliquot of each 
solution in triplicate was incubated with 180 µL of FRET complex and fluorescence 
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measurements were performed as described above. A 1.8 µL volume of 50 mM HEPES, 
150 mM NaCl buffer (pH 7.0) served as blank. 
Dose-response curves in saliva and blood serum 
Saliva samples were obtained from healthy volunteers. Each saliva sample was 
centrifuged to remove debris and the supernatant was stored at -80 °C until needed. A 
pool of saliva was obtained by mixing equal volumes of individual saliva sample 
supernatants followed by 5 min of vortexing. BAI-2 standard solutions, ranging in 
concentration from 1 × 10-3 M to 1 × 10-9 M, were prepared as described above. A 10 µL 
aliquot of each BAI-2 solution was added to 90 µL of pooled saliva to obtain spiked saliva 
samples ranging from 1 × 10-4 M to 1 × 10-10 M BAI-2 concentration. A 1.8 µL volume of 
the spiked saliva samples was incubated in triplicate with the FRET complex as described 
above. A 10 µL volume of 1 × 10-3 M boric acid solution in 50 mM HEPES, 150 mM NaCl 
buffer (pH 7.0) was added to 90 µL of pooled saliva to serve as a blank.  
Blood serum samples were obtained from healthy volunteers. A pool of serum 
was prepared by mixing equal volumes of individual serum samples followed by 
vigorous vortexing. A 10 µL aliquot of each BAI-2 solution, ranging in concentration from 
1 × 10-3 M to 1 × 10-9 M, was added to 90 µL of pooled serum to obtain spiked serum 
samples ranging from 1 × 10-4 M to 1 × 10-9 M BAI-2 concentration. A 1.8 µL volume of 
the spiked serum samples was incubated in triplicate with the FRET complex as 
described above. Because a serum matrix effect was observed, similar spiking studies 
were repeated by diluting the pooled serum 1:10, 1:25, 1:50, 1:75, and 1:100 with 50 
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mM HEPES, 150 mM NaCl buffer (pH 7.0). A 10 µL volume of 1 × 10-3 M boric acid 
solution in 50 mM HEPES, 150 mM NaCl buffer (pH 7.0) was added to 90 µL of undiluted 
and diluted pooled serum to serve as a blank.  
Detection of AI-2 in saliva and blood serum samples 
 Saliva samples were obtained from healthy volunteers and processed as 
described above. A 1.8 µL volume of each saliva sample was added in triplicate to the 
FRET complex and fluorescence measurements were performed as described above. 
Serum samples were obtained from patients with inflammatory bowel disease (IBD) and 
diluted 1:100 using 50 mM HEPES, 150 mM NaCl buffer (pH 7.0). A 1.8 µL volume of 
each 1:100 diluted serum sample was added in triplicate to the FRET complex and 
fluorescence measurements were performed as described above. A total of 10 saliva 
and 10 serum samples were analyzed. A dose-response curve was included in each 
analytical run and data were plotted using GraphPad Prism 5. AI-2 concentrations in 
samples were calculated after interpolating the FRET ratio values and multiplying by the 
dilution factor. 
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Results and discussion 
  
In this work, we designed and developed a biosensing system to detect the 
quorum sensing autoinducer-2, AI-2, class of molecules. The biosensing system was 
based on the principles of fluorescence resonance energy transfer, FRET, by employing  
a fluorophore attached to a recognition protein as the donor of a donor-acceptor pair 
where the acceptor is a fluorescent protein part of a LuxP-EGFP fusion protein.  
Specifically, MDCC is the donor and EGFP the acceptor. LuxP undergoes a 
conformational change upon binding BAI-2128,218. The X-ray crystal structure analysis of 
LuxP without BAI-2, i.e., apoLuxP and with bound BAI-2, i.e., holoLuxP revealed 
differences in the protein conformation (Figure 2). Hence, we postulated that we could 
detect BAI-2 with high sensitivity and selectivity by employing an appropriate reporter 
system to monitor this conformational change. 
EGFP and its variants are traditionally used as reporter elements in fusion 
protein constructs 219,220. Employing overlap PCR, the two genes, luxP and egfp, were 
joined together at the 3’- terminus of luxP.  The two genes were separated by 18 bases 
that encoded for a six-amino acid peptide linker, to allow for enough flexibility so that 
BAI-2 binding to LuxP was not hindered by EGFP. In addition, to ease the purification 
process, nucleotides encoding for six-His residues to be employed as an affinity 
chromatography tag to bind a Ni-NTA resin column were incorporated at the N-terminus 
of the protein.  The luxP-egfp construct was cloned into the pET28a(+) vector and placed 
under the control of a lac operon, which enabled overexpression of the fusion protein.  
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The use of the fluorophore MDCC, a coumarin derivative, as donor in the FRET 
system was based on our observation that coumarin caused an increase in the 
bioluminescence response of a V. harveyi MM32-based whole-cell biosensing system for 
AI-2 detection (Thesis Chapter 5). In this sensing system, the binding of AI-2 to the 
recognition element, LuxP, triggers a cascade of phosphorylation and de-
phosphorylation events that lead to the expression of the luxCDABE cassette and 
production of bioluminescence. One possible reason for the observed effect of 
coumarin is that it may act as an agonist and bind to the LuxP protein at the BAI-2 
binding site or bind to another binding pocket on the protein. Therefore, we 
hypothesized that MDCC, which is structurally related to coumarin, may also bind to the 
LuxP protein. Additionally, since EGFP is connected to LuxP, it may be in close enough 
proximity to MDCC so that FRET between MDCC and EGFP may occur. Furthermore, 
MDCC was excited at 425 nm, and the emission spectrum was recorded. An absorption 
spectrum for the fusion protein LuxP-EGFP was also obtained. We confirmed that the 
emission of MDCC overlaps with the absorption of the fusion protein, thus deeming it 
suitable as a donor for use in our proposed FRET system (Figure 3).  
In order to optimize the experimental conditions, various molar ratios of MDCC 
and fusion protein were tested; upon exciting at 425 nm, the emission intensities of 
MDCC at 475 nm and LuxP-EGFP at 507 nm were measured. The LuxP-EGFP construct 
alone exhibited background emission at 507 nm when excited at 425 nm; however, in 
the presence of MDCC, the emission intensity of the construct increased. Figure 4 shows 
the emission spectra from three different concentrations of the fusion protein, with and 
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without a fixed concentration of MDCC. An increase in emission intensity of the fusion 
protein was observed with increases in its concentration, both, in the presence and 
absence of MDCC. Protein concentrations greater than 5 × 10-8 M did not show any 
improvement in the FRET ratio, i.e., the ratio of the emission intensities of acceptor and 
donor. Further, we found that a solution of MDCC and fusion protein, at final 
concentrations of 2.5 × 10-7 M and 5 × 10-9 M, respectively, resulted in the highest FRET 
ratio. This solution of LuxP-EGFP and MDCC, which was used in all subsequent 
experiments, is referred to as “FRET complex”. Incubation times longer than 15 min did 
not improve the FRET ratio from the fusion protein-MDCC solution. Therefore, all 
experiments were performed by incubating the FRET complex for a period of 15 min.  
The FRET complex was then incubated with solutions of BAI-2 at concentrations 
ranging from 1 × 10-5 M to 1 × 10-12 M. The BAI-2 standard solutions were prepared 
using 1 × 10-3 M boric acid in 50 mM HEPES, 150 mM NaCl buffer, pH 7.0. It has been 
previously reported that in the biosynthesis of BAI-2, a 4 equivalent amount of borate, 
with respect to the starting material S-ribosylhomocysteine, was sufficient to obtain a 
borate isomer of AI-2104. Hence, we ensured that boric acid was in sufficient excess 
while preparing our BAI-2 standards. The presence of boric acid did not affect the pH of 
the solution221, thus not affecting the properties of the fluorophore and the 
conformation of the LuxP-EGFP fusion.  As shown in Figure 5, as the concentration of 
BAI-2 increased, the acceptor emission peak at 507 nm decreased, while the donor 
emission peak at 475 nm increased; this caused a dose-dependent decrease in the FRET 
ratio. The biosensing system developed herein allowed us to detect BAI-2 at sub-
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nanomolar levels with a limit of detection (LOD) of 1 × 10-10 M, which is the lowest limit 
of detection reported for a LuxP protein-based biosensing system128,216. The limit of 
detection was defined as the analyte concentration that produced a signal lower than 
the average of the blank minus three standard deviations of the blank. In addition, a 
dynamic range of five orders of magnitude and linear response over three orders of 
magnitude was observed (Figure 6).  
To test our hypothesis, which postulates direct binding of MDCC to the LuxP 
protein in the FRET process followed by an observed FRET signal and not to a direct 
interaction of MDCC with EGFP, we performed experiments using MDCC and 
commercially available EGFP.  While maintaining all the experimental conditions  
described above, various concentrations of EGFP were incubated with 2.5 × 10-7 M 
MDCC. When the solutions were excited at 425 nm, no changes in the emission intensity 
of EGFP were observed as compared to EGFP alone, thus showing that the EGFP 
emission intensity was independent of the presence of MDCC. This clearly indicates that 
there are no interactions taking place between MDCC and EGFP that could result in a 
FRET signal. Further, when standard solutions of BAI-2 were added to the solution 
containing MDCC and EGFP, no changes in the emission intensities of MDCC and EGFP 
were observed (data not shown). These results point to the requirement for MDCC to 
bind to LuxP in order to be in close proximity of EGFP for the energy transfer to occur. 
One of the limitations of the previously reported LuxP protein-based sensors is 
their inability to respond to non-borate forms of AI-2128,216. As noted in the introduction, 
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the BAI-2 precursor, DPD, generates various hydrated non-containing boron isomeric 
forms that exist in equilibrium. Rather recently, Globisch et al. reported the existence of 
an additional isomer of DPD222, although currently, only two forms of AI-2 are known to 
take part in QS, namely BAI-2 in V. harveyi and R-THMF in S. typhimurium.  Nevertheless, 
it is speculated that other isomeric forms might also be involved in the quorum sensing 
regulatory pathways of certain bacteria222. To that end, we tested the ability of our 
sensing system to respond to the hydrated forms of DPD. A dose-response curve for 
DPD was obtained by incubating various concentrations of DPD with the sensing system.  
The dose-response curve had a dynamic range of over three orders of magnitude with a 
limit of detection of 1 × 10-9 M (Figure 6). The ability to detect both forms of AI-2 is 
significant as the sensor can be utilized in applications where samples might contain 
borate free as well as borated AI-2.  
The selectivity of our protein biosensing system was evaluated by exposing it to 
(5R)-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one (ascorbic acid) and 5-
methyl-4-hydroxy-3(2H)-furanone (MHF).  The reason for choosing furanone derivatives 
was because of literature reports claiming that furanones affect the AI-2 bacterial 
quorum sensing circuitry, although the mechanisms of action have not been 
elucidated195,223,224. Solutions of these compounds at concentrations ranging from 1 × 
10-5 M to 1 × 10-12 M, were incubated with the protein biosensing system and the 
potential emission due to FRET was observed. Ascorbic acid did not elicit a change in the 
concentration range tested. On the other hand, MHF induced a response in the protein 
biosensing system at concentrations of 1 × 10-6 M and 1 × 10-5 M. Due to solubility 
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constraints, higher concentrations of MHF could not be tested. Based on these 
observations, we conclude that the biosensing system is able to respond to the AI-2 
class of compounds and to structurally related furanones. However, it is important to 
point out that the biosensing system responded to MHF at concentrations at least three 
orders of magnitude higher than that of AI-2 molecules. The response of the sensing 
system to various concentrations of BAI-2, DPD, MHF, and ascorbic acid is shown in 
Figure 6. 
Next we explored the feasibility of employing our sensing system for the 
detection of AI-2 in saliva and blood serum. For that, we investigated potential matrix 
effects by creating pools of saliva and serum samples, respectively, and spiking them 
with various concentrations of BAI-2 to obtain dose-response curves in these matrices. 
As shown in Figure 7, the slope of the dose-response curve obtained in saliva was nearly 
identical to the slope of the dose-response curve obtained in buffer and both curves can 
be superimposed. Serum, on the other hand, caused a shift of over 25 nm in the MDCC 
emission peak. Therefore, serum dilution studies were performed that showed that 
1:100 dilution was necessary in order to effectively eliminate the matrix effect 
mentioned above. As it can be seen from Figure 7, the dose-response curve in 1:100 
diluted serum overlapped with the dose-response curve obtained in buffer.  
We then employed the biosensing system to detect AI-2 molecules in individual 
saliva and serum samples. AI-2 was not detected in any of the 10 blood serum samples 
tested. These results conform to those of our previous study where, using a V. harveyi 
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MM32-based whole-cell biosensing system, we were not able to detect AI-2 in serum 
samples (this dissertation, chapter three). While it is possible that serum does not 
contain levels of AI-2 that are detectable by protein or whole-cell biosensing systems, 
physical-chemical methods119 may be employed to confirm the presence or absence of 
AI-2 in serum. On the other hand, three out of ten saliva samples showed distinct levels 
of AI-2, varying between approximately 1 × 10-8 M and 1 × 10-10 M (Table 1). The 
presence of AI-2 in saliva was also demonstrated in another study using a whole-cell 
biosensing system (this dissertation, Chapter 2). Analysis of additional samples is 
necessary to potentially establish the method developed herein as an analytical tool for 
detection of AI-2 to be employed in the diagnosis and monitoring of bacterial-related 
conditions.  
Conclusion 
We designed and developed a FRET protein-based sensing system for AI-2 
detection, which employed the LuxP protein as the recognition element along with the 
fluorophore MDCC and the photoprotein EGFP, genetically fused to LuxP, as the FRET 
donor-acceptor pair. The biosensing system proved to be rapid, in that it required an 
incubation time with the analyte of only 3 min to obtain a dose-dependent response; 
this represents a significant improvement as compared to conventional physico-
chemical methods. Furthermore, the protein biosensing system described in this work 
has a lower limit of detection for BAI-2 (1 × 10-10 M) than previously reported protein 
biosensing systems employing LuxP combined with synthetic fluorophores216 (1 × 10-6 
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M) or yellow and cyan fluorescent proteins as reporters128 (> 1 × 10-8 M BAI-2). One of 
the main advantages of our biosensing system lies in its ability to respond to non-borate 
forms of AI-2. This broadens the scope of the biosensing system for use in applications 
where detection of non-borate forms of AI-2 is required; for instance, human 
pathogens, such as S. typhimurium, are known to employ non-borate forms of AI-2 for 
QS regulation. Detection of QSMs in clinical samples has attracted attention, especially 
in bacteria related conditions such as cystic fibrosis25 and Crohn’s disease170. We 
demonstrated that the developed biosensing system can be applied to the detection of 
QS AI-2 molecules in saliva and blood serum. In conclusion, our FRET-based protein 
biosensing system offers rapid, sensitive, selective, and quantitative detection of AI-2 
molecules, and has potential to be used in clinical applications.  
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Figure 1(A). Quorum sensing signaling molecules of V. harveyi. (a) HAI-1, (b) CAI-1, (c) 
BAI-2, and (d) NO. (B) Biosynthesis of BAI-2.  
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Figure 2. The 3-D crystal structures of apo-LuxP, without bound AI-2, (left) and holo-
LuxP, with bound AI-2, (right). Protein data bank structures 1ZHH (apo-LuxP) and 2HJ9 
(holo-LuxP). 
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Figure 3. The emission spectrum of MDCC (blue) overlaps with the absorption spectrum 
of LuxP-EGFP (red). 
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Figure 4. Emission spectra of the LuxP-EGFP fusion protein. LuxP-EGFP at 1 × 10-10 M 
(orange), 1 × 10-9 M (green), and 5 × 10-8 M (blue) concentrations in the presence of 2.5 
× 10-7 M MDCC. LuxP-EGFP at 1 × 10-10 M (pink), 1 × 10-9 M (red), and 5 × 10-8 M (white) 
concentrations in the absence of MDCC. Samples were excited at 425 nm. 
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Figure 5. FRET response of construct to BAI-2. A decrease in FRET signal with increase in 
concentration of BAI-2 was observed. The solutions were excited at 425 nm; the 
emission peak wavelengths of MDCC and LuxP-EGFP are 475 nm and 507 nm, 
respectively. The FRET complex contained 2.5 × 10-7 M MDCC and 5 × 10-8 M LuxP-EGFP. 
BAI-2 concentrations were 1 × 10-5 M (red), 1 × 10-6 M (violet), 1 × 10-7 M (green), 1 × 10-
8 M (yellow), 1 × 10-9 M (orange), 1 × 10-10 M (pink), and 1 × 10-11 M (blue). The FRET 
complex with 1 × 10-3 M boric acid (BAI-2 diluent) served as control (white). 
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Figure 6. Dose-dependent response of the protein biosensing system to BAI-2 (red), DPD 
(blue), MHF (black), and ascorbic acid (green). 
-12 -10 -8 -6 -4
70
80
90
100
110
Concentration (M)
N
o
rm
a
li
z
e
d
 F
lu
o
re
s
c
e
n
c
e
 I
n
te
n
s
it
y
 
 
  
201 
 
Figure 7. Comparison of dose-response curves obtained in buffer (red), undiluted saliva 
(blue), and 1: 100 diluted blood serum (black). 
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Table 1. Analysis of clinical samples using FRET based biosensing system. 
Sample AI-2 concentration (M) %RSD 
Saliva 1 2.5 × 10-10 2 
Saliva 2 4.2 × 10-10 6 
Saliva 3 6.9 × 10-9 3 
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CHAPTER SEVEN 
CONCLUSION AND FUTURE STUDIES 
 Similar to higher organisms, bacteria have the ability to communicate with each 
other. This phenomenon, termed quorum sensing (QS), enables bacteria to coordinate 
their behavior in a cell-density dependent manner. Bacteria synthesize small molecules, 
known as quorum sensing molecules (QSMs), which are transported out of the cell and 
can enter other bacteria. By monitoring these molecules, bacteria can monitor the cell-
population density since the QSM concentration in the surrounding environment is 
proportional to the number of bacterial cells. At a certain population size, several genes 
that are under the control of QS regulation are expressed. In many species of bacteria, 
QS controls behaviors such as biofilm formation, antibiotic and virulence factor 
production, swarming motility, and sporulation. 
 Inflammatory Bowel Disease (IBD), which includes Crohn’s disease (CD) and 
ulcerative colitis (UC), is a chronic gastrointestinal inflammatory condition with 
unknown etiology. The involvement of bacteria in IBD is supported by the identification 
of serological markers against microbial antigens and improvement in patient health 
after treatment by antibiotics. In addition, the bacterial flora has been shown to be 
different in healthy individuals and patients with IBD, with less diversity and modified 
relative abundance of species in IBD.  Given that QSMs are bacterial products involved in 
the regulation of functions involved in bacterial pathogenicity, we hypothesized that 
monitoring of the levels of QSMs in physiological samples might provide information on 
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the bacterial load and on the status of the disease, thus offering a non-invasive 
diagnostic tool that can be used for management of IBD as well as other bacteria related 
conditions.  
The first step towards achieving this goal is to develop tools and methods that 
can detect QSMs in physiological samples in a sensitive and selective manner. 
Physiological samples such as saliva, stool, and bowel secretions might contain QSMs at 
concentrations that represent their systemic level. To that end, we developed a method 
to detect QS autoinducer-2 (AI-2) molecules in these physiological samples by 
employing a Vibrio harveyi based biosensing system. Whole-cell biosensing systems 
offer several advantages; for instance, they can withstand a variety of environmental 
conditions (ionic strength of media, wide range of pH) and provide information about 
the analyte bioavailability. Due to their sensitivity and selectivity, whole-cell biosensing 
systems have been used in a variety of environmental and biomedical applications. The 
V. harveyi based whole-cell biosensing system developed in this work encompasses a QS 
regulatory system as recognition element and the bioluminescent luxCDABE gene 
cassette as reporter element. The biosensing system produces bioluminescence in 
response to the presence of AI-2 molecules. Most importantly, the bioluminescence 
produced is proportional to the amount of AI-2 present in the environment of the 
sensing cells. Therefore, by measuring bioluminescence we can quantitate the amount 
of AI-2 present in a sample. By employing the developed method, we obtained limits of 
detection of 25 nM and 50 nM in saliva and stool matrices, respectively. In addition, 
analysis of physiological samples obtained from IBD patients revealed the presence of 
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AI-2. Specifically, different levels of AI-2 were observed in stool samples from different 
individuals; this observation supports the hypothesis that changes in the microflora of 
the inflamed intestine may result in changes in the levels of AI-2. To our knowledge, this 
is the first attempt to quantify AI-2 levels in saliva, stool, and bowel secretion samples 
from IBD patients. 
Furthermore, we investigated blood serum for the presence of QSMs. Saliva and 
stool samples are advantageous to use since they are collected non-invasively; however, 
blood samples only require minimally invasive collection and are commonly employed 
to detect a variety of biomarkers pertaining to several diseases. Additionally, blood is 
also routinely collected from IBD patients to determine various parameters, including 
inflammation status and presence of specific antibodies, and to differentiate between 
CD and UC. Since we were able to detect QSMs, both, N-acyl homoserine lactones 
(AHLs) and AI-2 in saliva and stool samples, we hypothesized that these molecules may 
also enter the blood stream. To that end, we developed analytical methods for the 
detection of QSMs in blood serum by utilizing whole-cell biosensing systems for AHL and 
AI-2 molecules, respectively. E. coli based whole-cell biosensing systems containing 
plasmid pSB406 or pSB1075 were employed to detect short and long chain AHL 
molecules, respectively, while a V. harveyi based biosensing system was used to detect 
AI-2 molecules. The developed methods allowed us to achieve nanomolar limits of 
detection in serum with all three sensors. Most importantly, the analysis of blood serum 
samples from IBD patients and controls revealed differing levels of short-chain AHLs. 
Serum samples of healthy individuals exhibited undetectable levels of short chain AHLs, 
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while IBD samples showed the presence of short chain AHLs with slightly higher levels in 
UC patients as compared to CD patients. Since no previous reports existed that could 
support the presence of AHLs in serum, we deemed it necessary to employ a 
conventional analytical method to validate our findings. To that end, we confirmed the 
presence of AHLs in blood serum by analyzing pooled serum samples using high 
performance liquid chromatography coupled with tandem mass spectrometry. 
Furthermore, when we employed a mice model of colitis, which is representative of 
human IBD, we detected a difference between the levels of AHLs in, both, serum and 
stool samples of colitic mice and control mice. Although a limited number of mice were 
used, this observation supports our hypothesis that microflora perturbations caused by 
acute inflammation can lead to changes in the levels of QSMs.  These findings can serve 
as a basis for further studies aimed at proving the use of QSM detection as a diagnostic 
and monitoring tool for IBD as well as other bacteria-related conditions. 
In addition to whole-cell based biosensing systems for QSM detection, we also 
developed a protein based biosensing system to detect AI-2 molecules. In wild type V. 
harveyi, the borated form of AI-2 (BAI-2) binds to the periplasmic binding protein LuxP, 
which undergoes a change in conformation upon binding. By using techniques of 
molecular cloning, we fused egfp, coding for the enhanced green fluorescent protein 
(EGFP), to the C-terminus of luxP. The LuxP in the LuxP-EGFP fusion protein is able to 
bind to 7-diethylamino-3-((((2-maleimidyl)ethyl)amino)carbonyl)coumarin (MDCC), an 
environmentally sensitive fluorophore. Based on the emission and absorption spectra of 
MDCC and EGFP, we developed a protein biosensing system, LuxP-EGFP-MDCC, 
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exploiting the principle of Förster Resonance Energy Transfer (FRET). In this construct, 
energy is transferred from MDCC to EGFP. The presence of BAI-2, which is the cognate 
molecule of LuxP, causes a decrease in the FRET ratio. Using this system, we achieved a 
limit of detection of 0.1 nM, the lowest obtained using LuxP protein based sensing 
systems and lower than that afforded by the developed whole-cell based biosensing 
system. Additionally, the sensor is selective to the AI-2 class of molecules and is able to 
respond to, both, BAI-2 and non-borated forms of AI-2, thus widening the sensor’s 
utility for applications where AI-2 as well as BAI-2 molecules might be present. 
Furthermore, the protein biosensing system was characterized and optimized for 
detecting AI-2 molecules in physiological samples such as saliva and blood serum. 
In addition to disease detection, monitoring of QSMs can also prove useful for 
early detection of food contamination and, thus, prevention of foodborne illnesses. 
Bacteria are known to thrive on a variety of food surfaces. Moreover, certain foodborne 
pathogens are known to employ QS regulation and QSMs have been found in various 
foods, including milk and meat products. Therefore, detecting QSMs in food samples 
can provide a convenient method for early detection of food spoilage. To that end, we 
developed methods to detect QSMs in food matrices by employing whole-cell 
biosensing systems that can detect AHLs and AI-2 molecules. We selected ground beef 
and milk as model foods. We showed that QSMs can be detected in these foods with 
minimal sample processing, while maintaining the analytical parameters of the sensing 
systems. In addition, we applied the sensing systems to detect QSMs produced in 
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artificially spoiled food samples. This further corroborates that whole-cell biosensing 
systems can be applied to detect food spoilage. 
Finally, we tested a number of compounds originating from Generally 
Recognized As Safe (GRAS) substances for their effect on QS. These compounds were 
previously found to act as antibacterials, although their mechanisms of action have not 
been elucidated. For that, we tested these compounds to evaluate whether they may 
act through interference with bacterial quorum sensing. Such compounds were 
incubated with whole-cell sensing systems alone and in the presence of QSMs. This 
allowed us to assess their ability to induce a response in the sensing systems, as well as 
to interfere with the bacterial sensing systems response to QSMs. Selected compounds 
were also incubated with bacteria that produce QSMs to evaluate their effect on QSM 
synthesis. Our study identified four such compounds, namely ascorbic acid, t-cinnamic 
acid, tannic acid, and coumarin that affected bacterial QS. 
As research at the molecular level in the fields of biology and microbiology 
continues, novel features of bacteria are revealed. QS is one such feature of bacteria 
that has been discovered and studied extensively only over the past two decades. Given 
the close association between bacteria and humans, it is imperative that we enhance 
our understanding of QS. We believe that the ability to detect QSMs represents a step 
towards understanding the intricate workings of bacteria in the human body. While we 
lay the foundation, additional work is necessary to illustrate that QSM detection can be 
utilized as a diagnostic tool. This would involve analysis of large numbers of clinical 
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samples, such as saliva, stool, bowel secretions, and blood serum, as well as tissue 
specimens to ascertain that the levels of QSMs correlate with the status of the disease.  
While in the present work we mainly focused on IBD, in principle, these 
biosensing systems could also be used to detect QSMs in other bacteria-related 
conditions. Furthermore, the developed cell and protein sensing systems could be 
immobilized on optical fibers or incorporated into microfluidic platforms to generate 
portable analytical devices. This would enable the sensing systems to be used in on-site 
applications, such as, in the physician’s office and at the patient’s bedside in hospitals. 
Further enhancements in the protein-based sensing system can be brought 
about by employing a variety of approaches. For instance, the length of the linker 
between the two proteins in the fusion can be changed. A linker length of six amino 
acids was employed in the protein construct described in this work; varying the linker 
length may further improve the sensor’s limit of detection for AI-2 molecules. 
Additionally, the selectivity of the sensor could be tailored in order to enable the 
recognition of individual forms of AI-2. In that regard, it is possible to alter the protein 
construct by employing other variants of the GFP protein, which would facilitate 
multiplex detection.  
QS biosensing systems are ideal for the screening of synthetic as well as natural 
compounds. The list of such compounds is extensive; while we tested a few compounds 
originating from GRAS substances, many other compounds have shown antibacterial 
properties and should be evaluated for their effect on QS. The compounds found to 
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affect QS could then be studied in animal models to investigate their effects in vivo. This 
could be achieved by feeding the animals with a known amount of the QS interfering 
compound for a period of time and then comparing the QSMs levels found in various 
specimens of the treated animals with those of control animals. Bacterial involvement in 
conditions such as IBD is supported by improvement in patient health due to antibiotic 
treatment. It would be interesting to study QS interfering compounds, alone and in 
combination with antibiotics, to determine if they are effective in treating bacterial 
conditions. This hypothesis could also be tested using animal models and evaluating a 
number of circulating molecules and tissue parameters.  
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